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When I first arrived at the Department of Biochemistry, Biophysics and 
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catalysts. So when I heard somebody among my new lab-mates discussing about 
transglycolytic syntheses, gelling polysaccharides, goat antibodies or cloning 
procedures I was quite disoriented. Thanks to Prof. Sergio Paoletti, I had the 
opportunity to perform severa! studies in the amazing field of glycobiology and to get 
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and past experiences, he put his trust on me, gave me hospitality within his research 
group and guaranteed me three years of financial stability. I would like to acknowledge 
my tutor, Dr. Amelia Gamini, because her human and scientific support was very 
important. She taught me to be selective toward those projects that may be fruitful for 
my scientific development and to judge and discuss more critically the results of my 
work. I' m grateful to Dr. Amedeo Vetere for stimulating my scientific curiosity 
involving me in severa! interesting programmes, not last for building the collaboration 
with the Institute for Biotechnology of the University of Hall e-Wittenberg (Germany ). 
I thank Dr. Eleonora Marsich for helping me in resolving so many problems 
concerning protein biosynthesis and purification and for encouraging me also after 
unsuccessful experiments. I gratefully acknowledge Dr. Cristiana Campa because she 
showed me the importance and beauty of analytical chemistry and exhibited a great 
willingness in satisfying ali my demands. I would like to thank also Prof. Rainer 
Rudolph and Dr. Christian Lange who followed me constantly during my foreign four-
months stay in Halle, showing extraordinary care towards my research activity. I am 
thankful to Prof. Doriano Larnba, because he gave me the "magie formula" for protein 
refolding. I express my gratitude to Dr. Anna Coslovi and Dr. Sabrina Semeraro who, 
sharing the sarne PhD route with me, were always close to my bad or good mood. 
Thanks to Dr. Federico Paroni's kind help with cloning experiments, I was able to 
continue working on the Hpylori lysozyme biosynthesis project. I thank all other 
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members of my laboratory because working with them, also in such a narrow piace 
like T21 and Tl7, was and continues to be a real pleasure. I would like to thank also 
the workgroup of Pro f. Enrico Panfili for the nice lunch time we spent together. 
Finally I would like to thank my sister Alessandra for keeping always a 
watchful eye on me, as actually a mother does. I am endlessly grateful to my bizarre 
husband for his contagious sense of humour and for cooking so many dinners for me. I 
can not forget to thank our beautiful families which supported us generously during ali 
these years. 
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Generai introduction 
The subjects coming under systematic study in this issue range over a number 
of biomolecular sciences, such as molecular biology, carbohydrate chemistry, 
analytical biochemistry and protein chemistry, being only apparently uncorrelated. 
Indeed the topi es we dealt with ali merge in a single field, i. e., in the so-called "sweet 
science of glycobiology". The term glycobiology was first coined in 1988 by 
Rademacher, Parekh and Dwek (1), thus indicating that this tender aged discipline 
gained only recently wide acceptance among the scientific community, which 
recognized carbohydrates as fundamental molecules for life on Earth. In their simplest 
form ( as sugar monomers or homopolysaccharides) they serve as primary energy 
source for sustaining life. For the most part, however, carbohydrates exist as complex 
molecular conjugates, hence playing a more intriguing role in biology (2). 
Until recently the study of carbohydrates lagged far behind the structural 
investigation of some other class of biomolecules, such as nucleic acids or proteins. 
Namely the latters have traditionally attracted far more scientific attention and have 
; . ~. 6 
been the main focus of biomolecular research over the past 50 years. These two classes 
of biologica} compounds, accordingly with the "centrai dogma", were considered as 
molecules having unique properties as information-carriers. This universally 
acknowledged rule establishes the direction of the genetic information flow, i. e., from 
DNA to mRNA, and from mRNA to protein (3). DNA is the blueprint of life. lt 
contains the information that is transferred from one generation to the next and acts as 
a template for the synthesis of mRNA. mRNA in turn mediates the production of 
proteins, abundant and versatile molecules whose main function is to catalyze most of 
the reactions in living cells. However, the cascarle of such genetic information does not 
terminate with proteins. In fact, building up a celi, not only nucleic acids and proteins 
are required, but also two other kinds ofbiomolecules: carbohydrates and lipids (3). 
The linearity of protein and nucleic acid polymers and the regularity of the 
bonds (amide and phosphodiester bond respectively) joining each monomeric unit, 
have allowed the development of efficient and reliable tools for their analysis and 
synthesis, essentially aimed to determine their primary structure or sequence. Similar 
tools achievement for carbohydrates has been hampered by their structural and 
chemical complexity. Carbohydrates can polymerize in many shapes and sizes, from 
linear chains to highly branched compounds, bristling with antennae-like arms (4). 
Moreover, these complex glycans, may often appear in conjunction with other types of 
biomolecules, for example with lipids or proteins forming a great variety of hybrid 
macromolecules, called glycoconjugates, such as glycolipids, lipopolysaccharides, 
glycoproteins, peptidoglycans or proteoglycans. Hence, in comparison to DNA and 
protein characterization, the advancement of carbohydrate structure investigation has 
faced unique challenges in the pursuit of developing analytical and biochemical tools 
that clarify their structure-function relationship. Fortunately an increasing and 
concerted effort emerged in the past decades in order to develop technical means 
needed for carbohydrate structure definition. Improvements in mass spectrometry 
combined with the development of enzymatic and chemical tricks have made 
carbohydrate sequencing faster, more reliable and more widely applicable. 
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1.1 Wbat is glycobiology? 
Defined in the broadest sense, glycobiology is the study of structure, 
biosynthesis and biology of saccharides, considered as sugar chains or as integrai part 
of glycoconjugates, which are widely distributed in nature. 
The field of glycobiology ranges from the chemistry of carbohydrates and the 
enzymology of glycan-modifying proteins to the functions of glycans in complex 
biologica! systems. A continuous flow of infonnation between several chemical, 
biochemical and medicai branches is needed for a suitable study of this class of 
compounds and maybe now it becomes slightly clearer why, in our discussion, so 
many research fields will be embraced. 
Glycobiologists state that glycans do represent a third-class of bio-informative 
polymers, next to nucleic acids and proteins. The indication that a more sophisticated 
biologica! role than simply energy suppliers is played by glycans reside in the large 
abundance by which they cover celi surfaces of ali living organisms as well as occupy 
the intracellular spaces constituting the so-called extracellular matrix. Moreover the 
glycan potential for structural diversity and complexity, far greater than that of nucleic 
acids or proteins, is essential for encoding biologica! infonnation (5). The extremely 
high complexity of glycans originated from the high variety of both linkage and 
branching occurrence, lacks by other bio-informative macromolecules. 
1.2 The role of glycans 
Carbohydrates are far away from having a pure decorative function: even 
though it was widely believed that carbohydrates are dull compounds that serve only 
as supporting materials ( e.g. cellulose in plants and chitin in insects) and as energy 
reservoir (glycogen in animals), their main non-trivial task is to act (i) as structural 
components or (ii) as signalling molecules. It should not be difficult to imagine that a 
large spectrum of biologica! functions is assigned to glycans, given their astonishing 
structural variety and complexity (6). 
(i) The structural roles of glycans are evident if their protective, stabilizing, 
organizational and barrier functions are considered. The glycans attached to matrix 
molecules, such as proteoglycans, are important for the maintenance of tissue 
structure, porosity and integrity. As an example, the extemal location of glycans on 
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most glycoproteins can provide a generai shield, protecting the underlying polypeptide 
from recognition by proteases or antibodies. Glycans are also involved in the proper 
folding of newly synthesized proteins in the endoplasmic reticulum (ER) and in the 
subsequent maintenance of protein solubility and conformation. As another example, 
we recall the naturally occurring hyaluronic acid, an heteropolysaccharide present as a 
large molecular weight molecule (see section 1.5.1), which is found in the tissue of 
higher animals, in particular as intracellular space filler (7). lt is normally found in 
greatest concentrations in the sinovial fluid of articular joints (8) where it plays an 
important role in tissue hydration and lubrification: indeed, when not bound to other 
molecules, it is able to hold water giving a stiff and viscoelastic substance. 
(ii) The trafficking roles of carbohydrates become particularly important in 
building up complex multicellular organs and organisms, which requires interactions 
of cells with one another and with the surrounding matrix. Glycoconjugates are in fact 
ubiquitous: they are found inside the cells, both in the cytoplasm and subcellular 
organelles, and within celi membranes as well as in extracellular fluids and matrices. 
Ali cells in nature carry a dense array of covalently attached glycans on their surfaces. 
They normally do not exist as free-standing polymers, but are rather assembled onto 
specific proteins to form protein-glycan conjugates. Since most glycans are attached on 
the outer surface of celluiar and secreted macromolecules, their location is such to 
enable them to modulate or mediate several cell-cell and cell-matrix interactions, 
transmitting important biochemical signals into and between cells (6, 9). In this way 
these sugars guide the cellular communication that is essential for normal celi and 
tissue development (10, 11). Thanks to this particular location, this complex 
carbohydrates are actively involved in celi proliferation and differentiation too (12). 
Glycans also manage interactions between different organisms ( e.g. between host and 
parasite) and play a key role in molecular recognition and adhesion (13-16). Owing to 
their constant presence at the cell-extracellular interface, glycans are located in an 
environment of many proteins such as growth factors, cytokines, immune receptors, 
enzymes and others. Another important function attributed to glycans is to control and 
modulate protein activity at the cell-extracellular interface by specific sugar-protein 
interactions. Glycans may act as well as scaffolds mediating protein-protein 
interactions. 
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1.3 Techniques in glycobiology 
Due to their inherent structure complexity, carbohydrate sequence 
determination is not easily achieved. Despite carbohydrate biosynthesis is a non-
template driven process, nowadays there is much evidence that the particular 
composition of glycans attached to each core protein is not random, but results from 
the coordinated action of a large repertoire of sugar-transferring enzymes, called 
glycosyltranferases, which leads glycans to be expressed as an ensemble of diverse 
structures. Glycans always need to be considered as a heterogeneous mixture of 
different chemical structures when isolated from cells and tissues. 
Without highly efficient methods for analyzing and synthesizing carbohydrates, 
detailed knowledge of the structure and function of each carbohydrate moiety is 
basically very hard, if not impossible at ali. Knowing the fine structure of complex 
carbohydrates is clearly criticai in order to understand their unique biologica! function. 
Up to now, arriving at this knowledge has been arduous and technically challenging. 
Techniques used in glycobiology must face really many difficulties. 
First of all obtaining a given glycan in sufficient amount for analysis is often a 
major problem, especially when dealing with poorly expressed glycoproteins. This 
materia! paucity complicates carbohydrate detection through conventional analytical 
techniques, such as nuclear magneti c resonance (NMR) or Ii qui d chromatography. The 
issue of limited starting materia! is not a trivial matter. Although scientists dealing 
with DNA or proteins can artificially synthesize multiple copies of their biologica! 
molecules using laboratory shortcuts such as the polymerase chin reaction (PCR) and 
recombinant protein expression, no a.Iilplifying procedures do exist for glycans. 
A second problem concems the sample purity: glycobiologists must also 
contend with the microheterogeneity of sugar structures. Purifying these sugar variants 
is not simple. Multiple separation steps are typically required to obtain pure samples; 
this process, however, often undercuts yields. 
A third problem refers to glycan structure stability: some compounds are 
particularly susceptible to fragmentation when high-energy methods, such as mass 
spectrometry (MS), are used to examine their structures. Other carbohydrate chains, if 
subjected to chemical hydrolysis, may loose functional groups of low stability and 
modify their chemical structure. 
lO 
Unlike DNA and proteins, no technology has been developed to allow 
carbohydrates to be sequenced using straightforward techniques. lnstead, sugar 
structures must be solved by a combination of procedures that bave traditionally 
required considerable technical skill. Among them we can list separation 
methodologies such as gas (GC) or liquid (LC) chromatography and capillary 
electrophoresis (CE), or the new forms of MS ( equipped with soft-ionization sources) 
and the increasingly more sensitive technique of NMR as great tools for separating or 
analyzing glycan mixtures at analytical or preparative scale. These technical 
approaches make often use of an array of hydrolyzing enzymes ( exo-glycosidases) that 
specifically cleave individuai sugar monomers from one end of more or less complex 
sugar chains. 
Given the immense structural variability of glycan structures, which assumes a 
particular degree of sophistication in mammalian systems, and their frequently low 
abundance, glycobiology will continue demanding the best out of analytical tools and 
methodologies. 
1.4 Glycans and disease 
Not surprisingly, given the importance of carbohydrates in biology, defects in 
their metabolism can bave disastrous consequences (17, 18). For example, in 
Gaucher's and Fabry's diseases, inherited mutations in carbohydrate-processing 
enzymes, cause glycolipids to accumulate in certain tissues, leading to kidney, heart 
and brain damages. The inability to fonn certain glycoproteins results in another set of 
inherited diseases, called congenita! disorders of glycosylation, which can result in 
symptoms ranging from chronic diarrhea to life-threatening neurologica! problems. 
There are some human diseases involving a class of linear and sulphated 
polysaccharides of varying length and chemical composition, known as heparan 
sulphates, which result from having an excess of the glycans. Among these, there are 
various lysosomal storage diseases, the so-called mucopolysaccharidoses, where a lack 
of active heparan sulphate-degrading enzymes leads to a toxic buildup of glycans that 
damages tissues. These inherited diseases are disabling and sometimes fatai to 
children. Other pathologies arise from heparan sulphate deficiency. One well-studied 
disease is the hone disorder clinically known as hereditary multiple exostoses. People 
Il 
with this skeletal disorder have many hone protuberances, or exostoses. The genetic 
cause of the disease is a mutation that disables a glycosyltranferase responsible for the 
extension of heparan sulphate chains. In between these two extreme situations -
having excess or a restricted amount of heparan sulphate - there is a third and more 
common scenario: heparan sulphate may simply be formed in an inappropriate amount 
and structurally defective. Indeed, the uncontrolled expression of glycans is implicated 
in many common human ailments, from neurodegenerative diseases, such as 
Alzheimer's and possibly Parkinson's diseases, to growth dysplasias, cardiovascular 
disease and even cancer (19-21). 
As another example, knockouts of the N-acetylglucosamine- or N-
acetylgalactosamine-transferase, involved in the early stage biosynthesis of two classes 
of glycans (respectively N- and 0-glycans) covalently attached to proteins that 
undergo glycosylation, a very common posttranslational modification, often result in 
severe phenotypes, namely developmental disorders, tmmune disfunction, 
inflammation deficits and even embryonic lethality (22). As such mutations affect the 
majority of cells and their glycoproteins is well understood. But transgenic mice 
containing a knockout of later-stage enzymes, such as fucosyl- or sialyl-tranferases, 
which are involved in celi type diversification and capping of N- and 0-linked glycans, 
provide more discrete and consequently more difficult-to-detect phenotypes (23, 24). 
More generally, sugar structures are also targets for pathogens seeking entry 
into the cells of their host. As an example, given the similarities between epithelial celi 
surface carbohydrates and human milk oligosaccharides, the latter may act as soluble 
receptors for different pathogenic microorganisms in the respiratotry, gastrointestinal 
and urinary tract, preventing the attachment of microbes to epithelial cells, thus 
increasing the resistance ofbreast-fed infants (25). 
Carbohydrates are also important for tumour development because cancer cells 
alter their surface glycoprotein expression to evade the immune system. By cloacking 
themselves with the right assortment of glycoproteins, the tumour cells can invade 
other tissues without being identified as aliens. In other words, tumour cells show a 
different glycosylation pattern of cell-surface glycoproteins with respect to the 
"normal" cells from the same tissue or organ (26). Since many of these glycoproteins 
are excreted, altered glycosylation has the potential to be used as biomarker for cancer, 
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especialiy in eariy stages of the neopiastic deveiopment (27, 28). For this reason it is 
important to view cancer not only mereiy at the genetic Ievei, but also from the 
perspective of giycosylation. 
Nevertheless, neariy ali type of cancers invoiving solid tumours progress 
through similar stages. These include oncogenesis, where cancerous cells originate, 
tumour growth and finaliy metastasis. The carbohydrate microarchitecture of 
glycoconjugates is perturbated at each of these stages, and, as pointed out earlier, since 
glycans ( especialiy those pertaining to the extracellular matrix) bind to a muititude of 
proteins invoived in celi proiiferation and differentiation, without a careful 
orchestration of their biosynthesis, uncontrolled and malignant celi growth becomes 
likeiy. 
1.5 Biomolecules under investigatio~ 
The groups of biomoiecuies that are examined here are nameiy specific 
carbohydrate chains or giycans, commonly occurring in nature, that assemble with 
proteins either through covalent bond, fonning giycoproteins, or through weaker 
interactions, such as hydrogen bonds, van der Waals or electrostatic forces, originating 
sugar-carbohydrates compiexes. 
The study of this Iatter class of moiecuiar compounds has proven that 
carbohydrates (either alone or in conjunction with other biomolecules) act as 
recognition detenninants in a great variety of physiological processes and that the 
messages encoded by their structures are deciphered from complementary sites Iocated 
on carbohydrate-binding proteins, historically calied Iectins (29). 
1.5.1 Common saccharide motifs 
Monosaccharides are de fin ed as polyhydroxyaldehydes or 
polyhydroxychetones and represent the basic structural monomers of ali glycans. 
Hence a monosaccharide can not be hydrolyzed into a simpler uni t. A sugar monomer 
has an aldehyde group at one end of the carbon chain or a chetone group on an inner 
carbon. These two types of monosaccharides give rise to the so-called aldoses or 
ketoses. Free monosaccharides can exist as open chain or ring fonn at five (furanose) 
or six (pyranose) centres, but ring forms are the rule in oligosaccharides, which are 
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linear or branched chains of monosaccharides attached to one another via a glycosidic 
linkage. The ring form of a monosaccharide generates a new asymmetric ( anomeric) 
centre. 
A glycosidic linkage involves the attachment of a monosaccharide to another 
sugar residue, typicaily via the hydroxyl group of its anomeric centre, generating an a 
or a {3linkage, depending on the chirality of the anomeric carbon. Thus, forming a di-
or oligo-saccharide, two different termini can be recognized: the reducing end with a 
terminai monosaccharide still retaining its reducing power conferred by the unreacted 
aidehydic or carbonylic function, and the non-reducing end with a terminai 
monosaccharide whose aidehyde or ketone has been involved in the formation of the 
glycosydic linkage via a condensation reaction (see Figure 1.1). 
r-- Glucose ~ r--- Fructose ~ 
CH20H 
H20 
Jl 
o 
OH 
OH H 
H G~0<.(1-2)-Pl1u:tmr: 
Su erose 
DehydrBtion synthesis of 8 sucrose molecule 
by the condensBtion of glucose Bnd fructose 
Figure 1.1: Formation of a glycosidic linkage and loss of a water molecule. 
A sort of directionaiity or polarity can thus be assigned to carbohydrate chains, 
with strict analogy to the 5' and 3' end ofnucleotide chains or the amino and carboxy 
termini of polypeptides. Forming a glycoconjugate, the reducing end is located on the 
inner part of a glycan chain and the non-reducing end normally occupies the outer part 
of this sequence. Structures are commonly written from the non-reducing ( outer) end 
to the reducing (inner) end. Ifthe chain is branched, more than one non-reducing ends 
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can be listed. Indeed, when a monosaccharide constituent is involved in more than two 
glycosydic linkages, it represents a branchpoint in the structure. The ability to form 
branched structures is an important feature of carbohydrates. 
Let' s focus on the glycosydic linkage: i t involves the anomeric hydroxyl group, 
in a or fJ con:figuration, of one monosaccharide and any available hydroxyl group of a 
second monosaccharide. An enormous number of possible linkage variations can re sul t 
in comparison to the unique combination that originates binding two nucleotide bases 
or aminoacids. Furthermore, these two types of linkage stereochemistries confer 
different structural, chemical and physical properties and diverse biologica! functions 
to sequences that are otherwise identica! in composition. For example maltose 
(Glca(l-4)Glc) and cellobiose (Glc,B(l-4)Glc) differing only in the ai{J 
stereochemistry of their linkage, exhibit significantly different characteristics. 
The glycosydic linkage is the potentially most flexible part of a disaccharide 
structure. Whereas the chair conformation of the constituting sugar monomers in ring 
form is relatively rigid, the torsion angles around the glycosydic bond may vary to 
some extent. Thus a disaccharide can adopt multiple conformations in solution, 
differing in the relative orientation of the two monosaccharides with respect to each 
other. The combination of structural rigidity and flexibility is typical of complex 
carbohydrates and essential to their biologica! functions. 
Structural diversity of oligosaccharides found in glycoconjugates really appears 
to be enormous. As described earlier, this is due to the number of different ways in 
which sugar monomers may be linked to each other regarding linkage position, 
anomeric con:figuration, pyranosidic or furanosidic ring form and chain branching. 
Fortunately, for the student of glycobiology, naturally occurring biologica! 
macromolecules contain relatively few of the possible monosaccharide units in a 
limited number of combinations. 
The common monosaccharides found in higher animai oligosaccharides are 
listed below, along with their standard abbreviations: 
Hexoses: six-carbon neutral sugars including glucose (Glc), galactose (Gal) and 
mannose (Man). 
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Hexosamines: hexoses with an aminogroup at the 2-position, which can be 
either free or, more commonly, N-acetylated: N-acetylglucosamine (GlcNAc) 
and N-acetylgalactosamine (GaiNAc ). 
Deoxyhexoses: six-carbon neutral sugars without the hydroxyl group at C-6, 
fucose (Fuc) 
Pentoses: five-carbon sugars, xylose (Xyl) 
Hexuronic acids: hexoses with a negatively charged carboxy group at the 6-
position, glucuronic acid (GlcA) and iduronic acid (IdoA) 
Sialic acids: famìly of nine-carbon acidi c sugars, of which the most common is 
N-acetyl neuraminic acid (Neu5Ac) 
This limited set of monosaccharides seems to dominate the glycobiology of 
higher animals, but several others can be found in lower animals (e.g., tyvelose), 
bacteria (e.g., rhamnose and muramic acid) or plants (e.g., apiose and galacturonic 
acid). A variety of modifications of oligosaccharides enhance their diversity in nature 
and frequently serve to confer certain physico-chemical properties to a saccharide 
chain or to mediate specific biological function. The hydroxyl groups of different 
monosaccharides can be subjected to phosphorylation, sulphation, methylation, 0-
acetylation or fatty acylation. Amino groups can remain free or be N-acetylated or N-
sulphated. 
Since only certain monosaccharide units (Iisted above) are frequently found in 
nature, one can reasonably deduce that correspondingly particular di- or oligo-
saccharide sequences are preferentially formed in glycan biosynthesis. 
In contrast to the unique saccharidic core regions of different classes of 
glycoprotein (see section 1.5.2), certain outer oligosaccharide sequences are often 
shared among ali different types of glycans. For example, N- and 0-linked glycans, 
often carry the subterminal disaccharide Galf3(1-4)GlcNAc (N-acetyllactosamine, 
LacNAc) which can sometimes be repeated, or less commonly GalNAcp(l-4)GlcNAc 
units. These chains may be modified by fucosylation or branching and are typically 
capped by sialic acids, fucose or a-Gal, fJ-GalNAc or fJ-GlcA units. 
A glycosaminoglycan (GAG) is a Iinear copolymer of acidic disaccharide 
repeating units, each containing a hexosamine and a hexose (Gal) or a hexuronic acid 
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(GlcA or ldoA). The type of disaccharide unit defines the GAG as chondroitin or 
dermatan sulphate (GalNAc{J(l-4)GlcA/IdoA), heparin or heparan sulphate (GalNAca 
(1-4)GlcA/IdoA). A very comrnon type of GAG is hyaluronan, made of repeating 
(GlcNAc{J(l-4)GlcA) units. GAGs (exept for hyaluronan) also typically bear sulphate 
esters substituting either hydroxyl or amino functions, generating 0- or N-sulphate 
groups. 
In naturally occumng glycoconjugates, the glycan portion of the entire 
macromolecule can vary greatly, from being very minor in amount to being the 
dominant component. Often, as in typical glycoproteins, the carbohydrate moiety 
consists of several oligosaccharide chains covalently attached to the polypeptidic 
backbone. 
1.5.1.1 Oligosaccharide motifs recognized by endogenous receptors 
One of the most important biologica! roles of glycans relies on specific 
recognitioh of glycan structures by other molecules of the same organism, generally 
protein receptors called lectins (30). 
Toxin 
Glycoprotein 
Glycol ipid 
Figure 1.2: Oligosaccharides mediate recognition processes between a celi and endogenous 
(selt) or exogenous (non-selt) receptors. 
The earliest studied endogenous receptors recognizing glycan sequences were 
those mediating clearance, turnover and intracellular trafficking. For example, a well-
documented interaction has been reported to occur between endogenous desialilated 
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serum glycoproteins, which expose the f3-Gal saccharide unit, and a C-type-lectin 
(which binds to carbohydrates in a calcium-dependent manner), i.e., the 
asialoglycoprotein receptor (31, 32). This receptor is an abundant heterooligomeric 
protein predominantly expressed on hepatocyte plasma membrane. After 
intemalization by absorptive endocytosis, those "waste" glycoproteins are delivered to 
lysosomes for degradation. Therefore the receptor-mediated clearance of 
asialoglycoproteins is an important aspect of the turnover of plasma glycoproteins. 
Patients with hepatic cirrhosis or hepatitis exhibit an elevated amount of those 
glycoproteins in serum. 
Another very interesting example of interaction between an <;>ligosaccharidic 
sequence and an endogenous receptor is represented by the multi-step adhesion 
process during leukocyte extravasation, which is an important event in self-defense 
mechanism at a site of inflammation (see Figure 1.3) (33). This interaction involves a 
particular class of lectins, the so-called selectins (C-type-lectins), a family of "sticky" 
molecules that are expressed on the surface of leukocytes and on activated cells lining 
the inside ofblood and lymph vessels (endothelial cells). Three types ofselectins have 
been discovered so far: L-selectins are generally expressed on almost ali leukocytes 
(34), whereas E- and P-selectins are inducible on vascular endothelium upon 
stimulation with cytokines (35). Every selectin has affinity to oligosaccharides with 
sialil-Lewisx determinant (sLex, Neu5Aca(2-3)GalfJ(l-4)[Fuca(l-3)]GlcNAc), which 
is present both on leukocytes and on epithelial celi s. Only during inflammation, E- and 
P-selectins are produced upon citokine stimulation on epithelial cells and act as hooks 
to capture leukocytes, thanks to reciproca! selectin-sLex recognition, in order to bring 
them to the si te of infection. 
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Figure 1.3: Multistep adhesive and signalling events during leukocyte extravasation: 
inflammation and lytnphocyte homing. 
1.5.1.2 Oligosaccharide motifs recognized by exogenous receptors 
The primary step of colonization and infection of most pathogenic organisms requires 
their binding to host target cells via recognition of specific glycan sequences (36-39). 
These microbes normally attach to the mucosal surfaces of the respiratory or 
gastrointestinal tract, which are the nìost exposed to the invasion of such parasites. The 
mechanism of adhesion starts with a specific interaction between bacterial proteins, 
generally named adhesins, and epithelial cell glycoconjugates of the host. In Table 1.1, 
reported below, some of these interactions are highlighted. 
pathogenic bacterium targeted tract oligosaccharide sequence 
l:'schaic!Jiu coli unnnn Galui l -..f)(ìal(J 
.\'tl'l'J J( (}('()('(' 1/.\ l )/l!.' l l/} /(J Il i(/ l' l\:~piraLor; (ìlc.\.\cjJ( l-3)(djJ( 1-.i)(ìk.\",\c 
.\t Uj !h l 'f O(' l! Cl! 1.1 .Il lj )l'l Jj J/i_ \ '/ ict l l llrJ!l<ln (ì:tlj]( 1-..f Kìlc\-\c 
/\l'l! dO l i/1) IIU.\ Uc'f' 11g i l/ (i.\ LI rcspiratur:- C ìalY\cjJ( 1--J. J(ì:ll 
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Table l. l: Some oligosaccharide sequences recognized by bacterial adhesins. 
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For example, the bacterial infection caused by Helicobacter pylori, a gram-
negative bacterium able to colonize specifically the gastric mucosa of primates, can 
degenerate into chronic gastritis and even into more severe diseases, such as peptic 
ulcers, gastric lymphoma and carcinoma ( 40). After a prolonged study based on its 
mechanism of infection, it became clear that the adhesion mechanism of this 
pathogenic bacterium was mediated by a particular oligosaccharide motif present on 
the surface of stomach epithelial cells (41, 42). Nowadays it is known that Hpylori 
adheres to multiple and vicina} oligosaccharidic sialilated sites, e. g. to the sialil-lactose 
trisaccharide ( 43). 
Streptococcus pneumoniae IS a maJor pathogenic microorganism of the 
respiratory tract. The host-parasite interaction usually starts as an asymptomatic 
colonization of the nasopharyngeal mucosa. This state can evolve to local infections, 
such as acute otitis media or systemic infections like septicemia or meningitis (44). 
During colonization the bacterium produces a number of hydrolyzing enzymes, 
namely sialidases, which are able to chemically modify the structure of the 
carbohydrate chains set on the mucosa! surface, leading to the exposure of a new 
oligosaccharidic pattem which allows the pathogen to stick on (45). This sequence is 
represented by GlcN Ac{K_ 1-3 )Gal{K_ 1-3 )GlcN A c, w h ere only the outer disaccharide, 
located on the non-reducing terminus, is specifically recognized by S.pneumoniae. 
Identica! free glycan sequences, contained in human milk, can act as soluble receptors 
of the pathogen, block adhesion and impede the target cells to be reached by the 
bacterium (46). Hence breast-fed infants generally lack such respiratory diseases. 
1.5.1.3 Synthesis of oligosaccharide sequences 
The synthesis of pure and structurally defined oligosaccharide sequences to be 
used in biologica! studies is of great interest to glycobiologists. The studies are mainly 
aimed to probe the role of a glycan in some biologica! recognition processes (e.g., 
binding of bacteria, toxins or viruses to mammalian celi surface glycans) or the 
specific recognition of a glycoconjugate by a celi surface receptor. The glycans in 
question can be often very large, but the saccharidic epitopes usually recognized by 
carbohydrate-binding proteins tend to be more limited in size and span from l to 4 
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sugar units. The synthesis of rather short oligosaccharidic chains, here addressed, tums 
out to be then of valuabie importance. 
Mammalian giycans, as previousiy illustrated, are forrned from only ten 
monosaccharides (D-Gic, D-Gal, D-Man, D-Xyi, L-Fuc, D-GicNAc, D-GalNAc, D-
GicA, L-ldoA and Neu5Ac), which are considered the "building biocks" of giycans. 
Each of these monosaccharides can, in principie, form giycosidic linkages either in a 
or f3 configuration with another saccharidic monomer, although not ali of the possible · 
linkage types really occur in nature. 
Tbere is no generai route for saccharide synthesis, which has been 
accomplisbed both through cbemical and enzymatic methods. The challenge of 
oligosaccbaride synthesis can be easily understood by comparing it with the automatic 
synthesizers of polypeptides and oligonucleotides commercially availabie today. No 
sucb facilities exist for the synthesis of oligosaccharides, which is far more compiex. 
Suppose we are only interested in the cbemicai synthesis of a simpie disaccharide 
made up of two giucose units joint together through a 1-4 linkage. This means that ali 
OH groups, except those invoived in the linkage, must be protected. Then the glycosyi 
donor must be activated at the anomeric centre with a good Ieaving group (L) in order 
to coupie with the giycosyi acceptor having a singie free OH group in position C4. 
Formation ofthe giycosidic linkage creates a new asymmetric center, whicb can bave 
either the a or f3 configuration ( see Figure 1.4). Cieariy, mixtures are not wanted; 
therefore, stereospecific methods are required to produce the correct anomer of the 
target disaccharide. Yieids are generaliy in the 60-80% range, with anomeric ratios 
seidom better than 20: l and often 6: l or worse. One can easily deduce that even more 
severe limitations arise if Ionger saccbarides are synthesized: in the exampie reported 
here, a single generic protecting group (P) was used for ciarity, which would render 
problematic the selective recovery of one OH group required for chain extension. Until 
now much effort bas been spent in deveioping leaving groups that improve the stability 
and reactivity of the giycosyi donor ( 47-50). However, since protecting groups have 
been shown to beavily influence the anomeric linkage configuration of the synthetic 
product, severa! protecting and deprotecting strategies bave aiso been studied and 
appiied (51-53). 
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Figure 1.4: Chemical synthetic protocol for a hypothetical Glc(l-4)Gic disaccharide. P is a 
generi c hydroxyl protecting group an d L a given leaving group. 
In the past few decades, enzymatic approaches have been gaining popularity 
for the synthesis of oligosaccharides on a preparative scale, in direct response to the 
many difficulties still present in the chemical method (54, 55). Enzymes feature 
exquisite stereo- and regio-selèctivity and catalyze the reactions under very mild 
conditions. Extensive protection-deprotection chemistries are thus unnecessary and the 
contro! of anomeric configuration is simple. Glycosyltransferases, the enzymes that 
synthesize oligosaccharides in nature, and glycosidases, the enzymes that hydrolyze 
glycosidic bonds in vivo, have been both used for synthetic purposes. A drawback of 
the enzymatic approach, however, is that, although enzymes are excellent at catalyzing 
the synthesis of natura! products, their ability to accept novel saccharides with unusual 
or unnatural structure as substrates may be poor. 
Glycosyltransferases catalyze the transfer of a nucleotide-activated sugar 
residue (such as UDP-Glc, UDP-Gal, UDP-Xyl, UDP-GlcNAc, UDP-GalNAc, UDP-
GlcA, GDP-Man, GDP-Fuc and CMP-Neu5Ac) to growing oligosaccharide chains 
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(56). The sugars can be transferred with either retention or inversion of the anomeric 
configuration, being the last a more common event. Usually the nucleotide-activated 
substrates are relatively expensive b1,1t can be prepared from sugars or sugar 
phosphates through enzymatic or biologica! methods that have been worked out. Until 
recently, only a bovine fJl-4 GalT was commercially available in amount sufficient to 
prepare milligram quantities of oligosaccharide. The tremendous progress made in the 
cloning of glycosyltransferases, however, has now brought on the market severa! other 
galactosyltransferases and new fucosyltransferases aa well as sialiltransferases. 
Glycosidases were used well ahead of glycosyltransferases for the preparative 
synthesis of oligosaccharides (57). Indeed, due to their stability and to the easiness of 
their isolation, these enzymes were more commonly available. Glycosidases normally 
catalyze the hydrolysis of glycosidic linkages and must therefore be "coaxed" into 
providing useful synthetic activity. Frequently, glycosidases are used in the so-cali ed 
transglycosylation reactions where they transfer a monosaccharide from a relatively 
cheap donor substrate, such as a sugar halide or a p-nitrophenyl glycoside, to an 
acceptor saccharide. For some glycosidases, the reactions are very regiospecific, but 
for others, mixtures of positional isomers are frequently and unpredictably obtained. 
The example where a ,8-D-galactosidase was used to synthesize the very linkage it 
normally hydrolizes is illustrated in Figure 1.5. The transfer of Gal, from its p-
nitrophenyl glycoside to free GlcNAc, can result in different yields of the 1-4-linked 
N-acetyllactosamine (LacNAc) derivative and the 1-6-linked isomer a/lo-LacNAc, the 
percentages being dependent on the bacterial source of the enzyme (Bacillus circulans, 
or Escherichia coli) (58). 
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Figure l.S: Example of a glycosidase from different bacterial sources producing two different 
disaccharides on transglycosylation using a p-nitrophenyl glycoside as the don or. 
Further improvements in the synthesis of oligosaccharides, based on the use of 
glycosidases, bave been attempted immobilizing these enzymes on solid supports, in 
order to ease the recovery and recycling of the biocatalysts (59, 60). The synthesis of 
LacNAc in solid phase will be discussed thoroughly in chapter 6. 
1.5.2 Glycoproteins 
As already pointed out, the centrai dogma of molecular biology bas been 
revised to include also carbohydrates in the development of life. Tbe informational 
cascade that flows from DNA to mRNA, and from mRNA to proteins does not 
terminate bere, but with glycosylation of freshly synthesized polypeptidic cbains. 
Indeed, more than 60% of ali produced proteins are posttranslationally modified 
through glycosylation. Tberefore glycosylation is a very widespread posttranslational 
modification (PTM) of proteins in eukaryotic systems. Beginning with the relatively 
simple glycosylation in yeast, the glycosylated proteins are becoming increasingly 
more intricate structures in higber organisms, througb the elaborate and energetically 
costly mecbanism of adding enzymatically different sugars and trimming tbe structures 
to tbe "rigbt dimensions". This tendency to give bighly tuned structures could be 
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attributed to the metabolic responsiveness of the more advanced cellular types, created 
presumably through the necessities of intercellular communication in multicellular 
systems and to the evolution of the immune system as a response to parasite invasion. 
As mentioned above, carbohydrates may shape the active three-dimensional 
structure of proteins and protect them against proteolytic degradation. Nevertheless, 
glycans also represent a sort of mobile prolongation of a globular protein, reaching 
further away from its outer surface for sustaining specific interactions with other 
molecules. Furthermore, glycosylation is perhaps the most extensive and complex 
form of PTM and i t provi d es for protein functional diversity, i. e., to generate numerous 
phenotypes from a limited number of genotypes. Since biosynthesis of glycans is not 
subjected to a template-forced mechanism, but is under contro l of a library of 
glycosyltransferases, a protein can undergo different types of glycosylations, owing to 
the type of organ/tissue/cell it belongs to or to the physiologicallpatophysiological 
state it encounters. 
1.5.2.1 Basic structures for glycoprotein glycans 
The common classes of oligosaccharides found on eukaryotic cells are 
primarily defined according to the nature of the linkage (core) regions to the non-
glycosydic counterpart, i.e., to the protein: (i) an N-glycan (or N-linked 
oligosaccharide) is a sugar sequence covalently bound via GlcNAc to the aminogroup 
of an asparagine residue (Asn) of a polypeptide chain within the consensus peptide 
sequence Asn-X-Ser/Thr, where X represents any amino acidic residue, except Pro. N-
glycans share the common trimannosyl chitobiose (the Man3GlcNAc2 pentasaccharide) 
core region and can be generally divided into three main classes, depicted in Figure 
1.6: high-mannose type, complex-type and hybrid-type; depending on the type of 
antennae extending from the core region. (ii} an 0-glycan (or 0-linked 
oligosaccharide) is typically linked to the polypeptide backbone via GalNAc to the 
hydroxyl group of a serine or threonine residue and can be shaped into a variety of 
different structural core classes. Hence, 0-glycans do not share a common core 
structure, but they comprise a number of different regions with some common motifs 
(61, 62). Some are illustrated in Figure 1.6. 
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Figure 1.6: 0- and N-glycosylation of proteins. The most common mammalian glycan 
structures are highlighted. 
Potential glycosylation sites may be predicted from a gtven amino acid 
sequence. However, which of these potential sites is actually glycosylated, depends on 
other aspects of the protein structure and on the celi type in which the protein is 
expressed. Generally both N- and 0-glycans show high propensity toward branching 
and formation of multiantennary structures, but while N-linked glycoproteins contain 
only a few oligosaccharide chains, which are separated by severa! amino acid residues, 
0-linked glycoproteins contain a high number of chains in close proximity forming 
clusters (63). Both N-linked and 0-linked glycan structures can be divided into neutra! 
and acidic oligosaccharides, depending on whether they feature terminai sialic acid 
residues. Less commonly, the acidi c character is imparted to an oligosaccharide 
through sulphation of selected residues. The functional importance of terminai sialic 
acid residue has widely been appreciated in experiments demonstrating a partial or a 
complete loss of biologica! activity after treatment of a glycoprotein with sialidase 
enzymes (64-66). Another important variation may reside with the Iinkages of the 
sialic acid residues that are particularly accessible and thus available for various 
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recognition and binding phenomena. For example, the difference of a(2-3) versus a(2-
6) sialil-galactosyllinkages in celi-celi interactions has been demonstrated (67-69). 
The most well-characterized route for the biosynthesis of different classes of 
glycans occur within the lumen of the ER-Golgi-plasmalemma pathway (see Figure 
l. 7). Thus, for example, newly synthesized proteins originating from the ER are either 
co-translationally or post-translationally modified with sugar chains at various stages 
in their itinerary toward their final destinations. The N-linked glycosylation begins in 
the ER and continues in the Golgi complex, whereas the 0-linked glycosylation takes 
piace exclusively in the Golgi apparatus. The process of glycosylation begins when the 
protein is targeted to the glycosylation pathway during translation of mRNA into 
protein. The ribosome machinery is attached to the ER and the nascent protein is fed 
into the lumen of the ER as translation proceeds. In the ER, one set of biosynthetic 
enzymes (mostly glycosyltransferases) attaches sugar nucleotides, made in the cytosol 
and specifically transported into the lumen of the organelles, to specific portions of the 
protein. Other glycosylation enzymes then either add more activated saccharide 
residues to theses core structures, or partially trim the structures back so that new 
sugars can be added to a different part of the growing carbohydrate chain. Proteins in 
the lumen of the ER and in the ER membrane are in their initial state of glycosylation 
process. They undergo further processing when transported into the Golgi complex, 
where N-linked sugars are modified in many different ways. On the contrary, 0-linked 
glycans do not enter the ER, but are directly fashioned in the Golgi plasmalemma. lt is 
worthy to mention that only properly folded proteins can leave the ER and move to the 
Golgi complex. This quality-control system is guaranteed by the concerted action of 
some carbohydrate-binding proteins (chaperone proteins) which hold unfolded proteins 
long enough in the ER until correct folding is achieved. The Golgi complex is the 
major sorting center of the celi and is differentiated into: (i) a cis compartment, which 
is the closest to the ER and where core-N-glycosylated proteins are received; (ii) a 
mediai compartment; (iii) a trans compartment, which exports proteins to a variety of 
destinations. These compartments contain different enzymes and mediate distinctive 
functions. 
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Figure 1.7: The ER-Golgi-plasmalemma pathway for protein glycosylation in vivo. 
Sometimes, the build up of the sugar chain is not performed attaching one 
sugar residue after another, but directly adding pre-formed oligosaccharide blocks on 
the growing chain. Like the sugar nucleotides, these bulky oligosaccharide blocks are 
also made on the cytoplasmic face of these intracellular membranes and flipped across 
to the other side, i. e., in the inner side of the ER or the Golgi compartments, where 
they are available for the sugar chain extension. 
Carbohydrate processing in the Golgi complex is called terminai glycosylation, 
in order to distinguish it from the core glycosylation, which takes piace in the ER. 
Drastic structural diversification can occur as a result of the terminai glycosylation 
process. Once glycosylation is complete, specific carbohydrate markers help freshly 
glycosylated proteins to leave the Golgi and migrate into the correct celi compartment. 
As an example, Man-6-P targets lysosomal enzymes to reach their final destination 
(70). Lysosomes are organelles that recruit such hydrolyzing enzymes in order to 
degrade and recycle damaged cellular components or material brought into the celi by 
endocyotosis. 
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The most commonly held model envisions glycosylation enzymes as being 
physically lined up along the ER-Golgi pathway in the precise sequence in which they 
actually work. This appears to be an oversimplified view, since there is a considerable 
overlap among these enzymes and the actual distribution of a given enzyme very likeiy 
depends on the celi type. 
One of the most fascinating and yet frustrating aspects of protein giycosyiation 
ts the phenomenon of microheterogeneity. This term indicates that at any given 
glycosylation site on a given protein synthesized by a particular celi type, a range of 
variants can be found in the precise structure of the glycan. Even the extent of this 
heterogeneity can vary considerably from glycosylation site to glycosylation site, from 
protein to protein and from celi type to celi type. Thus, a given glycoprotein can exist 
in numerous glycoforms, each effectively being a distinct molecuiar species. 
Mechanistically, this heterogeneity might be explained by the rapidity with which this 
multiple, sequential, partially competitive glycosylation reactions must take piace in 
the Golgi apparatus, through which the newly sinthesized glycoprotein is passing. 
From the practical point of view, microheterogeneity explains the anomalous 
behaviour of glycoproteins observed in chromatographic or electrophoretic analysis: 
for example in 2D-gel-electrophoresis glycosylated proteins appear not as a single 
spot, but as a "train" of spots, varying in mass and sometimes also in isoelectric point, 
especially if various amounts of charged Neu5Ac residues are responsible for the 
outcome of the different glycoforms. Therefore microheterogeneity makes the 
complete structural analysis of most glycoproteins a difficult task. 
From a functional point of view, the meaning of this heterogeneity remains stili 
unclear. It is possible that this is intended for either diversifying endogenous 
recognitions functions ami/or for evading microbes and parasites that can bind with 
high specificity to certain glycan structures. 
1.5.2.2 Sequencing glycoprotein oligosaccharides 
Why should a glycobiologist try to solve the structure of a glycoprotein 
oligosaccharide? 
As already pointed out earlier, N- and 0-glycan chains of glycoproteins, as well 
as the level and the spectrum of glycoprotein expression, may be altered in cells that 
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undergo a physiological change. In generai, N-glycans are often highly branched and 
sialylated in cancer, while 0-glycans are often truncated and sialylated (71). The 
increased number of branches of N-glycans in tumour cells provides additional 
attachment sites for N-acetyllactosamine units (LacNAc, GaiJ1(1-4)GicNAc) 
disaccharide) and terminai sialic acid residues or other determinants that may function 
in celi adhesion and in the protection of the cancer celi surface, promoting survival in 
the blood stream and invasion of tissues. Here the N-glycan structure elucidation of the 
glycoprotein before and after pathological development has clearly been related to the 
time course of the malignancy. 
As another example, it is worthy to cite the vast pharmaceutical interest based 
o n the biosynthesis of recombinant glycoproteins that are of paramount importance in 
the treatment of those human diseases that can be alleviated through enzyme 
replacement therapy (ERT). Since glycosylation is influenced by the type of 
biotechnoiogical methodology used (celi line, culture conditions and so on), an a 
posteriori characterization and contro} of a correct glycosylation pattem of the newly 
synthesized glycoproteins is necessary in order to ensure consistent product quaiity. 
Among ali glycosylated structures, N-glycans are maybe the most complex but, 
simultaneously, their numerous functions have been most extensively studied. 
Compared to the abundant fmdings on N-glycans, considerably less has been known 
about the 0-linked structures and their biologica! roies. The studies in this area have 
been complicated by the apparent lack of a consensus sequence for 0-glycosylation 
sites and the frequency at which many Ser and Thr resides are located together in 
patches. Finally also the lack of enzymes that could be used to remove such glycans 
from their respective giycoproteins represented a problem. The recent years' 
availability of N-glycanases (72) that, providing a facile cleavage of Asn-linked 
oligosaccharides, has revolutionized the analysis of N-glycans compared to 0-glycans, 
which instead stili need the chemical approach to be cleaved off from their 
polypeptidic backbone. 
The goal of analytical glycobiology is to bring advanced analytical methods to 
the task of mapping cellular processes and explaining the function of glycoproteins 
from analyticai data. This modem analytical methods involve a display of glycosyiated 
structures into an "oiigosaccharide map", in terms of glycan monosaccharide 
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constituents, sugar linkage types, carbohydrate sequence, location of branch points, 
information about glycosylation sites and presence of non-saccharidic substituents. 
In order to achieve complete structural assignments, the isolation of the 
glycoprotein from various biologica! materials is first of ali required. Glycoproteins of 
interest may be either soluble or membrane-bound molecules. Any isolation protocol 
has to be adjusted to take into account the physicochemical properties of a given 
glycoprotein. Then the glycoprotein of interest or a class of glycoproteins can be 
purified by most conventional separation methodologies, including gel electrophoresis 
and chromatographic methods (ion-exchange, size exclusion, reversed phase and 
affmity liquid chromatography) or a specific isolation principle based on the use of 
immobilized lectins on a chromatographic resin. Once the glycoproteins and/or their 
variants have been isolated, a wide series of analyses are then feasible. There are no 
generai rules to follow in the characterization of a glycoprotein. Commonly, a 
combination of diverse orthogonal analytical strategies is employed in order to study 
either the saccharidic or the peptidic constituents of a glycoprotein. It should be 
possible to study unk.nown glycoproteins as long as their complexity is not extremely 
high, bearing in mind, however, the likely existence of glycosylation variants, known 
as glycoforms. 
One possibility is to directly perform glycoform separations through CE. In 
fact, due to the high resolving power of this technique, numerous attempts have been 
made to use capillary electromigration methods for both qualitative and quantitative 
assessment of glycoprotein microheterogeneities. CE offered valuable solutions to the 
analytical challenge for protein heterogeneity assessment, especially in the glycoforms 
characterization of biotechnological or pharmaceutical relevant recombinant proteins, 
such as the recombinant human tissue plasminogen activator (rtPA) or the recombinant 
human erythropoietin (rhEPO) (73-76). Beside CE, matrix-assisted laser 
desorption/ionisation time-of-flight mass spectrometry (MALDI!TOF-MS) and 
electrospray/ionisation mass spectrometry (ESI-MS) (see section 3.5.1) have emerged 
over the past decade as powerful tools for the analysis of large biomolecules, 
contributing extensively to progress in life sciences. To a variable extent, the intact 
glycoproteins can be resolved to their individuai glycoforms by both methodologies, 
depending on their mass and the degree of glycosylation. On one band, it has been 
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shown that MALDI/TOF instruments now often furnish sufflcient resolution to detect 
glycoforms of small glycoproteins with a single glycosylation site and a Iimited 
number of glycans (77). Unfortunately, broad and unresolved peaks are observed in the 
case of large glycoproteins with multiple glycosylation sites (78). It was demonstrated 
that the appropriate choice of experimental parameters, which determine the 
desorption/ionisation of glycoproteins, can improve signiflcantly mass measurement 
reproducibility and resolution (79). On the other hand, ESI-MS presents many 
difflculties due to the data complexity rising from multiply charged ion formation. 
Moreover it has been observed that enzymatically deglycosylated proteins "spray" 
better than their corresponding glycoconjugates. Satisfactory desolvation conditions 
for intact glycoproteins have been successfully tested using the so-called nano-ESI/MS 
(80). 
More often the glycoprotein backbone has to be hydrolyzed into smaller 
fragments (i. e., peptides or glycopeptides ), using enzymes, sue h as trypsin, for further 
structural determination. The identiflcation of glycosylation sites could then be 
feasible by comparison of the glycopeptide maps resulting from the MS-analysis 
before and after deglycosylation. If an ESI-MS is used, the coupling of the mass 
spectrometer with a separation apparatus, such as CE or LC ( equipped with a 
microcolumn), is then recommended to reduce the complexity of the analysis. 
A preliminary analysis of N-glycan monosaccharide composition is otherwise 
necessary. The complete hydrolysis of glycans and polypeptides into sugar and amino 
acid monomers can be performed through acid hydrolysis with trifluoroacetic acid 
(TF A). Milder hydrolysis releases terminai sialic acids and eventually terminai fucose. 
The mixture of monosaccharides can then be subjected to LC or CE, in order to 
establish type and amount of any single saccharide present in the mixture. The most 
probable structure of the examined N-glycan sequence may than be predicted or at 
least hypothesized. 
The classica! structural determination approach, however, of glycoprotein 
oligosaccharides relies on the chemical or enzymatic release of N-glycans from 
specific glycoproteins. The individually separated oligosaccharides provide the best 
opportunity for subsequent structural investigation. 
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Maybe the most comrnon method to release both N- and 0-glycans from 
glycoproteins relies on the use of hydrazine for chemical hydrolysis. This approach, 
however, suffers from severa! major disadvantages. By cleaving amidic bonds 
(including the linkage between N-glycans and Asn), the reagent destroys the protein 
backbone and any information pertaining the site and the extent of glycosylation are 
consequently lost. Moreover N-acetylaminosugars and sialic acids are hydrolized as 
well, calling for a re-N-acetylation step. Therefore, hydrazinolysis covers now a 
secondary role with respect to the more favoured enzymatic release. 
N-glycans can be released enzymatically from glycoproteins by severa! 
commercially available enzymes. Peptide N-glycosidase F (PNGase F) is the most 
widely used. The enzyme cleaves off the intact glycan chain, whose terminai 
glycosylamine is readily converted to a regular reducing sugar. The enzymatic glycan 
cleavage also converts asparagine (Asn) to aspartic acid (Asp) at the glycosylation site, 
yielding a slightly modified protein. PNGase F has very wide specificity, cleaving ali 
N-glycans except those bearing a(l-3) linkages at the protein bridging GlcNAc 
residue. lndeed, N-linked glycans carrying a Fuca(l-3) linked to the inner GlcNAc 
residue, comrnonly found in plants, are inaccessible to the PNGase F, whereas are 
easily subjected to cleavage by other endoglycosidases, like PNGase A. As discussed 
in an earlier review, other endoglycosidases with variable degrees of specificity are 
also available (81). 
Both enzymatic and chemical approaches lead to the release of an 
oligosaccharide chain with a terminai reducing end, ready to be chemically modified to 
eventually fulfil the physicochemical properties properly required by the analytical 
method of choice. Very often glycans, especially if analyzed through GC, LC or CE, 
need to be coupled to a derivatizing agent at their reducing termini in order to acquire 
high volatility, UV or fluorescent activity they are intrinsically devo id o f. 
Once isolated from their polypeptidic counterpart, the oligosaccharide mixture 
can then be analyzed. Separation of glycans in time and space appears essential to 
investigating complex glycan pools released from glycoproteins. Chromatography, 
electrophoresis and mass spectrometry are both complementary and competitive in this 
respect. MS is inherently faster in displaying complex oligosaccharide maps, but 
chromatographic and certain electromigration techniques can more readily distinguish 
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various isomeric structures. Although MALDIITOF-MS is very useful in determining 
structures of glycans with the aid of bioinformatics, which can assign the most 
probable N-glycan structure of a given experimental mass-to-charge value, the use of 
enzymatic sequencing is superior for a conclusive, complete and accurate 
determination of glycan structure (82). Besides, NMR spectroscopy deserves also to be 
mentioned as a valuable and non-destructive analytical tool for glycan 
characterization. However, one major drawback from the use of NMR for glycan 
analysis is the relatively large amount of sample that is required, commonly at the 
milligram level, whereas in glycobiology the rule is to deal with submicrogram 
amounts of biologica! materia!. 
The different methodological approaches that are reported above, bave been 
summarized for clarity in the Scheme 1.1. 
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1.5.3 Carbohydrate-protein complexes 
Tbe interaction between carbobydrate and protein is an a priori condition to 
initiate a great deal of recognition processes whicb affect numerous biological events. 
Many different glycan-binding proteins bave been described so far and tbeir 
interactions with glycans bave been studied by a wide variety of approacbes. Tbe 
common features of these complexes are tbe reduced dimensions of the glycan-binding 
sites (spanning in average ca. 2.5 sugar residues) and the bond strength keeping 
together tbe two interactive partners, whicb are chiefly referred to bydrogen bonding, 
bydropbobic as well as cbarge and dipole interaction. 
Mucb of tbe early history related to glycan-protein interactions addressed the 
recognition of glycans by enzymes, such as the endoglycosidase lysozyme, capable of 
specifically cleaving {3(1-4) linkages between N-acetylmuramic acid and GlcNAc of 
peptidoglycan layers constituting bacterial celi walls. Tbe snapshot of this interaction 
in three-dimesional space was realized solving the crystal structure of the lysozyme-
tetrasaccbaride complex (83). Up to now a lot of protein-carbobydrate interactions 
bave been cbaracterized, not only through X-ray diffraction but also through 
alternative biopbysical methods. From these and more recent studies, it is clear that the 
recognition of sugars by lectins, the generai term denoting proteins with glycan-
binding activity, occurs by several mecbanisms. 
Tbe main question, which spontaneously rises while studying sucb specific 
glycan-protein interactions, is: "Why does an antibody, a plant lectin, a bacterial 
adhesin or toxin bind only a limited number of glycans among the thousands that cover 
the celi surface?" Said in other words: "Tbe molecular process in whicb the 
bydrophilic glycan moiety leaves the aqueous pbase to enter a protein combining site 
is really energy favoured?" Mucb attempts were made in order to understand the 
energetics of glycan-protein binding, but they were mostly unsuccessful. Also the 
calculation of tbe dissociation constants (:Ki) governing those interactions was 
recognized to be a difficult task. 
Tbe overall process of binding involves the meeting of a solvated 
polyhydroxylated glycan and a solvated protein-combining site. If the surface of the 
glycan is complementary to the protein-combining site, water can be displaced and 
binding occurs. When the complex finally forms, it exhibits a new surface to the 
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surrounding medium which will also be hydrated. Solvation and desolvation energies 
are very large due to entropy, while the energetic contributions of the multiple weak 
forces that participate in the new bond formation are rather small, hence errors in the 
estimation of the overall energy change are likely, making the calculations of binding 
energies and ~ difficult. 
The monovalent binding of a lectin (L) to a glycan (G) is ruled by the 
equilibrium (l) reported below and their affmity constant Ka is defined by the 
relationship (2). Remembering that Ka = ~-I, then the standard free energy associated 
to the binding process (ò.G0) and the l<tJ are related by equation (3): 
L+G? LG (l) 
Ka = [LG] l [L ][G] (2) 
ò.Go = - RT In Ka (3) 
R is the universal gas constant and T the Kelvin temperature. Ka is related to 
standard variations of enthalpy (ò.Ho) and entropy (ò.So) in the following manner: 
ò.Go = Mio- TASo 
Although protein-carbohydrate interactions are important in many biologica! 
events, they appear relatively weak when examined experimentally: ~ normally range 
from ~M to mM in most cases. Hence the binding between an individuai protein and 
an individuai carbohydrate is typically quite weak. Nature obtains strong and specific 
responses through multiple protein-carbohydrate interactions, a phenomenon known as 
multivalency (84). In multivalency two or more ligands are linked in order to achieve 
simultaneous binding to two or more receptors. These multivalent carbohydrate-
protein interactions may typically take piace at celi surfaces, where one or both of the 
components are sequentially attached to cellular membranes on a wide surface area 
(85). These are fluid and dynamic interfaces, which suggest that properties such as 
flexibility and adaptability may play important roles in these multivalent interactions. 
Multivalency can enhance the weak binding of monovalent carbohydrates by many 
orders ofmagnitude and bring them within the biologica} relevant range (i.e., l<tJ in the 
nM range) (86). While binding of a monovalent lectin to a monovalent ligand is easily 
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defined by the equilibrium kinetics described earlier, multiple occurring affinities are 
more accurately described by a set of equilibria. Moreover multivalency raises 
questions of affinity versus avidity, which refers to the strength of multivalent ligand 
binding and is obviously described by complex kinetics. Indeed, for multivalent 
ligands and lectins, the values reported for affmity are apparent affinity constants and 
usually measure the avidity. Another complication is that ligands for some lectins may 
be glycoproteins or polysaccharides with potentially multiple binding sites for one 
lectin. In summary, the density of binding sites on the ligand and the valency of the 
lectin may dramatically alter the apparent affmity of binding. 
From a generai point of view, this multivalent-fashioned interaction enables a 
high and versatile modulation and regulation of the celi-celi and cell-matrix 
recognition processes. Furthermore, two other considerations favour multivalent 
interactions with respect to monovalent ones: frrst of ali, multiple interactions present 
high reversibility in the presence of competitive ligands (87), avoiding receptor 
entrapment in non-efficient binding events. Secondly, multiple protein-carbohydrate 
interactions show very good resistance to shear-stress (88), a common phenomenon 
affecting cells that interact with each other in the blood stream. 
T o understand the interaction between a glycan and a protein, many parameters 
have to be defined, including the molecularity and kinetics of the interaction, the 
equilibrium binding constants, the entropy and enthalpy variations which occur during 
the process. Because of the complications explained earlier, most of the performed 
glycan-protein interaction studies involved relatively small sized glycan ligands. 
Nowadays a lot of methodological approaches are used in the determination of these 
interactions, which range from X-ray diffraction, NMR, titration calorimetry, surface 
plasmon resonance to frontal affinity chromatography. 
1.5.3.1 Biosynthesis of a sugar-binding protein 
The availability of relatively high amounts of pure protein and carbohydrate 
moieties is required if the characterization of their specific interaction is carried out 
using X-ray crystallography, NMR spectrometry or simply more than one 
experimental method. How to produce a certain oligosaccharide sequence has already 
been described, or at least generally indicated, in section 1.5.1.3. In this paragraph, 
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issues and problerns concerning rnethods usually ernployed for preparing proteins for 
further characterization in assembly, if possible, with their natural substrates, are 
instead addressed and discussed. The procedure here reported, holds for every type of 
recombinant protein, i. e., a protein that is obtained through recombinant DNA 
techniques. As shown in chapter 7, the reported approach will be applied for the 
synthesis of a sugar-binding protein, such as a lysozyme from Helicobacter pylori. 
The idea that underlies the problem of expressing large amounts of a 
recombinant protein is to prepare a DNA segment that encodes the right amino acidic 
sequence of the desired protein and introduce i t into an appròpriate host, which is ab le 
to retain and faithfully replicate the DNA. The DNA segment must contain all of the 
elements necessary for high-level RNA expression; moreover, the RNA, when 
expressed, must be recognized by the translational machinery of the host. The 
recombinant protein, once expressed, assurning it is reasonably stable in the host, 
needs to be properly folded either by the host or, if not properly fold,ed in the host, by 
the experimentalist. Finally the protein needs to be purified and its quality assessed to 
ensure it is both relatively homogeneous and monodisperse. 
Unfortunately, no single strategy for producing proteins for structural studi es 
appears to be universally successful and, often, the most expedient route to reach a 
satisfactory expression of a recombinant protein is the simultaneous pursuit of sçveral 
expression strategies with the use of multiple expression constructs. However, to 
prepare a recombinant protein, generally means to face the following steps: 
Creating an expression construct. T o obtain the gene of interest is the fist step 
in preparing an expression system. If the nuclei c sequence encoding for the protein is 
available, it is usually a simple matter to prepare the desired DNA to be cloned using 
the polymerase chain reaction (PCR), whose purpose is to make a huge nurnber of 
copies of a given gene (clone DNA or cD N A) (89, 90). Then, the newly synthesized 
cDNA has to be linked to an appropriate vector, generally a small circular piece of 
bacterial DNA (plasmid), prior to be integrated into the host. cDNA fragments and 
plasmide vector can be linked together thanks to the major tool of recombinant DNA 
technique, i.e., the restriction enzymes and DNA ligases (91, 92). Restriction enzymes 
recognize specific nucleotide sequences, which bave to be present both on the termini 
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of the segment cD NA and on the plasmi d, and cut the backbones of these molecules at 
that sequence. Then, complementary ends present on the cONA and the plasmid can 
join together by action of DNA ligase and a hybrid DNA formes. The ends of the 
cONA must be previously modified through PCR using appropriate oligonucleotide 
primers that have been designated to introduce useful restriction sites in the DNA 
fragment to be amplified. cONA can be engineered into commercially available 
expression vectors that already contain, upstream or downstream the DNA insert, a 
nucleic sequence that encodes a certain small peptide tag or a larger protein domain 
which will be translated as an ensemble with the desired protein: such fused elements 
can be used further for affinity chromatography and can greatly simplify the 
purification ofthe recombinant protein (93, 94). Tags range in size from severa! amino 
acids (hexahistidine tag, His6) to tens of kilodaltons (glutathione S-transferase tag, 
GST). After affinity purification, these tags are usually removed using proteases, 
which recognize specifically a certain amino acidic sequence and cleave in between 
the recombinant protein and the tag. 
Choosing an expression system. It is usually appropriate to begin with 
prokaryotic (Escherichia coli) expression systems that are the easiest to use in terms of 
homing the DNA construct into the host cell, growth of the recombinant organism and 
purification of the resulting protein (95). E. coli cells actually transformed, i.e., 
containing the engineered plasmid, must somehow be selected from those that are 
"empty". Generally ali commonly available expression vectors carry selectable 
markers, which usually confer resistance to an antibiotic, typically ampicillin and/or 
kanamycin. Ampicillin resistance is conferred by the expression of a fi-lactamase that 
is secreted from cells and breaks down the antibiotic. If the desired protein is toxic to 
E. coli, as are a substantial number of recombinant proteins either for straightforward 
reasons (e.g., they bind DNA or interfere with electron transport) or for reasons that 
are not obvious or predictable, then an inducible system is required to avoid basai 
transcription of the gene. Generally inducible expression systems based on the lac 
repressor are used, which are usually induced with isopropyl-fi-0-
thiogalactopyranoside (IPTG). Better contro! of induction can usually be obtained 
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using a bacteriophage T7 RNA polymerase expression system to direct the controlled 
expression of the target gene (96-98). 
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Figure 1.8: Clonation of a DNA fragment into a plasmid and transformation ofthe host celi. 
Setting culture conditions. The celi culture, starting from a single transformed 
bacterial colony grown on selective plate, can be performed either in shake flasks or in 
a fermenter using a proper culture medium, which must contain a C source (glucose, 
glycerol, etc.), salts and amino acids. During the whole process, aerati o n, p H and 
temperature must be constantly controlled. The production of E. coli cells and the 
amount of recombinant protein relative to the E. coli host proteins are sensitive to ali 
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of the variables reported. In generai, vigorous aeration is helpful for flask cultures, 
whereas most fermenters are supplied with an 0 2 electrode, which helps to previde 
optimal air delivery. E. coli grows faster at 37 oc than at lower temperatures, however, 
in some cases the relative yield of a recombinant protein can be substantially increased 
by growing E. coli expression strains at temperatures belo w 3 7°C. 
Refolding proteins from inclusion bodies. When screening express10n 
constructs for production of recombinant protein, four scenarios are most commonly 
encountered: 
- high-level expression of soluble recombinant protein 
- high-leve! expression of the recombinant protein, with a greater/lesser proportion of 
the protein in inclusion bodies 
- no expression or very low levels of expression 
- lysis of cells 
The first result is the most welcome. The third and fourth events are usually 
encountered when active proteolysis of the recombinant protein occurs or when 
biosynthesized proteins induce a negative response in the host cell. For example, 
proteases are notoriously difficult to be produced in large amounts. 
The most frequently observed result is the second: apparently, a forced over-
expression of any recombinant protein beyond certain limits, is sufficient to drive the 
protein into aggregation and inclusion body formation (99). This failure of properly 
foldi~g in E. coli, can be explained considering that the recombinant protein is made in 
overwhelming amounts and at such high velocities, that the majority of synthesized 
protein has not enough time to interact with molecular chaperones and other folding-
helper proteins (protein disulfide isomerases and peptidyl-prolyl cis/trans isomerases) 
(100). The aggregation of unfolded proteins in insoluble inclusion bodies is both a 
blessing and a curse. Proteins in inclusion bodies are essentially immune to proteolytic 
degradation. Additionally, inclusion bodies predominantly contain the over-expressed 
recombinant protein and only small amounts of host celi materia}, hence i t is usually 
relatively easy to obtain them in pure form. Unfortunately, the recombinant protein 
obtained from inclusion bodies must be refolded. 
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The formation of inclusion bodies is the result of aggregation of non-native and 
non-active proteins. Factors that alter the folding pathway and/or affect the 
concentrations of unfolded or misfolded proteins can have a dramatic influence on the 
yield of soluble protein. As an example it has been reported that variations in culture 
conditions result in quite different yields of soluble and insoluble protein: in many 
cases reducing the temperature just prior to induction from 3 7 o c to 30 o c (or even 
Iower temperatures) resulted in longer post-induction times for obtaining high protein 
yields but also in the recovery of a high amount of soluble protein (101). Some use 
other shortcuts in order to favour the formation of soluble protein over the insoluble 
fraction: for example, the addition of 2% ethanol 30 minutes before induction, triggers · 
an increase of soluble chaperone concentration, leading to a higher amount of correct 
folded material. 
If none of these expedients aids in enhancing the ratio between soluble and 
insoluble recombinant protein, no other way remains left, but finding a proper way to 
isolate, solubilize and refold these insoluble aggregates (102-104). Inclusion bodies are 
usually harvested after centrifugation ofthe celllysate in the solid fraction. These solid 
pellets are usually solubilized in high concentrations of denaturing agents, such as 6 M 
guanidinium chloride (GdmCl) or 8 M urea. To guarantee the complete reduction of 
any accidentally formed disulfide bonds, reducing agents, such as dithiothreitol (DTT), 
dithioerythritol (DTE) or P,.mercaptoethanol should be present during solubilization. 
During refolding of solubilized inclusion bodies, the denaturant moiety is sequentially 
removed in favour of the so-called refolding buffer, which contains ali those additi ves 
that may help the protein to restore its native conformation. There is no universal 
composition of the refolding buffer that brings any recombinant protein into the 
properly folded state, however some common features in designing a refolding strategy 
actually exist: 
If the target protein contains disulfide bonds in its native structure, low 
molecular weight thiols (such as reduced/oxidized glutathione, the cysteine/cystine or 
the cystamine/cysteamine couple) are used to facilitate correct disulfide bond 
shuffling. The correct pairing of disulfide bridges is essential to protein folding and the 
possible combinations of incorrect disulfide bond formation increase exponentially 
with the number of cysteines that are available for pairing. 
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The question of whether the buffer transfer from unfolding to folding 
conditions should be performed by dialysis or dilution is stili controversial. In some 
case, higher folding yields might be obtained by dialysis as compared to rapid dilution 
of the denaturant (105, 106); however, buffer exchange by dialysis presents 
considerable disadvantages with respect to reproducibility, handling and ease of scale-
up. Furthermore, many proteins form highly aggregation-prone folding intermediates 
at intermediate denaturant concentrations. Slow removal of the denaturant by dialysis 
then often inevitably leads to quantitative and irreversible precipitation of these 
intermediates. In these cases, rapid or stepwise removal of the denaturant by dilution 
reduces protein losses by aggregate formation. Diluting the solubilized protein into 
refolding buffer is in most cases much more convenient and efficient than the removal 
of the denaturing agent by dialysis (l 07). 
u N 
aggregate misfolded 
Figure 1.9: Diagram ofrefolding course. U, I and N correspond to the unfolded, intermediate 
and native state ofprotein, respectively. 
Protein refolding represents the conformational change from unfolded 
(denaturated) to folded (native) state (see Figure 1.9). At high denaturant 
concentrati o n, proteins are unfolded (U) ( disordered), well solvated and flexible. On 
diluting the protein in denaturant solution with the refolding buffer, the protein adopts 
an intermediate conformational state (I) showing lower solubility than in the unfolded 
state as well as a higher tendency to aggregate or misfold into a rigid and compact 
structure. It is therefore important to help correct folding of the intermediate into the 
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more stable native structure (N), yet maintaining the solubility and flexibility of the 
intermediate. It is actually an optimal habit to assist the refolding pathway, limiting its 
unproductive side-reactions by using additives in the refolding buffer. For a number of 
proteins, improved refolding has been observed upon addition of osmolytes, such as 
sugars or polyalcohols, which generally stabilize the native states of proteins (l 08). 
Several amino acids ha ve been found to be beneficiai for the in vitro folding of certain 
proteins (109). Namely, the presence ofL-Arg as a co-solvent in concentrations above 
0.4 M was found to promote, through a yet unknown mechanism, the refolding of 
many different proteins and to suppress their aggregation (107, 110). 
Once the protein has been isolated, solubilized and refolded, conventional 
purification procedures (see next section) may be employed. The behaviour of the 
refolded protein should be assessed through protein activity assays (if any exist) or 
through LC: improperly folded proteins will be prone to aggregation and give broad or 
trailing peaks during column chromatography. 
Purification strategies. Ali protein purification is achieved by separation 
methods exploiting those physicochemical and biologica! properties that differently 
characterize one protein from others. Differences in size, charge surface and 
hydrophobicity ease protein separation essentially in LC methods. In ion exchange 
(IEC) and reverse phase liquid chromatography (RP-LC), proteins are separated by 
different partitioning between a mobile and a stationary phase. Proteins are let to 
adsorb onto the resins under certain medium conditions and are then eluted, either 
isocratically or in gradient, from the column using other medium conditions. Size-
exclusion chromatography (SEC), in which no partitioning between different phases 
takes place, rather acts as a sort of molecular sieve, leading to size separation. This 
technique provides a useful indication of whether the protein, at the end of the 
purification procedure, is a well defined, folded, compact, monodisperse population or 
whether it exists as oligomeric, aggregate, unfolded or extended form. 
The most powerful approaches are those that most clearly differentiate the 
desired protein from the other proteins present: as discussed previously, it is possible 
to modify the recombinant protein so that it contains a sequence element - the affinity 
tag - that can be exploited for affinity chromatography (AC). Numerous systems 
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pairing vectors for creating fusion protej.ns with appropriate resins for AC are now 
commercially available. Examples of these fusion element/affinity resin pairs include 
HiS61'Ni++-nitriloacetic acid, glutathione S-transferase/glutathione. Finally, · once 
isolated, the fusion protein may either be tag-cleaved or remain tag-fused prior to 
characterization studies. If the tag is made of a few amino acids, structural 
characterizations can be performed on the uncleaved protein. Ifa tag-free protein is 
instead needed, removal of the tag usually requires the presence of a si te for a specific 
protease and, after enzyme digestion, the final cleaved product can be isolated and 
characterized. 
Although there are a number of ways to check the purity of a recombinant 
protein, the most convenient and widely used, invblves electrophoretic procedures. For 
analytical purposes, most experimentalists use SDS-PAGE and Coomassie brilliant 
blue gel staining in order to detect important contaminants or heterogeneity in the 
protein preparation. 
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Scope and outline 
Carbohydrate sequences, either free or covalently bound to proteins or lipids on 
the outer celi membrane, contain much structural information exploited in many 
biological communication processes. The messages stored in their three-dimensional 
molecular structures are promptly deciphered through interaction with complementary 
sites located o n the surface of many proteins ( cytokines, hormones, toxins, antibodies, 
lectins, adhesins, etc.), at such a selective level to be comparable to a "lock and key" 
recognition event. 
Changes in the structure of celi surface carbohydrates are particularly sensitive 
to conditions of the celi biology, such as the state of differentiation, cell cycle or 
growth conditions. 
The high degree of structural information combined with the fine-tuned 
rnodulation of their cellular expression, bestow carbohydrates to be scheduled as 
recognition rnolecules. The characterization of carbohydrate structure and the study of 
the rnultivalent interaction mechanisms between carbohydrates and sugar-binding 
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proteins is essential to understand the physiological functions of these molecules in 
health and disease. The ultimate scope, indeed, of the glycobiologist is to develop 
saccharidic diagnostic markers of disabling or life-threatening pathologies, design 
sugar inhibitor models aimed to interfere with a harmful recognition process or 
produce pharmaceuticals, such as glycoproteins, which are aberrantly or insufficiently 
expressed in humans hit by inherited and metabolic disorders of glycosylation. 
In this global scenario, we approached some glycobiological relevant issues 
from a methodological point of view. 
One scope of this thesis was to develop and optimize experimental procedures 
aimed to improve the detection of mono- and oligo-saccharides present as widespread 
components in mammalian glycoproteins. Indeed carbohydrates inherently lack 
chromophores, resulting completely "transparent" to UV -vis detectors generally 
supplied with most commonly used analytical apparati. Conjugation with an UV-
sensitive molecule, therefore required, is easily performed at the sugar residue 
positioned at the reducing end via reductive amination. However, N-acetylamino 
sugars, usually bridging 0- and N-linked oligosaccharide sequence to the protein core, 
are generally not efficiently labelled with chromophores commonly used in 
derivatisation procedures. A false estimation of the amount of GlcNAc and GalNAc, 
occupying the reactive terminus of respectively N- and 0-glycan sequences, may then 
result. A comparative study aimed at the development and optimisation of a labelling 
procedure enhancing N-acetylamino sugar detectability has been performed with the 
ultimate scope of a simultaneous CE analysis of a mixture of those monosaccharides 
which are most frequently encountered as components of mammalian and plant 
glycoproteins. 
The developed labelling method, based on sugar derivatization with 2-
aminobenzoic aci d, has been successfully used also for monitoring the p. D-
galactosidase-catalyzed synthesis of N-acetyllactosamine (LacNAc), performed using 
p-nitrophenyl-galactopyranoside as glycosyl donor and GlcNAc as glycosyl acceptor. 
The synthesis was carried out in heterogeneous phase, i.e., anchoring the enzyme on a 
solid support in order to achieve a more stable and active biocatalyst and to facilitate 
the recovery of both enzyme and product. The obtained kinetic data were compared 
with those observed using the enzyme freely acting in solution. 
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A further scope of this thesis was to identify and quantify oligosaccharide 
portions of glycoproteins of biothecnological, like p.glucosidase, or therapeutical 
interest, such as membrane glycoproteins. In this respect two alternative ways of 
processing glycoprotein carbohydrates using recombinant human placenta} {3-
glucosidase and bovine fetuin were addressed. The former glycoprotein, a lysosomal 
enzyme involved in the degradation of glucocerebrosides, obtained from genetically 
engineered tobacco plants, was subjected to complete chemical hydrolysis, 
derivatization and CE analysis. The nature and amount of the component 
monosaccharides of the N-glycan moiety were established in order to predict the 
potential immunogenicity of the recombinant glycoprotein for delivery to humans. 
The scientific relevance of studying the glycosylation pattem relied on the 
possible detection of specific tumoral markers expressed at early stages of the 
pathology. To develop and optimise a methodological stategy, based on the enzymatic 
release and analysis through LC-MS, that could be exported to the glycosylation 
pattem studi es of membrane glycoproteins, the commerciai fetuin was here used. 
Mainly for structural purposes much effort has been devoted also to scale up 
the biosynthesis and purification of the Helycobacter pylori lysozyme, an enzyme with 
autolytic activity against bacterial celi walls. It is reasonable to suppose that a specific 
interaction between the lysozyme and N-acetilmuramic acid is essential for this 
pathogenic ba.cterium to invade and colonize the gastric epithelium of primates. In 
order to attempt structural characterizations, either alone or in complexed form with 
the sugar substrate, the biosynthesis scale-up was required. This could be performed 
after identification of the gene encoding the lysozyme sequence in the genomic 
sequence of Hpylori, cloning the DNA sequence of interest into a suitable expression 
vector and promoting the high-level expression of the lysozyme in E. coli. Although 
different expression systems were developed and attempted, the best expression vector 
turned out to be the pGEX, leading to the obtainment of GST-fused protein. Once 
isolated, characterization was started with specific sugar-protein binding studies 
carried out by capillary affinophoresis. Given its structural similarity with the natura} 
substrate ofthe enzyme, the LacNAc disaccharide was then tested as ligand. 
In conclusion this PhD work deals with the development of bioanalytical and 
synthetic methodologies directed toward a suitable structural investigation and 
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production of specific oligosaccharidic sequences. Further, attention was focused also 
on the research of advanced biotechnological procedures for the large scale 
biosynthesis and purificati o n of an oligosaccharide-binding protein. 
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Techniques and methods 
3.1 Electrophoresis methods 
Defined in the broadest sense, electrophoresis refers to the migration of 
electrically charged species dissolved or suspended in an electrolyte support medium 
under the influence of an electric field. Cations migrate toward the negatively charged 
electrode ( cathode) and anions are forced to m o ve toward the positively charged 
electrode ( anode ), while neutral solutes are not attracted to either electrode. The 
separation ofthe analytes exploits their different charge-to-mass ratio, i. e., smaller and 
more highly charged solutes move more quickly. The major difference between 
electrophoretic techniques relays on the type of support medium where analytes are 
run, which can be a free solution, a thin layer of gel, etc. 
Ali the electrophoretic methods share the same physical principle: ifa molecule 
has a net charge q, then application of an electric field E will result in an applied force 
F = q E. This force will cause acceleration of the particle until a steady state velocity v 
is reached. At this velocity, frictional forces (Ffr) are equal and opposite to the applied 
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force: F-Ffr =O. Being Ffr = fv, it results that the stady state velocity v by which a q 
charged particle moves under an applied electric field E is: 
v=qE/f 
where f is the parti c le translational frictional coefficient. F or a molecule of 
radius a and strongly interacting with a moving fluid of viscosity 1), the friction 
coefficientfis given by the Stoke's law f= 63t1)a. Then fora molecule ofradius a with 
a charge equal to ze (where e is the charge on the electron): 
v = zeE/6.7t'lla 
F or a unidirectional field E the molecule travels in a straight line and the 
electrophoretic mobility !l can be defined as the velocity per unit field: 
!l= v/E= ze/6.7t'lla (l) 
Unfortunately, real molecules, especially of relatively large size, hardly can 
approximate spherical model. Even if their shape can approximately be spherical their 
charge distribution is not expected to be spherically symmetric. An immediate 
difficulty comes from what to cali the net charge on a macromolecule. Fora charged 
macromolecule in aqueous solution there are counterions, some more tightly 
associated with the polymer, others more loosely. Consider, for example, what will 
happen if an electric field is applied to a positively charged macromolecule with only 
enough anions in solution to neutralize this charge: the molecule will tend to migrate in 
one direction, the counterions in the opposite direction. Due to the enormous 
electrostatic energy involved in separating any net charge only little, if any, net motion 
will occur. A large amount of electrolyte can be added to weaken this ion pairing. 
However, differently from other techniques, in electrophoresis this procedure 
introduces more difficulties. On one side the added electrolytes, forming an ionic 
atmosphere around the molecule, will effectively reduce the net charge on the polymer 
(screening effect). On the other side this ion atmosphere creates an electric field, felt 
by the macromolecule that together with the applied field, will determine its mobility. 
This ion atmosphere is generally treated as a continuous distribution of charges, 
ignoring individuai charges. In this case the electrostatic potential felt at distance r 
from the uniformly ze charged sphere of radius a in a medium of dielectric constant E 
is simply given by: 
(;, = ze/Er with r >a 
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A "screened" potential is obtained when the same uniformly charged sphere is 
in an electrolyte solution that, can be shown, is given by: 
~ = (ze/tr)exp[k(a-r)](l+ka) 
k is a screening parameter, having dimensions of inverse length and depending 
from the ionic strength (i.e. the sum over the molar concentrations multiplied by the 
square charges of ali the ionic species in solution). I t regulates the extent to which the 
potential of an ion falls off more rapidly in an electrolyte solution than it would if there 
were no counterions: the higher the ionic strength the more effectively the potential of 
an ion is screened. If under an applied electric field the screened potential remains 
constant the predicted electrophoretic mobility is espressed by Henry's equation: 
~ = (ze/63t11a)f(ka)/(l +ka) (2) 
where f(ka) is a function that has been tabulated by Henry. In equation (2), 
distorsions of the ion atmosphere induced by the applied electric field as well as by ion 
motions are not considered. More complete theories have taken into account the 
formidable problem of calculating ali these effects. The result is an equation with the 
same leading term of equation (2) but with many additional terms. The simple theory 
of equation (2) predicts a linear increase of the mobility with increasing charge. The 
more complete theories show that at sufficiently high charge density the mobility is 
less than that expected from equation (2) and can even start to decrease as z increases. 
In ali cases, however, they are not adequate to explain the observed macromolecular 
electrophoresis. Holding only for spheres of uniform charge density, the models are 
very poor representations of a protein or a nuclei c acid. However, equation (2) can be 
used to have a simple estimation of approximated values of the electrophoretic 
mobility of macroions. 
3.1.1 Slab gel electrophoresis 
A very common method for analyzing and separating proteins by 
electrophoresis uses a discontinuous polyacrylamide gel matrix as a support medium, 
which has the advantage of high resolving power for small and moderately sized 
proteins (l O-l 000 kDa), minima! interaction with the migrating molecules and good 
physical stability. Electrophoresis through polyacrylamide gels leads to enhanced 
resolution of sample components because the separation is based on both molecular 
56 
sieving and electrophoretic mobility. Generally the separation is performed running the 
samples in a sodium dodecyl phosphate (SDS)-rich gel, a necessary component to 
achieve denatured and essentially anionic polypeptide chains. Hence, being charge-to-
mass ratio nearly the same among SDS-denatured proteins, the final separation 
depends almost entirely on size. This type of slab gel electrophoresis is often called 
"denaturing electrophoresis" or SDS-polyacrylamide gel electrophoresis (SDS-PAGE). 
Preparing the gel. Gel preparation requires casting two different layers of 
acrylamide between glass plates. The lower layer, called separating or resolving gel, is 
responsible for actually separating polypeptides by size. The upper layer, the stacking 
gel, includes the sample wells. It is designed to sweep up proteins in a sample between 
two moving boundaries so that they are compressed (stacked) into micrometer thin 
layers when they reach the separating gel. Polyacrylamide gels are prepared by the free 
radica! copolymerization of acrylamide and the cross-linking agent N,N'-
methylenebisacrylamide in a solution containing also 0.4% SDS, 1.5 M Tris-HCI 
buffer (pH 8.8) and an initiator-catalyst system, i.e., ammonium persulfate (APS) and 
N,N,N',N'- tetramethylethylenediamine (TEMED). Gels can be prepared with different 
pore sizes by changing the concentration ofthe cross-linking agent and, given a certain 
acrylamide-cross link:er ratio, gel concentrations should be selected so that proteins of 
interest are resolved. For example, a typical gel of 7% acrylamide composition nicely 
separates polypeptides with molecular mass between 45 and 200 kDa, while a denser 
gel, say 14%, usually resolves ali ofthe smallest polypeptides in a mix. 
Preparing the sample. Native or intact proteins are notoriously difficult to 
separate reproducibly. Good denaturation can be obtained mixing protein samples l :l 
with a buffer containing l% SDS, 10% glycerol, 10 mM Tris-HCI (pH 8), l mM 
ethylene diamine tetraacetic acid (EDT A), in presence of a reducing agent such as 
dithiothreitol (DTT) or f)-mercaptoethanol and a small amount of bromophenol blue as 
tracking dye. EDT A is a preservati ve that chelating divalent cations, reduces the 
activity of proteolytic enzymes requiring calcium and magnesium ions as cofactors. 
Glycerol simply renders the sample denser than the running buffer, so the sample will 
remain in the bottom of a well rather than float out. The dye allows the experimentalist 
to monitor the progress of the electrophoresis. SDS, DTT and beat are responsible for 
the actual denaturation of the sample. SDS breaks up ali high-level protein 
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organizations to produce linear polypeptide chains coated with negatively charged 
layers of SDS molecules. Due to Coulomb repulsion between like charges, the proteins 
are more-or-less forced to stretch out. Many proteins have significant hydrophobic 
properties and may be tightly associated with other molecules, such as lipids, through 
hydrophobic interaction. Heating the samples to at least 60°C sh~es up the molecules, 
allowing SDS to bind in the hydrophobic regions and complete denaturation. However, 
some quaternary structure may stili be retained through covalent disulfide bonds 
between cysteines. Disulfide bridges can be readily disrupted by DTT, a strong 
reducing agent. 
Running the gel. After polymerization, the gel plate is placed between two 
buffer reservoirs, generally filled with the electrode buffer (25 mM Tris, 192 mM 
glycine, 0.1% SDS). The assembly of a gel running must allow current continuity 
between the gel plates and the run buffer chambers. Then the sample is loaded into 
each well (generally 20 J..tg of denatured protein), including a standard mixture òf 
proteins with known molecular weight, and a proper voltage is applied. The 
negatively-charged proteins will move toward the anode and when the dye front 
approaches the bottom of the gel the run is stopped. 
Staining the proteins. For protein detection the slab is removed and stained 
overnight with an appropriate dye, usually 0.1% Coomassie Blue dye in 50% methanol 
and l 0% glacial aceti c aci d, that electrostatically interacts with proteins. Dye in excess 
is washed out by "destaining" with l 0% aceti c aci d and decreasing amounts of 
methanol (from 50 to 7%) in few steps. 
3.1.2 Capillary electrophoresis (CE) 
CE and its numerous variant modes, although not ali mentioned here, represent 
an extremely versatile method for separation and analysis of a wide range of analytes, 
ranging from large biomolecules, such as proteins and nucleic acids, to metal and 
organic ions while having the capability to resolve enantiomers or sugar isomers and 
non-charged molecules. Its methodological value is enhanced by short separation times 
and a requirement for very small amounts of analyte, a key feature when dealing with 
biologica! samples. 
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However, as can be deduced from the theoretical overview shortly addressed 
in section 3.1, the interpretation of data from CE analysis on large sized molecules, 
such as proteins and nucleic acids, is not so easy to handle, being the electrophoretic 
mobility difficult to predict. Conversely, the experimental mobility of a solute 
molecule is readly obtained. 
As depicted in Figure 3.1, the CE equipment consists of a power supply, two 
buffer reservoirs, a buffer-filled capillary tube and an on-line detector. Platinum 
electrodes connected to the power supply are immersed in each buffer reservoir. A 
high voltage is applied along the capillary and a small plug of sample solution is 
injected into one end of the capillary. Components in the solution migrate along the 
length of the capillary under the influence of the resulting electric field and the 
molecules are detected as they exit from the opposite end of the capillary. Some 
important elements of the CE apparatus are here presented more in detail. 
Detector 
e 
Buflèr CatJMe 
Electrcde Electrcde 
Figure 3.1 : Experimental setup for capillary electrophoresis. 
Capillary. The distinctive feature of the method is that separations are carried 
out in a narrow bore capillary tube, the cross section of which is typically 25-100 !J.m. 
The length of the capillary differs in various applications, being commonly in the 
range of 25-100 cm. The capillaries used are generally made of fused silica with an 
external polyimide protective coating, providing for an increased mechanical strength. 
A window for detection purposes is created by removing a small portion of this 
coating. In some cases, especially when reduction of sample adsorption onto the 
internai capillary layer or removal of the ionic charged surface of the silica wall are 
required, a capillary with chemically modified inner surface is used. Coated capillaries 
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are obtained by covalently binding ( coating) different substances, such as linear 
polyacrylamide (LPA) or cross-linked polyvinylalcohol (PVA). Either coated or not, 
the capillary is fili ed with an electrolyte ( conducting) solution through the ends 
dipping into reservoirs containing the electrolyte buffer. Electrodes, generally made of 
platinum and connected to a high voltage power supply, are also inserted into the 
electrolyte reservoirs to complete the electrical circuit. 
Sample injection. A small volume of sample (from IO to 100 nL) is injected 
into the capillary by dipping one end into the sample vial and applying gas pressure on 
the free surface of the sample. A volume of sample solution is then forced by pressure 
to travel into the capillary. This type of method, known as pressure or hydrodynamic 
injection, allows also the capillary to be filled with the running electrolyte solution. 
Power supply. Application of a voltage causes the motion of the ions from the 
inlet of the capillary towards the electrode of opposite charge placed at the outlet of the 
capillary. The potentials applied, either positive or negative, usually range from l O to 
30 kV, i. e., almost 100 orders ofmagnitude higher than in slab electrophoresis, and the 
currents produced generally do not exceed 50-l 00 !!A. Heat generated inside the 
capillary can be effectively dissipated through the walls of the capillary and suitable 
temperature contro! systems, allowing high voltages to be applied and separations to 
be performed in a very short time frame (typically 30 minor lower). 
Detector. The most frequently used detector is a UV -visible absorbance 
spectrophotometer, which is standard on commerciai CE instruments. Alternative 
detector modes commercially available include fluorescence, laser induced 
fluorescence, conductivity and pulsed amperometric detection. The detector, placed 
just near the outlet ofthe capillary, can be interfaced to a computer for data acquisition 
and analysis of the so called electropherogram (i. e. the plot of the measured electric 
signa! versus time ). 
In electrophoresis the mobility of any ion is govemed by the balancing 
between the propelling forces impressed by the electric field and the retarding, 
frictional forces of the moving liquid which are both function of molecular mass and 
shape of the analyte. However, the small cross-sectional area of the capillary used in 
CE brings into play the phenomenon of electroendosmosis, neglected in conventional 
electrophoresis. The walls of a fused silica capillary contain ionisable silanol groups. 
; i (; 60 
By silanol deprotonation, occurring at pH values higher than 4, the capillary inner 
surface, becoming negatively charged, acquires a~ potential that induces a no longer 
random distribution of cationic species in the electrolyte solution to preserve 
electroneutrality. A layer oftightly bound cations immediately adjacent to the capillary 
wall, associated with a layer of more loosely interacting ions, largely cationic in 
nature, is then formed (see Figure 3.2). 
Glass capillary 
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Figure 3.2: The fonnation ofthe electroosmotic flow (EOF) in a fused silica capillary induced 
by an electric field. 
The ,application of a positive voltage, with the negative electrode set at the 
outlet of the capillary, forces these more loosely bound cations to tra ve l toward the 
cathode. The motion of the cations, surrounded by their hydration shells, establishes as 
a consequence a bulk flow in the same direction. This so-called electroosmotic jlow 
(EOF) effectively acts as an "electrically-driven pump" toward ali solute molecules, 
forcing neutral molecules and even those with a negative charge to move along the 
capillary towards the cathode. Although the EOF, therefore, does not necessarily 
represent a disadvantage, its extent and influence has to be kept under control to not 
invalidate the experiment reproducibility. EOF can be readily measured by injection of 
a neutral marker, such as acetone, and measuring the time it takes to reach the detector. 
The magnitude ofEOF, expressed in terms of electrophoretic mobility (!l), is given by: 
!lEOF = t~41tYJr [cm2Ns] 
where t is the dielectric constant of the running buffer, ~ the zeta potential, 'Yl the 
viscosity of the buffer and r the capillary radius. Here, differently from what reported 
in section 3.1, the neutral marker is not interacting with the fluid, the frictional forces 
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are weaker and the slip conditions for whichf= 4rtr] apply. From the equation it turns 
out that the electrolyte composition will influence the EOF. High pH will increase the 
ionisation of the silanol groups, increase the zero potential and therefore enhance the 
electroendoosmotic effect, while increasing the ionic strength decreases EOF as the 
zeta potential is reduced. The EOF is generated through the entire length of the 
capillary and therefore produces constant flow rate at ali distance along the capillary. 
3.1.2.1 Capillary zone electrophoresis (CZE) 
The simplest form of the technique is often termed free solution or zone 
electrophoresis. In CZE the capillary is filled with a buffer with constant composition 
and the source and destination reservoirs are filled with the same buffer. The migration 
of analytes in free electrolyte solution under the influence of an electric field is 
affected by their charge-to-size ratio as expressed more simply from equation (2) of 
section 3.1. As already stated, prediction of the mobility is therefore not simple in 
practice. CZE is a widely used mode of electrophoresis being applicable to the 
simultaneous separation of anions and cations, but not neutral molecules, which are 
swept, unresolved, through the detector together. In normal polarity, i. e., setting the 
cathode at the outlet of the capillary, EOF pumps the solutes through the capillary 
from the anode to the catode. The order of elution in CZE is cations, neutrals, then 
anions, as depicted in Figure 3.3. Since cations migrate through the capillary in the 
same direction as the EOF, from anode to catode, their rates of migration are grater 
than the EOF. Cations elute in order to their charge-to-size ratios, with small, highly 
charged cations eluting frrst. Neutral molecules, which move through the capillary 
under the influence of only the EOF and are not separated from each other, elute after 
the cations. Anions, that attracted to the positive electrode tend to migrate in the 
opposite direction of the EOF, elute last. Usually the EOF is greater than the 
electrophoretic velocities of the anions, so most of them are also carried toward the 
catode. Anions elute in reverse order to their charge-to-size ratios, with small, highly 
charged anions eluting last. 
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Figure 3.3: Elution order ofneutral (N) and charged molecules in normal polarity CE under the 
influence of EOF. 
EOF can be reversed, so that the order of elution is anions, neutrals and cations. 
Morepver EOF can be eliminated through suitable coating of the inner capillary wall. 
Without EOF and norma! voltage polarity, only cations will migrate through the 
capillary. Anions will migrate towards the anode and the neutrals will stay at the point 
of injection. Hence CZE can be used to separate almost any ionized compound that is 
soluble in a buffer. 
Measuring the electrophoretic mobility. The mobility of a given charged 
compound can be easily obtained from experimental CE data. Assuming that Ìobs is the 
time that a solute takes to migrate from injection to detection window separated by a 
distance letr, then its observed electrophoretic velocity Vobs is: 
Vobs = leff l Ìobs [cm/s] (l) 
In free solution electrophoresis the electroosmotic flow is present as well. The 
velocity observed for a solute molecule is then the slim of its intrinsic velocity v and 
the velocity ofEOF, VEoF: 
Vobs =V+ VEOF (2) 
with VEoF obtained by measuring the migration time of a neutra! marker, tEoF: 
VEOF = leff l tEOF [cm/s] (3) 
The intrinsic velocity v of an ion is then given by: 
V = leffl'Ìobs - leffl'tEoF 
Being the electrophoretic mobility the velocity per unit field, !l- = v/E, ( equation 
(l) of section 3.1) and remembering that the electric field E generated by a voltage V 
applied to two electrodes located at a distance L is E = V IL i t follows that: 
!l-= (leal!obs -leaftEOF) (LN) [cm2Ns] (4) 
Equation (4) allows to obtain the intrinsic mobility of a given ion in CZE 
making use of simple experimental parameters, such as the inlet to detection window 
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length Oetr), the capillary total length (L), the applied voltage (V) and the observed 
migration times ofthe examined ion (tobs) and ofthe EOF (tEof). 
3.1.2.2 Micellar electrokinetic capillary chromatography (MEKC) 
One of the obvious limitations of CZE is that the range of molecules, which 
can be separated, is restricted to those which carry a charge. The development of 
MEKC mode provides a method for the separation of electrically neutral compounds 
associating the phenomenon of EOF with a form of partition chromatography. Besides 
the electrolyte running buffer, the separation conditions require also the addition of a 
detergent, mainly the anionic surfactant sodium dodecyl sulfate (SDS), [CH3-(CH2)u-
O-S03 · N a+]. Above a specific concentration, the so-called criticai mi celiar 
concentration (CMC), hydrophilic and water soluble head groups form an outer shell 
whereas hydrophobic tails condense into a non-polar core into which solutes can be 
trapped. As an example, in Figure 3.4 some of the proposed micelle structures are 
reported. MEKC can be considered as a sort of chromatographc technique since solute 
separation Qccur by differential partitioning of analyte molecules between a two phase 
system: a polar/aqueous/mobile phase and a non-polar/micellar/pseudo-stationary 
phase. When an anionic surfactant such as SDS is employed, the micelle migrates 
toward the anode (injection end) by electrophoresis. The EOF transports the bulk 
solution toward the negative electrode due to the negative charge on the surface of 
fused silica. Since the EOF is usually stronger than the electrophoretic mobility of the 
micelle, under alkaline conditions the anionic micelle travels toward the cathode 
( detection end) with slower velocity. When analyte is injected into the micellar 
solution, a fraction of it is incorporated into the micelle and it migrates at the velocity 
of the micelle. The remaining fraction of the analyte remains free from the mi celle and 
migrates either with the electroosmotic velocity (neutra! analyte) or with 
electrophoretic mobility ( charged analyte ). The greater the percentage of analyte that is 
distributed into the micelle, the slower it migrates. The analyte must migrate at a 
velocity between the electroosmotic velocity and the velocity of the mi celle ( elution 
window). 
As a generai rule, then, the amount of time that an analyte spends in the 
micelles is proportional to its hydrophobicity. Highly hydrophilic water-soluble 
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molecules, preferentially interacting with the buffer, are carried through the capillary 
at the rate of the EOF and are the first to e Iute. Very hydrophobic molecules are totally 
solubilized into micelles and, travelling through the capillary at the same rate as the 
micelles, are the last to elute. Ali other species, with intermediate hydrophobicity, are 
expected to elute between totally hydrophobic and totally hydrophilic compounds (see 
Figure 3.4). The measured migration times are thus proportional to the strength ofthe 
solute-micelle interactions which, in turn, reflects their hydrophobicity scale. 
Mic~l1ur + ..... , .,____ 
FJow 
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----------
Figure 3.4: Separation principle in MECK under norma! polarity conditions. 
3.2 Western blot (WB) 
-
Western blot (WB) is a biochemical method used to detect proteins by testing 
them against specific antibodies. The name western blot was given to the technique by 
W. Neal Burnette (1) and is a pun on the name southern blot, a technique for DNA 
detection developed earlier by Edwin Southern. 
Typically, in order to test purity of a biopolymer as well as to estimate its molar 
mass, protein samples previously fractionated through SDS-P AGE are transferred (or 
blotted) from the gel to a thin support matrix, where, strongly bound and immobilized 
onto the membrane surface, they become available for chemical or biochemical 
reactions. When protein identification with highly specific and sensitive 
immunological detection techniques is performed, the procedure is called western 
blotting. 
Protein transfer. Usually two types of support matrices are commercially 
available for transfer, nitrocellulose and polyvinyl difluoride (PVDF) membranes. The 
membrane is put face-to-face with the gel, assembled in a sandwich-like arrangement 
between a wet double or triple layer of filter paper. The semi-dry transfer is then 
generally afforded through an electroblotter, placing the sandwich between two 
platinum electrodes and applying a voltage ( 4 mA/cm2), which moves the negatively 
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charged SDS-protein adducts towards the anode. Protein binding is based upon 
hydrophobic interactions, as well as charged interactions between the membrane and 
the protein. As a result of this transfer, proteins are exposed on a thin surface layer for 
detection. 
Detection of proteins. Since the membrane has been chosen for its ability to 
bind proteins, steps must be taken to prevent non-specific protein interactions between 
i t and the antibody used for detection of the target protein. It is therefore necessary to 
block protein binding sites on the membrane that are not occupied by the blotted 
proteins. This is essential because antibodies used to detect blotted proteins are also 
proteins and will bind to the membrane and interfere with the detection procedures. 
Free protein binding sites on the membrane are saturated placing the membrane in a 
dilute solution of protein, typically bovine serum albumin (BSA) or casein (major 
protein in non-fat dry milk), with a minute percentage of detergent such as Tween 20. 
The blotted membrane, with ali protein binding sites occupied, can now be treated with 
analytical reagents for detection of specific proteins. 
In generai antibodies are proteins of the immunoglobulin G (IgG) class and are 
generated when a host species or immune celi culture is exposed to the protein of 
interest (or a part thereof). They are then harvested anq used as sensi ti ve and specific 
detection tools that bind the protein directly, ben ce primary antibodies. The primary 
antibody binds to the target protein forming an antigen-antibody complex. Usually a 
dilute solution of primary antibody is incubated with the membrane under gentle 
horizontal agitation. Typically, a buffered saline solution containing small percentages 
of detergent and sometimes of powdered milk or BSA is used. Being the formed 
antigen-antibody complex usually undetectable, the membrane is exposed, after 
remo val of unbound primary antibody, to a secondary antibody, directed against the 
generai class of primary antibody and usually linked to a reporter enzyme, such as 
alkaline phosphatase or horseradish peroxidase. As an example, if the primary 
antibody was produced in rabbit serum, then the second antibody would be anti-rabbit 
IgG, usually raised in goat or borse. Most commonly, a horseradish peroxidase-
conjugated secondary antibody is incubated with a chemiluminescent agent and the 
antigen-antibody-antibody complex formation is determined and quantified by the 
intensity of emitted light. In turn the emitted light is letto impressa sensitive sheet of 
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photographic film placed against the membrane and its intensity determined by 
densitometry. 
3.3 Protein determination 
Biochemical research often requires the quantitative measurement of protein 
concentrations in solution. Severa! techniques have been developed. However, many 
have limitations because they either are not sensitive enough or they are based on 
reactions with specific amino acids in the protein. Since the amino acid content varies 
from protein to protein, no single assay will be suitable for ali proteins, in other words, 
there is no universal protein determination assay. Moreover, the solution matrix where 
the protein is dissolved, often interferes with protein detennination. 
Briefly, chemical reagents are added to protein solutions to develop a colour 
whose intensity is measured in a spectrophotometer. In parallel, a standard protein of 
known concentration is also treated with the same reagents and a calibration curve is 
constructed. Generally protein amounts between 1-20 j..tg are detected in the so-called 
micro assay format. The assay can be performed in a microwell plate, which is a very 
convenient way to process a large number of samples rapidly. Hence, despite the 
aforementioned disadvantages, assays will provide satisfactory result if the proper 
experimental conditions are used ami/or a suitable standard protein is chosen. 
3.3.1 The Bradford assay 
The Bradford assay is a very popular protein assay method because it is simple, 
rapid and sensitive (2). The assay is based on the binding of Coomassie Brilliant Blue 
G-250 (CBBG) dye to proteins at Arg and, to a lesser extent, at aromatic residues. The 
dye binds to these amino acids in the anionic form, which has an absorbance maximum 
at 595 nm (blue). The free dye in solution is in the cationi c form, which has an 
absorbance maximum at 470 nm (red). The assay is monitored at 595 nm in a 
spectrophotometer, and thus measures the dye in complexed form with the protein. In 
practice, a calibration curve is prepared using BSA or bovine IgG as standard proteins. 
The assay requires only a single reagent, an acidi c solution of CBBG. After additi o n of 
dye solution to a protein sample, colour development is complete in 2 minutes and the 
colour remains stable for up to I hour. Some proteins, especially hydrophobic, tend to 
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precipitate in presence of Coomassie dyes. This can be avoided by adding a specified 
amount of sodium hydroxide to the sample. The Bradford method has very few 
interferences by non-protein components: the only known interfering substances are 
detergents, Triton X-1 00 and SDS. 
3.3.2 The bicinchoninic acid assay (BCA) 
The principle of the bicinchoninic acid (BCA) assay relies on the formation of 
a Cu ++ -protein adduct under alkaline conditions, followed by reducion of Cu ++ to Cu + 
and complexation of the monovalent io n with BCA, leading to a colour change of the 
examined solution (3). Before starting with the assay, the BCA solution is mixed 50: l 
with a 4% (w/v) CuS04 solution, giving an apple-green coloured solution. When 
protein is added, Cu ++ reduces to Cu +, being peptide bonds, cysteines, cystines, 
tryptophans and tyrosines able to act as reducing agents. The amount of reduction is 
proportional to the protein present, of course. BCA forms a purple-blue complex with 
Cu + in alkaline environments, thus providing a basis to monitor the reduction of 
alkaline Cu ++ by proteins at an absorbance maximum of 562 nm. The colour complex 
is stable and less susceptible to detergents. However, the procedure is not so rapid 
requiring typically I h incubation ofthe reaction mixture at 60°C. 
3.4 Liquid chromatography (LC) 
Chromatography has been and will continue to be one of the most effective 
techniques for isolating and purifying all types of biomolecules. All chromatographic 
separations are based on the same principle, i. e., on the different affmity of molecules 
or ions towards two distinct phases, a stationary phase, immobilized onto a support, 
and a mobile or moving phase, which flows continuously over the stationary phase. 
The particles distribute themselves between the mobile and the stationary phase in a 
different extent: those that interact strongly with the stationary phase, are retarded in 
their movement through the chromatographic system, while those who show weak 
affinity for the stationary phase are more rapidly dragged by the mobile phase, often 
called the eluent. Molecules are therefore selectively eluted through the 
chromatographic system and finally separated. Generally the different polarity of the 
two phases plays a key role in chromatographic separations. 
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Chromatographic methods are classified according to the molecular mechanism 
which occurs in the particular interaction between the compound to be separated and 
the mobile/stationary phase couple, i.e., adsorption, partition, ionic exchange, size 
exclusion or affinity chromatography. Sometimes beneath a chief interaction 
mechanism, also a secondary one may be active in the separation process. In liquid 
chromatography, the stationary phase is solid while the mobile phase is liquid. The 
stationary phase is usually confined into a glass, plastic or metallic column and the 
mobile phase, a solvent or a buffer, is allowed to flow continuously through the solid 
materia!. 
A chromatographic separation. A small amount of sample to be analyzed is 
layered on the top of the column, packed by pouring a wet slurry of the solid in the 
already filled column with liquid phase. The sample mixture enters the column and 
begins to distribute between stationary and mobile phase. The chromatographic system 
is developed by continuous flow of the eluent. Maintaining the appropriate flow rate is 
important for effective separation: if the flow rate is set too high, there is not sufficient 
time for complete equilibration of the sample components among the two phases. Too 
low a flow rate allows diffusion of solutes, which leads to poor resolution and broad 
elution bands. Elution can be performed in one of these three different ways: (i) 
isocratically, when ali components are eluted by a single solvent, mixture of solvents 
or a buffer (ii) stepwise, applying sequentially a series of solvents usually with 
increasing polarity or ionic strength (iii) in gradient, or gradually changing the 
composition or ratio of two different elution solvents or buffers. The various 
components move through the column at different rates, owing to their different 
affinity toward the two phases. Those solutes that interact more strongly with the 
mobile phase elute through the chromatographic system more rapidly than those that 
are preferentially distributed in the stationary phase. These are sai d to be retained by 
the stationary phase. Retention is caused by intramolecular forces that exist between 
the solute molecules and those of the stationary phase. The retention of a solute in a 
chromatographic system is characteristic of the solute and can be used to help identify 
the solute. Finally, the separated components emerging at the column outlet dissolved 
in the eluent are subsequently collected, usually as discrete fractions in test tubes. The 
recovered liquid fractions should contain the individuai components of the originai 
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sample mixture. The completion of a chromatographic experiment calls for a means to 
detect the presence of solutes in the collected fractions. The detection method used will 
depend on the nature of the solutes and in generai i t exploits a certain physicochemical 
property of the isolated compound. Frequently amino acids, lipids or carbohydrates are 
detected by spotting fractions on a thin layer plate or a piece of filter paper and treating 
them with a chemical reagent that produces a colour. Proteins and nucleic acids are 
conveniently detected by spectroscopic absorption measurements at 280 and 260 nm, 
respectively. 
3.4.1 Size exclusion chromatography (SEC) 
The method of size exclusion chromatography ( aiso cali ed gel filtration, 
molecular sieve or gel permeation chromatography) exploits the physical property of 
molecular size, or in more technical terms, the hydrodynamic volume of molecules, to 
achieve separation. This technique has been of major importance in the purification of 
thousands of proteins, nucleic acids, polysaccharides and other biomolecules because 
the elution can be performed under physiological conditions. Moreover, this technique 
may be applied to molecular weight and molecular weight distribution determination 
as well as to quantitative analysis of molecular interactions. 
Separation principi e. In SEC the stationary phase consists of inert particles that 
contain small pores of a given size. Microscopic examination of a particle reveals an 
interior resembling a sponge. During the chromatographic development differently 
sized solutes of the same sample mixture behave differently passing through the 
column, because solutes larger than pores cannot enter the interi or of the gel beads, so 
they are limited to the space between the beads. The volume of the column accessible 
to very large molecules is, therefore, greatly reduced. As a result, they are excluded by 
the stationary phase and sweep through the column almost at the same rate as the 
eluent. Small molecules, however, capable of diffusing in and out of the beads have a 
much larger volume available for them. These molecules are completely permeated by 
the gel matrix. Therefore, they are delayed in their journey through the column bed. 
Molecules of intermediate size migrate through the column at a speed somewhere 
between those of large and small molecules. They do not enter completely the pores of 
the gel and occupy only a fraction of the whole bed volume. Therefore the order of 
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elution of different solute molecules is directly related to their molecular dimension. 
The elution volume, which is the volume of mobile phase necessary to elute a 
component, decreases roughly with the logarithm of the molecular hydrodynamic 
volume, often assumed to be proportional to molecular weight. 
Some physical properties of the gels affect considerably the success of a 
separation, as for example the .fractionation range, referred to the range of molecular 
weights which can be fractionated by the gel, the gel particle size, which is defined 
either by mesh size or bead diameter (J..tm) and the pore distribution, related to the 
distribution range of the pore dimensions of the gel. The chemical properties of the 
stationary phases, instead, are influenced by the nature of the beads, which can 
basically be of thrèe types: dextran, polyacrylamide and agarose. 
Applications ofSEC. Most chromatographic experiments can be classified as either 
group separations or fractionation. The frrst class involves dividing a solute sample 
into two groups, a fraction of relatively lo w molecular weight solutes and a fraction of 
relatively high molecular weight solutes. Specific examples of this are desalting a 
protein solution or removing small contaminants (dyes, detergents, etc.) from protein 
or nuclei c aci d extracts. F or group separations, a gel should be chosen that allows 
complete exclusion of the high molecular weight molecules. Gel fractionation, 
however, involves the separation of groups of solutes of similar molecular weights in a 
multicomponent mixture. In this case, a gel should be chosen so that the fractionation 
range includes the molecular weights of the desired solutes. 
SEC is generally considered a low resolution chromatography as is does not 
discem similar species very well and is therefore often reserved for the final 
"polishing" step of a purification. The technique can determine the quatemary 
structure of purified proteins which have low exchange times, since it can be carried 
out under native solution conditions, preserving macromolecular interactions. SEC can 
also assay protein tertiary structure as it measures the hydrodynamic volume (not 
molecular weight), allowing folded and unfolded versions of the same protein to be 
distinguished. The folded form will elute much later than the unfolded one, due to its 
globularity. SEC can be al so used to estimate the molecular weight of a pure protein or 
to measure the polydispersity, i. e., the distribution of sizes of molecules, of a synthetic 
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polymer. In both cases molecular standards of known size are run previously, then a 
calibration curve can be built to determine the sizes of the macromolecules of interest. 
3.4.2 Affinity chromatography (A C) 
The more conventional chromatographic procedures rely on rather non-specific 
physicochemical interactions between a stationary support and solute. The molecular 
characteristics of net charge, size and polarity do not provide a basis for high 
selectivity in the separation and isolation of biomolecules. The desire of more 
specificity in chromatography has led to the development of affinity chromatography. 
This technique offers the ultimate in specificity-separation on the basis of biologica! 
interactions. 
Separation principle. The biologica! function displayed by most 
macromolecules is a result of recognition and interaction with specific molecules or 
ligands. The most common example, summarized in the next equation, is the 
interaction that occurs between an enzyme molecule (E) and its substrate (S) with 
reversible formation ofthe complex (ES). 
E+S <> ES 
In practice, affinity chromatography requires the preparation of an insoluble 
stationary phase, to which appropriate ligand molecules (S) are covalently attached 
either directly or through a hydrocarbon chain of suitable length (spacer arm). The 
latter option is particularly useful for those macromolecules that, due to their steric 
hindrance, cannot approach a ligand that is directly fixed to the resin. Then the a:ffinity 
support is packed into a column through which a mixture containing the desired 
macromolecule (E) is allowed to percolate. There are many types of macromolecules 
in the mixture, especially if it is a crude celi extract, but only macromolecules that 
recognize and specifically bind to immobilized (S) are blocked in the column matrix 
through reversible formation of the ES adduct. After the non-binding molecules are 
washed away, the macromolecules ofinterest are eluted by gentle disruption ofthe ES 
complex. Often a simple change in pH or ionic strength or the addition of a mild 
denaturing agent is helpful to decrease the stability of the complex and favour the 
release of the desired molecule. Altematively, a selective substance added to the 
elution buffer is chosen to weaken the interaction existing between the ligand and the 
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blocked macromolecule. This substance may compete for the bound ligand displacing 
the macromolecule or, conversely, compete for binding to the combining site of the 
blocked macromolecule. 
The stationary supports used in gel exclusion chromatography are found to be 
quite suitable for affinity chromatography because they are physically and chemically 
stable under most experimental conditions, they have reactive functional groups (such 
as OH) to which an appropriate ligand may be attached. Clearly, the type of ligand to 
be immobilized can be selected only after the nature of the macromolecule to be 
isolated is known. If an enzyme has to be isolated, then a substrate analog may be used 
as ligand, but only if column conditions avoid catalytic transformation of the bound 
substrate. Furthermore, the ligand must display a strong, specific, but reversible 
interaction with the examined macromolecule and it must carry a reactive functional 
group for attachment onto the matrix. Severa! procedures have been developed for the 
covalent attachment of the ligand to the stationary support. Generally the procedures 
for gel modification are carri ed out through activation of the functional groups on the 
matrix and joining the ligand to the activated functional group on the resin. 
Application of A C. Affinity chromatography can be applied to the isolation and 
purification of virtually ali biologica! macromolecules. The application of affinity 
chromatography is extremely wide in biochemistry and biotechnology. Possibly the 
most common use of AC is for the purification of recombinant proteins. When proteins 
are expressed recombinantly, additional amino acids, an entire domain or a whole 
protein is often added to ai d in the purificati o n and manipulation of the protein. These 
additions to a protein are known asfosion tags. Proteins synthesized as fusions with an 
appropriate protein tag, are genetically modified so as to allow them to be selected for 
affinity binding. 
For example, immobilized meta/ ion affinity chromatography (/MAC) is a 
separation technique based on coordinate covalent binding between proteins and metal 
ions. However, not many naturally occurring proteins have affinity for metal ions, so 
the technique is mainly used to purify recombinant proteins which have previously 
been engineered to contain a histidine tail. A polyHistidine tag is an amino acidic 
motif in proteins that consists of at least 6 tandem histidine residues, often at the N- or 
C-terminus of the protein. Histidine binds tightly to copper or nickel bivalent ions. lf 
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the stationary phase, generally agarose functionalized with iminodiacetic or 
nitrilotriacetic acid (NTA), is immobilized with these ions, a mixture of proteins c an 
be separated on their ability to interact with copper or nickel. Only those proteins 
containing many histidine residues will be able to bind to the column, while those with 
low histidine content will be washed out. For elution, usually an excess amount of a 
Cu ++ or N t+ chelating agent, such as imidazole, ab le to compete with the His-tagged 
proteins for the metal coordination site, is used. 
As another example, recombinant DNA techniques are commonly used to 
create proteins as fusions with Schistosoma japonicum GST. GST stands for 
glutathione-S-transferase, a 220 amino acid sized tag. The GST displays high affinity 
for its substrate, glutathione. Sepharose beads can be coated with glutathione and such 
a matrix selectively binds GST -tagged proteins. When the fusion protein sticks onto 
the matrix, non-specifically bound proteins are removed through extensìve washing. 
Adding an excess of free glutathione to the affinity column will release the protein of 
interest. 
3.4.3 High performance liquid chromatography (HPLC) 
This technique is ideally suited for the separation and the and identification of 
amino acids, carbohydrat~s, lipids, nucleic acids, proteins, pharmaceuticals and many 
other biologically active molecules. HPLC is sometimes considered as the instrumental 
evolution of LC: compared to other forms of column liquid chromatography, now 
referred as classica! or traditional, HPLC has several advantages, such as high 
resolution and speed of analysis, improved reproducibility due to the ease of control of 
the experimental parameters and adaptability to large-scale, preparative procedures. In 
traditional chromatography, the smaller the particle size of the stationary support, the 
lower the flow rate of the eluent. The progress in HPLC is the result of the 
development of stationary phases of very small particle size and large surface areas 
and ofthe improvement of elution rates by applying high pressure to the solvent flow. 
The great versatility of HPLC is evidenced by the fact that ali chromatographic modes, 
including partition, adsorption, ion exchange and gel exclusion are possible. 
Furthermore, the technique is suitable for the analysis of thermo-labile compounds, 
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such as biologica! samples, which do not need to undergo a vaporization step (such as 
in GC) since HPLC operates at room temperature conditions. 
Stationary phases in HPLC. The solid supports in HPLC are typically small-
diameter, porous materials. Two types of stationary phases are available: (i) porous 
layer beads bave an inert solid core with a thin porous outer shell of silica, alumina or 
ion-exchanger resin. The average diameter of the beads ranges from 20 to 45 !J.m. They 
are especially useful for analytical applications, but, because of their short pores, their 
capacities are too low for preparative applications; (ii) microporous particles are 
available in two sizes, 20 to 40 f.A.ID with longer pores and 5 to l O tJ.m with shorter 
pores. These are now more widely used than the porous layer beads because they offer 
greater resolution and faster separations with low pressures. The microporous beads 
are prepared from alumina, silica, zirconia, ion-exchanger resins, and polymeric 
matrices. 
If the surface of the microporous particles is chemically modified through 
coating with a certain functional group, then a gelling phase is generally obtained and 
the resulting type of chromatography allows to separate the components of a mixture 
owing to the different extent in which they partition between the mobile liquid phase 
and the stationary phase that is also liquid (gel). Inert solid particles can be used as 
supports for the attachment of a great variety of reactive groups. The coupling of the 
stationary phase to a solid support ensures the formation of a stable system that is 
called chemically bonded phase. Most bonded phases are silica based and prepared by 
reacting the hydroxyl groups of the surface silica with an organic moiety to give 
alkylnitrile, phenyl, alkylamine or alkyl side chains. The latter, for example, can be 
obtained through the following reaction: 
+SOCI2 +RMgBr 
-Si-OH -Si-Cl .. -Si-R 
where R is a generic hydrocarbon chain. 
Conventionally, stationary phases are polar in kind and are used in association 
with hydrophobic mobile phases. This type of chromatography retains analyte based 
on polarity and is called norma! phase chromatography. The use of non-polar 
chemically bonded stationary phases with hydrophilic mobile phases is therefore 
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referred to as reversed-phase chromatography. This technique separates sample 
components according to hydrophobicity. This turns out to be very attractive for the 
separation of all types of biomolecules, but typically peptides or proteins, which are 
able to stick on stationary phases modified with hydrocarbons with their so-called 
"hydrophobic foot". 
Mobile phases in HP L C. Very-high-purity solvents with no particulate matter 
are required. The mobile phase must not react with the analytical sample or column 
packing. A solvent must be carefully chosen to avoid interference with the detector. 
Mobile phases for HPLC usually have lo w viscosity, in order to avoid the application 
of too high pump pressures. The mobile phase must be chosen to complement the 
stationary phase so that the selected interactions are concentrated in the stationary 
phase and are minimized in the mobile phase. Thus, a reversed phase would be used 
with a strongly polar mobile phase (e.g. water/methanol, water/acetonitrile and 
water/tetrahydrofuran mixtures). In contrast, if the strongly polar silica gel is selected 
for the stationary phase, then an organi c mobile phase would be appropriate (e. g. n-
heptane, n-heptane/methylene chloride ). 
Instrumentation. A schematic diagram of a typical high-pressure liquid 
chromatograph is shown in Figure 3.5. The basic components are a solvent reservoir, 
high-pressure pump, packed column, detector and recorder. 
Solvent 
Resonroir 
Pump 
Colw.nut 
Sample 
htjectDr 
(Loop Valve) 
U.V. - V"JBmle-----
Light Souréi" 
Strip 
Ch.art 
(or Computer) 
Detector 
Figure 3.5: A schematic representation of an HPLC equipment. 
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In order to avoid bubbles in the column and in the detector, solvents should be 
degassed. The pumps can provide high, constant and reproducible flow of solvent 
through the column, which is prepared from stainless steel or glass-Teflon tubing. 
Typical column internai diameters are 2.1, 3.2 or 4.5 mm for analytical separations and 
up to 30 mm for preparati ve applications. The length of the column can range :from 5 
to l 00 cm, but l O to 20 cm columns are very common. The sample is introduced onto 
the columns in an efficient and reproducible manner through a neoprene/Teflon 
septum of a syringe injector. The system is generally equipped with UV-visible 
photometric detectors to monitor continuously solutes leaving the column. The 
detector is non-destructive to the sample, so column effluent can be collected for 
further physico-chemical analysis. Most HPLC instruments are on line with a 
computer for data handling. Generally, the whole system is automatically controlled. 
3.5 Mass spectrometry (MS) 
A mass spectrometer is an instrument that produces ions and separates them in 
the gas phase according to their mass-to-charge ratio (m/z). Basically a mass 
spectrometric analysis can be envisioned to be made up of the following steps: 
Sample introduction-+ ionization-+ mass analysis-+ ion detection/data analysis 
Samples may be introduced in gas, liquid or solid states. In the latter two cases 
volatilization must be performed either prior to, or accompanying ionization. Many 
ionisation techniques are available today to produce charged molecules in the gas 
phase, even at atmospheric pressure. Once ions are formed, they can be accelerated, 
focused or brought to resonance by electrical and magnetic fields. The separation of 
the different ions, owing to their m/z ratio, is accomplished in the analyzer. Mass 
spectrometers operate at reduced pressure in order to prevent collisions of ions with 
residua! gas molecules in the analyzer during the flight from the ion source to the 
detector. 
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3.5.1 Electrospray ionization-quadrupole ion trap mass spectrometry 
(ESI!QIT-MS) 
Electropspray ionization. Bioanalytical mass spectrometry is currently 
enjoying a surge in activity as the new ionisation methods, such as electrospray 
ionization (ESI), enable mass spectrometers to measure molecular weights for very 
large, thermally labile and non-volatile biological molecules. Previously, bringing such 
macromolecules in the gas-phase without significant sample degradation had been a 
key limitation. Thanks to this advancement, mass spectrometry has become very 
popular in biologica! research ( 4, 5). ESI is an elegant and simple method that operates 
at atmospheric pressure and at moderate temperature and is probably the most gentle 
or softest ionization method available for MS. ESI allows production of ions in vapour 
phase directly from samples in solution and is therefore considered as one of the most 
important ionization techniques for the on-Iine coupling of liquid phase separation 
methods, such as HPLC or CE, with mass spectrometry (6). 
Nebulization by electrospray produces a very fme liquid aerosol of ionized 
molecules through electrostatic charging. Exposure of the liquid sample to a strong 
electrostatic field produces a charged mist of gas phase ions that are slightly excited 
above their ground state. Only little energy is transferred to the molecule during the 
ionization process. Generally this ionization mechanism does not disrupt or fragment 
the analyzed molecule, thus maintaining the survival of ali sample molecules. The 
preservation of the analyte is ensured also by keeping the temperature lo w and under 
contro l. 
Equipment. The most common ESI apparatus is made of a pointed hollow 
metal tube. When the power supply is turned on, a potential difference is applied 
between the needle and the counter-electrode placed in front of it. The liquid, 
mechanically pumped through the tube by a syringe, begins to exit the needle as fine 
charged droplets. During their travel towards the counter electrode, the highly charged 
droplets lose the solvent molecules and the sole charged analyte molecules remain. 
The result is a beam of ions that enter the high vacuum analyzer and are sampled 
according to their m/z ratio. 
Electrospray formation. The liquid sample, usually dissolved in a mixture of 
water and organi c solvent ( cornmonly methanol, isopropanol or acetoni trii e), is fed 
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through a thin stainless steel capillary tube (internai diameter approx. 0.1 mrn) in the 
electrospray source. A high potential (3-4 kV) applied at the end of the capillary tip 
creates an electrostatic spray of multiply charged droplets, ali at the same polarity, 
which are forced to leave the surface of the capillary and move towards the counter 
electrode. The spraying process is usually aided by a stream ofwarm nitrogen gas (the 
nebulizing gas) that flows through a tube co-axial to the main capillary. This procedure 
is referred to as pneumatically assisted nebulization (7, 8). In a simple approximation, 
the pneumatic nebulizer takes care of aerosol formati011, while the electric field 
charges the droplets. This small droplets are sprayed from the capillary into the dry 
bath gas at atmospheric pressure and travel through an orifice, placed on the counter-
electrode, towards the mass spectrometer high-vacuum system. In Figure 3.6 a 
schematic diagram of the typicallayout of an elecrospray chamber is reported. 
count~r el~ctrod~ 
l 
~----~ 
<l ryl n g g '"' 
........ ., 
l .... _.,., ..... ,., .... 
!· ....... .,. ..• """ 
ntmo!lpherlr. presnurr. 
s ampling cone/urlfice 
l sklmmer 
analyser 
Il O· Jl/1 O !> mb•ul 
• ltnbar• 
Figure 3.6: A schematic view of the electrospray ionization source. 
Ionization mechanism. The high electric field imposed by the power supply at 
the end of the metal capillary causes enrichment of ions of the same charge at the 
meniscus of the solution. This n et charge, attracted by the counter-electrode, forces the 
meniscus to assume a conica} shape and promotes the expansion of the li qui d in the so-
cali ed Taylor eone form. At the tip of the eone, the shape is that of a fine jet that 
breaks up into a cloud of highly charged fine droplets (See Figure 3. 7). When droplets 
separate from the liquid front at the end of the spray capillary, electric repulsion has 
become Iarger than the cohesive force (surface tension) that keeps the Iiquid together. 
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When this criticai point is reached, the charged liquid becomes unstable and fails apart 
at the tip ofthe capillary tube emitting an electrospray (9, 10). 
Reduction 
Oxidation 
e. 
Figure 3.7: Ion formation by electrospray ionization. 
According to the fon Evaporation Mode/, ion formation is believed to result 
from an ion evaporation process. The droplets, ejected from the capillaty tip, aided by 
the heated bath gas, undergo size shrinking as the solvent molecules evaporate from 
their surface. Therefore, the increase in charge density of the droplet forces the 
charged anaiyte ion to desorb out ofthe solution before the droplet breaks up (11). 
The Charged Residue Mode/, on the contrary, states that the formation of an 
individuai ion takes place only when solvent is completely removed. Consequently, the 
size of the droplet diminishes, while the totai charge does not change. Coulombic 
forces induce instability on the droplet surface; hence, the droplet breaks up into 
smaller droplets that contain only an analyte ion surrounded by many solvent 
molecules. When the diameter becomes less than l O nm, the remaining solvent leaves 
the analyte ion and a free or "naked" ion is formed (12). 
Whatever the detailed mechanism, it is clear that ESI produces multiply 
charged molecules from solution under mild conditions. Those ions generally arise by 
attachment of protons, aikali cations or ammonium ions for positive ion formation or, 
with reversal of the polarity of the nebulizing electric field, negative ions are formed 
by proton abstraction. 
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Figure 3.8: The ion evaporation model. 
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Figure 3.9: 'fhe charge residue model. 
Quadrupole ion trap. Technical improvements on mass spectrometric 
instrumentation over the last decade have made the quadrupole ion trap (QIT) an 
extraordinary device for biomolecular analysis. A QIT is an instrument which 
functions both as an ion store, in which gas-phase charged molecules can be confined 
for a certain period of time, and as a mass analyzer of considerable nominai mass 
range and variable mass resolution. 
As storage device, the ion trap allows to concentrate gaseous ions, either 
positively or negatively charged, in the absence of solvent in the same space. The 
confining capacity of the instrument arises from the formation of a trapping potential 
well when appropriate electric potentials are applied to the electrodes of the ion trap. 
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As mass-to-charge analyzer, the ion trap generally operates in the so-called 
"mass-selective instability scan" mode. This modality allows first the entrapment of ali 
ions formed over a given time period, then their sequential ejection, in order of 
ascending m/z ratio, accomplished by ramping in a linear fashion the amplitude of a 
radiofrequency (r.f.) potential applied to one ofthe ion trap electrodes (13). Following 
the mass-selective ejection, ions are sent to an electron multiplier detector and 
sampled. 
A prerequisite of this method of ion capture and ejection is that ions can be 
herded initially to the centre of the ion trap. The use of helium gas buffer within the 
trapping volume causes collisional cooling ofthe analyte ions and improves packing of 
the ions at the centre of the trap. 
Equipment. A quadrupole ion trap is an instrument roughly the size of a tennis 
bali. The core of the instrument is made of three rather oddly shaped hyperbolic meUù 
electrodes, a ring and two end-cap electrodes positioned, respectively, forming the 
side, the top and the bottom ofthe three-dimensional trap, as depicted in Figure 3.10. 
The end-cap electrodes are virtually identica! and resemble small inverted saucers. 
They are distinguishable by the number of holes in the centre of each electrode. The 
ring electrode is positioned symmetrically between the two end-cap electrodes. In the 
normal mode of use, the quadrupole field is established when the electrodes are 
crossed by an auxiliary a.c. potential of low amplitude, oscillating between the two 
end-cap electrodes and the ring electrode, while an r~f. oscillating drive potential of ca. 
l MHz is applied to the ring electrode. The ion trap is kept at high pressure relative to 
other mass analyzers, because of the presence of helium bath gas at a pressure of ca. l 
mTorr. 
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Figure 3.10: Model of a qudrupole ion trap mass analyzer. 
fon trapping. Ions created in the ionization chamber, for example in an 
electrospray source, are focused using an electrostatic lensing system into the ion trap. 
An electrostatic ion gate pulses open (-V) and closed (+V) to inject ions into the trap. 
The pulsing of the ion gate differentiates ion traps from "beam" instruments, such as 
quadrupoles, where ions continually enter the mass analyzer. In ion traps the time 
during which ions are allowed into the trap, called ionization period, is regulated in 
order to minimize space-charge effects. Space-charge results from the accumulation of 
too many ions inside the trap that causes a distortion of the electrical field leading to an 
overall reduction in performance. Eventually, ions are no longer trapped when the ion 
density becomes too large. Therefore, the potential pre-scan assesses the amount of 
ions entering the trap. Collisions with helium atoms within the ion trap dampen the 
kinetic energy of the ions and quickly contract trajectories toward the centre of the ion 
trap. This allows ions of a given rnlz ratio to form a tight packet from a diffuse cloud 
of ions, enabling effective concentration of the injected ions in a small three-
dimensional space (14). Trapped ions are further focused in the centre of the trap 
through the use ofan oscillating potential, called thefundamental radio.frequency (r.f.), 
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typically 1.1 MHz, applied to the ring electrode. The amplitude of this potential 
determines the stability of the trajectories of ions having a certain rn/z range and is 
eventually ramped to eject ions. 
An ion will be stably trapped depending upon the values of its mass (m) and 
charge (e), the size ofthe ion trap (r), the oscillating frequency ofthe fundamental r.f. 
(w) and the amplitude of the voltage on the ring electrode (V). The dependence of ion 
motion on these parameters is described by the dimensionless parameter qz (reported to 
the axial- or z-direction of space), as expressed by the equation: 
qz = 4eV/mr2~ 
For the case of existing commerciai ion traps, r = l cm, w = 1.1 MHz and V 
ranges from O to 7500 V. In addition, the motion of ions can be synchronized by 
applying an impulse excitation, using a d.c. pulse potential U placed on the ring 
electrode; which can al so affect the stability of the ion trajectories via a parameter az 
that depends upon the amplitude ofU, as shown by the following equation: 
az=-8eU/~~ 
az, along with qz and the frequency of the fundamental r.f., determine the 
frequency at which ions oscillate in the trap, known as the secular .frequency. To be 
more detailed, a three-dimensional representation of a stabile ion trajectory in the ion 
trap has the generai appearance of a figure-of-eight and is composed by an axial (z) 
and a radiai (r) secular frequency (15). 
As it may be evident by Figure 3.11., depicting the stability diagram of ion 
traj ectories in (az, qz) space for the regio n of simultaneous stability in both the r- an d z-
directions near the origin of the three-dimensional QIT, when the qz value reaches the 
0.908 value, trajectories become unstable. Hence, depending upon the amplitude ofthe 
potentials placed on the ring electrode, an ion packet of given rn/z ratio will have a qz 
value that will fall within the boundaries of the stability diagram and will be trapped. If 
the qz value at that voltage falls outside the boundaries of the stability diagram, the ion 
packet will hit the electrodes and be lost. 
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Figure 3.11: Regions of ion trajectory stability in the quadrupole ion trap parameterized in 
terms ofthe operating voltages and frequencies. 
fon ejection. Ions with different m/z values may bave stable orbits at the same 
time, as shown in Figure 3.12. Because ion trajectories become unstable when qz = 
0.908, a well defined a low-mass cutoff is obtained for a given value of the amp1itude 
of the applied r.f. voltage (V). No ions belo w that mass will be stored, but entrapment 
of the sole ions having a mass higher than that of the cutoff limit will occur. Low-mass 
cutoffs for various amplitudes of the applied r.f. fie l d are listed in Figure 3.12 . 
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Figure 3.12: Relative positions of ions with three different mass-to-charge ratios along the 
mass-selective instability fine 3z = O. The effect of increasing the amplitude of the fundamental rf 
voltage is shown in panels (a) through (c). 
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In Figure 3.12, the relative position of three ions of differing mlz values on the 
selective instability line az = O at three different values of the fundamental r.f. 
amplitude (V) is depicted. As the voltage is increased, the qz value for each ion also 
increases. Therefore, operating in the so-called "mass-selective instability scan" mode, 
ejection of ions from low to high masses is achieved simply linearly ramping the 
amplitude ofthe r.f. potential applied to the ring electrode. Increasing the amplitude of 
the fundamental r.f., the qz maximum value (0.908) for each trapped ion will be 
approached and exceeded; hence ali ions, in order of increasing mlz ratios, will be 
pulled out sequentially and axially through the openings of an end-cap electrode, thus 
allowing mass-selective and non-destructive detection of ions. However the V 
amplitude cannot be increased above certain values, due to practical difficulties 
encountered when interfacing high voltages to electronic circuitry. 
Resonant ion excitation. As the motion of ions confmed in a QIT is 
characterized by two secular frequencies, axial and radiai, ion motion can be excited 
upon resonant irradiation at either or both of these frequencies. Such irradiation can be 
induced when an additional oscillating a.c. potential is applied across the end-cap 
electrodes at a frequency that matches the secular frequency of an ion (16). This 
supplementary potential, also called tickle voltage, of a few tenths of a volt of 
amplitude, may increase ion kinetic energies and excite ion trajectories. This causes 
ions to move away from the ion trap centre leading to a linearly increase of the ion 
orbit amplitudes with time and to a radiai and axial expansion of the ion cloud. This 
process of ion ex citati o n is often referred to as tickling. 
Upon variation of the amplitude of the tickle signa! it is possible to choose 
whether ions should be ejected or should undergo fragmentation (17). 
If the amplitude is high, the increase in kinetic energy is large enough to force 
ions to escape from the trapping potential and to be ejected. This mode of "mass-
selective stability scan" mode can be either used to remove unwanted ions from the 
trap, as in ion isolation, or to eject ions mass selectively while the applied frequency is 
swept. Ion ejection, through holes in the end-cap electrode, is here performed at 
voltages lower than those required for ejection at qz of 0.908, extending the nominai 
mass range of the ion trap. 
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If the amplitude is low, the Iatter event will occur: resonant excitation is then 
used to promote multiple momentum-exchange collisions with helium atoms and 
induce ion dissociation. This process causes random fragmentation along the backbone 
of the analyzed charged molecule. 
Perhaps the biggest strength of the ion trap technique lies in the ability to 
perform repeated stages of mass selection, known as tandem mass spectrometry 
(MS/MS). This can be achieved first isolating a single ion species in the trap, 
designated as the parent ion, then promoting its fragmentation thanks to resonant ion 
excitation. A mass spectrum is generated by sequentially ejecting fragments or product 
ions formed by collision-induced dissociation (CID) ofthe parent ion from low to high 
mlz. This MS/MS technique greatly increases the amount of structural information 
obtainable for a given molecule. 
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Derivatization of saccharides for UV -visible detection 
on capillary electrophoresis 
4.1 Introduction 
Beside their historical role as energetic reserv01r of living orgamsms, 
carbohydrates are nowadays primarily considered for the key role played in many 
cellular events (l) The finely tunable biologica! role that carbohydrates play in extra-
cellular-signalling, recognition, adhesion, trafficking and proliferation phenomena 
allows to consider them as effective components of the information-carrier molecules 
family (2, 3). 
The undeniable importance of glycocoprotein as well as glycolipids functions 
in glycobiology moved an increasing interest toward the choice of reliable analytical 
tools for carbohydrate structure investigation. For carbohydrates, the diversity of 
homologues coming from isomerism, branching and linkage position as well as the 
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strong hydrophilicity make their analytical separation a challenging and difficult task. 
Among more traditional analytical techniques suitable for the analysis of sugar 
complex mixtures, capillary electrophoresis (CE) emerged as powerful separation 
technique, widely used for carbohydrate analysis, due to the high selectivity and to the 
low sample consumption (4-6). However, carbohydrate's inherent lack of chromo- or 
fluoro-phore groups generally requires sugar labelling to enhance detection properties. 
Reductive amination is one of the most frequently pre-column derivati:zation methods 
used to label carbohydrate with UV-absorbing and/or fluorophore groups (7-14) 
among which, 2-aminopyridine, aminonaphtalene sulfonates and amino benzene 
derivatives are the most widely used (15, 16). 
However, derivati:zation yield depends on the nature of the sugar and it has 
been reported that reductive amination of N-acetylamino sugars leads to lower 
amounts of stable secondary amines than that of their corresponding non N-acetylated 
sugars (17, 18). In this respect, studies addressed to acid catalysis of the reductive 
amination showed improvement of the labelling efficiency of N-acetylamino residues 
by using organic acids having higher acidity than the most commonly used acetic acid. 
(19-21). The improvement of the labelling efficiency of N-linked mono- and oligo-
saccharides there achieved by using citric acid as catalyst, was addressed, however, to 
the rather uncommon capillary electrophoresis-laser-induced fluorescence detection 
analysis (CE-LIF). In this work the reductive acid-catalyzed amination of various 
saccharides with 4-aminobenzonitrile ( 4-ABN), 2-aminopyridine (2-AP) and 2-
aminobenzoic acid (2-AA) (see Scheme 4.1) has been performed with the purpose of 
selecting the tag that, improving the labelling efficiency especially for N-acetylamino 
sugars, could straightforwardly lead to an easy characteri:zation of complex sugar 
mixtures by CE in the most common UV detection method. 
CN 
~NH 2 
Scheme 4.1: Chemical structure of 4-ABN, 2-AP and 2-AA labels. 
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Indeed, this comparative derivatization study is focused on the search of a 
reproducible and robust labelling that level detection properties of several neutral 
monosaccharides including N-acetylaminosugars. Particularly, optimization of 
labelling as well as of solute separation procedures was addressed to monitor 
qualitatively and quantitatively those sugar residues that are generally found as 
components of N- or 0-glycans of glycoproteins. In this respect specific attention has 
been dedicated to the analysis of N-ac~tyllactosamine (LacNAc), a sequence very 
frequently found at the non reducing termini of complex, multiantennary and non 
sialylated N-glycans (22, 23). In the case of 2-AA labelling procedure, the influence 
of acid strength on derivatization yield has been also shortly investigated for glucose 
(Glc), N-acetylgalactosamine (GalNAc) and maltotriose (Malt). 
4.2 Materials and methods 
Coup/ing reaction procedures: 
(a) 4-ABN labelling was perfonned following the same procedure elsewhere 
reported (12). Briefly, 10 !JL of an aqueous solution containing from 0.2 to 80 mM of 
each standard saccharide (Glc, Gal, Man, Fuc, Xyl, Rib, GlcNAc, GaiNAc, LacNAc, 
Glc-2-NH2 and Gal-2-NH2) were put in a screw-capped Eppendorftube, added with 90 
!JL of derivatizing solution (0.51 M 4-ABN, 0.159 M NaCNBH3 in 95% methanol and 
5% acetic acid) and the mixture was then heated at 90°C for 15 minutes in a dry-bath 
heating block. Samples were cooled to room temperature and diluted l :5 in bidistilled 
water before capillary electrophoretic runs. 
(b) 2-AP sugar derivatization was carri ed out as reported elsewere (24). l O !JL 
of aqueous solutions of standard sugars, in a concentration range as reported above, 
were mixed in a screw-capped vial with 40 !JL of 0.47 M 2-AP in a 1:2 HC16N: water 
solution. The mixture was then heated for 15 minutes at l 00°C. 2 f.A.L of reducing 
solution (prepared by mixing 10 mg ofNaCNBH3, 20 11L ofthe 0.47 M 2-AP solution 
and 30 f.A.L bidistilled water) were then added and the mixture was heated for 15 
minutes at 90°C. CE analysis was performed on five-fold diluted sample solutions. 
(c) 2-AA labelling was performed following the same procedure reported by 
Sato and collegues (25). l O f.A.L standard sugar aqueous solutions were mixed with 45 
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~-tL methanol and 45 !AL of derivatizing solution (0.25 M 2-AA, 0.159 M NaCNBH3 in 
99% methanol and l% of glacial acetic acid, or a saturated aqueous solution of citric 
acid or a saturated solution of maleic acid in l N HCI). The mixture was transferred in 
a screw-capped Eppendorf tube and heated at 60°C for 5 hours. Before capillary 
electrophoretic analysis, the samples were diluted five times with bidistilled water. 
Capillary electrophoresis. The system was an Applied Biosystem HPCE 
Model 270A-HT with UV detection coupled with a Turbochrom Navigator (4.0) 
software. A fused silica capillary tube (72 cm total length, 50 cm effective length, 50 
~-tm ID, 375 ~-tm OD) was chosen for the CE analyses. Separations were done at 30°C. 
The signal readings were performed at 214, 240 or 285 nm for the 2-AA, 2-AP or 4-
ABN-labelled sugars, respectively. A 20 or 21 kV potential was applied between the 
ends of the capillary to maintain recorded currents below 50 ~-tA. All analyses were 
carried out in normal polarity. Samples were loaded under vacuum at a pressure of 
16.9 kPa for 1.5 seconds. Before sample injection, the capillary was rinsed with 0.1 N 
NaOH for 2 minutes, then conditioned by flushing the running buffer for 4 minutes. 
These washes were performed at a vacuum pressure of 67.6 kPa 
In CZE mode, 150 mM borie acid in 50 mM NaH2P04 (pH 7.50) was used as 
running buffer to achieve good separation of 2-AA-labelled sugar complex mixture. 
180 mM borie acid in 30 mM sodium NaH2P04 (pH 7.0) was instead employed to 
separate those 2-AA-labelled sugars used to check the influence of acid catalyst 
strength on reductive amination. 
MEKC-UV was performed for 2-AP and 4-ABN labelled sugar analysis. A 50 
mM borax and 50 mM SDS solution resulted to be the best running buffer to achieve 
optimal 2-AP-labelled sugars separation, whereas a buffer containing 120 mM 
N~HC03 and 60 mM SDS (pH 8.00) was successfully employed for 4-ABN 
conjugates. 
Electrophoretic mobility were calculated by the equation: 
1-t =IL/tV -IL/to V [cm2V-1s-1] 
where l and L are the effective and totallength ofthe capillary, respectively. V 
is the applied voltage, t the measured analyte migration time and to, the migration time 
required for electroosmotic flow to travel distance l, is obtained from CE signal of a 
neutra! marker (methanol or water) added to the running solution. 
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4.3 Results 
MEKC analysis. Pre-column derivatizations of Man, Glc, Gal, GalNac, 
GlcNAc, Fuc and Xyl monosaccharides performed using 4-ABN and 2-AP as labelling 
chromophores yielded to uncharged sugar derivatives. As shown from 
electropherograms of Figure 4.1 and Figure 4.2, the tag coupling made, the otherwise 
highly hydrophilic carbohydrates, hydrophobic enough to undergo to a reasonably 
acceptable separation, disclosing differential partitioning ability between the micellar 
and the aqueous phase. 
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Figure 4.1: Electropherogram of a standard mixture of 4-ABN-Iabelled monosaccharides via 
MEKC (0.2 mM each sugar, 4 mM GaiNAc and GlcNAc). Running buffer: 120 mM NI4HC03 l 60 mM 
SDS (pH 8.00); applied potential: 20 kV; UV-detection: 285 nm; capillary coturno: 50 cm x 50 J.tm I.D. 
fused silica. Peak assignation: I: Man, 2: Glc, 3: GaiNAc, 4: Gal, 5: GlcNAc, 6: Fuc, 7: Xyl, 8: 4-ABN. 
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Figure 4.2: MEKC separation of 2-AP-Iabelled sugar mixture (0.2 mM each sugar, 4 mM 
GaiNAc and GlcNAc). Electrolyte carrier: 50 mM borax l 50 mM SDS; applied voltage: 20 kV; 
Detection window: 240 nm; capillary tube: 50 cm x 50 IJ.ffi I.D. fused silica. Peak assignation is the 
same as before. 9: 2-AP. 
As far as the 4-Al3N labelled saccharides is concemed, severa! buffer 
compositions were tested, varying the SDS surfactant concentration (:from l 00 to 120 
mM) as well as that of the simple electrolyte NH4HC03 from 20 to 80 mM. The 
condition optimization lead to a reasonably good separation of the complex mixture 
components (see Figure 4.1) achieved using 120 mM SDS and 60 mM NH4HC03 (pH 
8.0) as runnig buffer. This buffer composition was very similar to that elsewhere 
successfully applied (25 mM Tris-phosphate buffer, 100 mM SDS at pH 7.5) (12) to 
separate a mixture of 4-ABN- labelled mono- and oligo-saccharides that, however, 
lacked of N-acetylaminosugars. Althought ali the mixture components could be easily 
identified, Figure 4.1 shows that Gal and GalNAc signals are not resolved. 
Observed electrophoretic mobilities for the 4-ABN labelled sugars, listed in 
Table 4.1, suggested a Man<Glc<GalNac<Gal<GlcNac<Fuc<Xyl micellar partitioning 
ability order. 
Saccharide Labelling agent 
2-AA 2-AP 4-ABN 
--· ----------~-
galactosamine 0.573 
glucosamine 0.611 
N-acetylgalactosamine 0.850 0.760 1.417 
N-acety lglucosamine 1.151 0.932 1.457 
ribose 0.928 
fucose 1.031 1.087 1.522 
m annose 1.072 0.965 1.376 
galactose 1.090 l.155 1.429 
xylose l.l14 0.895 1.553 
glucose 1.187 0.965 1.407 
Table 4.1: Electrophoresis mobility (l04 cm2V-1s-1) ofsugar derivatives. 
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Tbe electropboretic mobilities bere reported for non acetylated sugars follows 
the same migration order than tbat observed elsewbere (12) wbereas, tbe lack of 
available referenced data for 4-ABN labelled acetylated sugars precluded any further 
comparison with present findings. In this respect, it is also wortb to notice that GalNAc 
and GlcNAc, in the sugar mixture bere analysed, required a concentration 20 times 
higher than that of all the other sugar components to reacb a signal of comparable 
intensity, strongly confirming their rather poor tendency towards labelling reaction via 
reductive amination. 
In order to achieve a reasonably good separation of 2-AP labelled saccbarides 
from the complex mixture severa! running buffer conditions were tried, either using 
CZE or MECK analytical methods. In CZE a concentration of l 00 mM borax was not 
sufficient to achieve sugar derivatives separation. In addition, the use of mucb bigher 
borax concentrations, as successfully done elsewbere (17), was bere precluded to 
avoid induced current effects that, given the relatively sbort capillary used (50 cm 
effective length), would certainly develop. 
Switcbing to MECK analysis, the first attempt was done using a running buffer 
of 100 mM SDS and 20 mM NHtHC03 in the 6.5 to 7.5 pH range, similarly to wbat 
above reported for tbe ABN-derivatives. Tbese conditions, bowever, lead to a ratber 
compressed electropberogram with acetylamino sugar signals unresolved, substantially 
appearing as a shoulder of a more intense peak likely belonging to derivatizing 
impurities (data not shown). T o replace NHtHC03 with borax in SDS buffer turned 
out to be then necessary to improve signal resolution and to allow for separation of 2-
AP derivatives. With the purpose of separation optimization, SDS and borax 
concentrations were then varied in the 25-70 mM and 50-100 mM range, respectively. 
Figure 4.2 sbows the electropherogram obtained by using an equimolar (50 mM) 
SDS-borax buffer composition that provided for a reasonably good signal resolution. 
However, even these conditions were not the optimal to achieve complete separation 
of the mixture components with the 2-AP labelled Glc and Man residues, moving with 
identica! migration time, left undistinguisbable. According to findings elsewhere 
reported (17), and bearing in mind that N-acety lamino sugars were composing the 
mixture at a concentration approximately 20 times higher than the non acetylated 
saccharides, only a reduced derivatizing efficiency, could then be invoked to account 
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for their recorded signal intensities. Electropboretic mobility values determined for the 
2-AA labelled sugars, reported in Table 4.1, sbow to increase following the order 
GalNAc < Xyl < GlcNAc < Glc ... Man < Fuc < Gal. 
CZE analysis. Reductive amination of saccbarides witb 2-AA was performed 
on a complex sugar mixture containing, in addition to the seven mono-saccbarides 
reported above, also Rib (used as standard), Glc-2-NH2 and Gal-2-NH2. Tbese latter 
were included since very often glycans released from glycoproteins by drastic 
bydrolyzing metbods (e.g.: by bydrazinolysis or treatment with concentrated HCI or 
TF A) are reported to convert N-acetylbexosamines into their deacetylated analogues. 
(21, 26) 2-AA derivatives are not only UV-sensitive compounds but, bearing a 
negative net cbarge at working pH greater than 2.5, are expected to be easily analysed 
via conventional CZE metbodologies. Although, in principle several running bu:ffers 
may be advisable to analyze 2-AA-labelled sugars, CZE running conditions similar to 
those adopted by Sato and coworkers (11) were bere adopted (150 mM borate, 50 mM 
pbospbate 50 at pH 7.5). As sbown in the elctropberogram of Figure 4.3, the 
separation of the complex sugar derivatives mixture was succefully achieved and 
required rather sbort analysis time ( only 23 min). Neither peak overlapping between 
the sugar isomers was observed, nor the signal of unreacted reagent, used also bere in 
large excess, reacbed the detector within the analytical time frame. 
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Figure 4.3: CZE analysis of 2-AA-labelled monosaccharides (0.2 mM each sugar). Carrier 
solution: 150 mM borie acid l 50 mM sodium dihydrogenphosphate (pH 7.50); set potential: 21 kV; 
UV -absorbance: 214 nm; capillary: 50 cm x 50 !J.m I. D. fused silica. Peak assignation is the same as 
before. l 0: Gal-2-NH2, Il: Glc-2-NH2 , 12: Rib. 
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Even more, the labelling reaction did not require the acetylated sugars 
concentration to exceed that ofthe other non-acetylated sugars mixture components to 
become detectable with, approximately, a comparable sensitivity level. 
In this respect specific attention has been dedicated to the analysis of LacNAc, 
a sequence very frequently found at the non reducing termini of complex, 
multiantennary and non sialylated N-glycans (22, 23). 
The sensitivity increase using 2-AA as labelling tag for the LacNac 
disaccharide is clearly shown in Figure 4.4 where the concentration dependence of 
UV signa! intensity is reported for 2-AP (solid circles), 4-ABN (open circles) and 2-
AA labelled (open squares) derivatives. 
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Figure 4.4: CE-UV signal as a function of amount of derivatized LacNAc. Open circles, 4-
ABN-LacNAc; solid circles, 2-AP-LacNAc; open squares, 2-AA-LacNAc. 
lnjluence of acid catalysts on 2-AA sugar derivatives. Following previously 
reported results (20) clearly showing the influence of acid strength on sugar reductive 
amination yield with ATPS label, the 2-AA labelling conditions here applied (see 
experimental section), although rather satisfying, were varied in order to check if it 
was worth to search for a further labelling reaction condition refinement. In the present 
study the influence of citric and maleic acid on the labelling yield of 2-AA-derivatives 
was shortly addressed and the results compared to those obtained using glacial acetic 
acid as organic catalyst. 2-AA labelling reactions were performed separately on Glc, 
GalNAc and maltotriose (Malt), chosen as standard compounds, of concentration 
• • o • • 
~ ~-, ;·~\ ~~;_.-,1~;-, 96 
varying in the 2-8 mM range. Reaction mixtures were then analysed via CZE and the 
normalized values of peak area, reported as a function of concentration, were least-
square fitted (y = m*x +q) to obtain the calibration constant m used as comparison 
measure for reaction yield. As shown in Table 4.2 any significant difference in 
labelling yield was observed for Gal and Malt passing from acetic to citric or maleic 
acid, whereas GalNAc-2-AA derivative yield actually increased on increasing catalyst 
aci d strength but to an extent, however, not as large ( one order of magnitude in the 
case of 6' -Sialyl-LacNAc-APTS) as elsewhere observed (20). 
··-------
Calibration constants 
Sugar derivative 
Acetic acid Citric acid Maleic acid 
·----" 
2-AA-glucose 116.3 123.3 124.5 
2-AA-galactosarnine 75.8 96.2 101.6 
2-AA-maltotriose 87.0 84.9 86.0 
·--------
Table 4.2: Influence of catalyst acid strength on m, the yield relating constant, for 2-AA 
Iabelling reaction. 
Likely, this findings account for the intrinsic acid character (pKa2-AA = 2.108) 
of the 2-AA chromophore that might, itself, act also as co-catalyst of the labelling 
reaction. 
Concentration detection limits of 4-ABN, 2-AP and 2-AA labelled saccharides. 
Reproducibility, linearity and sensitivity of the labelling procedures were tested. F or 
each sugar/dye couple, a calibration curve was built, plotting the integrated peak area 
(normalized with respect to migration times) versus the concentrations of the starting 
saccharide standards. The measurements were repeated almost three times and four 
points (mean values) were calculated and reported on the graph. The calibration curves 
of ali derivatized saccharides were approximately linear at least in the concentration 
range tested, with those obtained for 2-AA labelled residues showing the highest 
correlation coefficients (between 0.98 and 0.99). Due to dependence of reaction yield 
on the nature of both sugar and tag, the detection limits (signal-to-noise ratio of 3) 
varied considerably. The results, summarized in Table 4.3, showed that forali hexoses 
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or deoxyhexoses (Glc, Gal, Man and Fuc) the concentration detection limits were of 
comparable order of magnitude as 4-ABN and 2-AP derivatives and the sensitivity 
improved only slightly when 2-AA chromophore was used for labelling reaction. 
Instead, the concentration limit detection for acetyl-amino sugars dramatically 
dropped, ofmore than one order ofmagnitude, passing from 4-BN or 2-AP labelling to 
2-AA derivatives. 
-··--·--
saccharide 2-AA 2-AP 4-ABN 
6.oo* 1 o::o 
M .. 
3.89*ÌO:g Glucose 1.82*10"0 -
Galactose 1.53*10-6 2.49*10-6 2.40*10"
6 
Mannose 2.31*10"6 2.68*10-6 3.58*10"
6 
Fuco se 1.91 *10-6 2.94*10"6 2.62*10-6 
N-acetylglucosamine 2.21 * 10·6 1.03*104 2.36*10"5 
N-acety lgalactosamine 1.57*10-6 1.67*10"5 2.63*10"5 
N-acety llactosamine 1.24*10"6 1.74*10"4 9.37*10"6 
Table 4.3: Concentration detection limits (M) for 2-AA, 2-AP and 4-ABN labelled 
saccharides. 
4.4 Discussion 
MECK analysis. In MECK, similarly to the mechanism occurring in reverse-
phase chromatography, the hydrophobic "pseudophase" represented by the surfactant 
( e.g. :SDS) micelles enlighten the differences in hydrophobic character of the analytes 
leading to their separation by differential partitioning between the aqueous and the 
micellar phase. Observed electrophoretic mobilities for the 4-ABN labelled sugars, 
listed in Table 4.1, showing, in agreement with elsewhere reported findings (12), a 
Man<Glc<GalNac<Gal<GlcNac<Fuc<Xyl micellar partitioning ability order, should 
Iikely also reproduce the analyte hydrophobic scale. Only on a qualitative base few 
interesting features might be addressed on acetylated and non acetylated sugars 
comparison. As an example, while the presence of the acetyl group at C2, in GaiNac, 
(slightly) favour aqueous-phase interactions with respect to the non acetylated isomer, 
apparently, a rather strong hydrophobic character seem to be conferred to the OH-
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equatorial isomer leading GlcNac to be much better solubilized in micellar phase than 
Glc. More complex is the situation for 2-AP sugar derivatives where also borax-
complex stabilities additionally contribute to the separation mechanism. In this case 
capacity factors would likely be more helpful to disclose the balancing of the different 
involved contributions responsible for solute separation. However, the electrophoretic 
mobility characterizing Gal can be safely accounted for by the known greater stability 
of its borate complexes favoured by the C3-C4 cis-diol configuration (27, 28). The 
same sould apply for Fuc which electrophoretic mobility behaviour confirms the 
previously found ability (17) to strongly internet with borax-based environmen~ 
favoured by the proper C3-C4 diol configuration. Then, whenever is possible to be 
established, these interactions seemed to largely compensate for the hydroxyl group 
lack. In agreement with elsewhere reported fmdings (17), however, the C3-C4 cis-diol 
rule does not seem to apply for the acetyl group bearing Gal counterpart showing, the 
GalNac, the lowest electrophoretic mobility. A rather scarce availability of the C3-C4 
cis-diols for borax complexation can then be deduced. Besides, for the remaining 2-
AA-sugar derivatives, a better partitioning in aqueous phase when using 
SDS/NH4HC03 buffer paralleled preferential borax-based environment interactions as 
resulted from the comparison of Figures 4.1-4.2, as well as from entries 2 and 3 of 
Table 4.1. This findings, if as a first approximation, as suggested, is assumed that 2-
AP and 4-ABN labels have close hydrophobicity, leave the GalNac behaviour even 
more difficult to interpret. Apparently, the acetyl group that renders more hydrophobic 
the glucose isomer is here less available for micelle interaction (Figure 4.1 and entry 3 
of Table 4.1) leading to a more bulky sugar but unable, despite the proper C3-C4 cis-
dio l configuration, to form stable borax complexes (Figure 4.2 and column 2 ofTable 
4.1). 
CZE analysis. As far as CZE data are concemed, the rnigration behaviour of 
the 2-AA labelled sugars agreed quite well with that elsewhere reported (11) where, 
however, neither Xyl nor acetylated sugars were included. As can be deduced from the 
reported data, the charged 2-AA tag modifies the sugar bias towards borate 
complexation and the C3-C4 cis rule does not longer apply even for Gal residue. 
Indeed, Glc as well as GlcNac exhibited the highest electrophoretic mobilities. Even 
more, the lowest observed mobility pertained to GalNac. In line with the above 
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discussed results this finding indicated a very low tendency of GalNac to establish 
interactions with surrounding medium, further suggesting a highly self-stable, rather 
unperturbed structure. Besides, the ability for Fuc to form stable borax complexes 
favoured by the proper C3-C4 diol configuration is here again evidenced. 
2-AA labelling reaction yield As indicated by the results reported in Figure 4.4 
and in Table 4.3, the use of 2-AA as labelling reagent strongly increased the tendency 
of acetylamino sugar towards reductive amination reaction (see Scheme 4.2). 
o=<CH3 00-O 
?tt-0~~0 H + ~ NHz HO~ OOHI~ 
OH OH 
Scbeme 4.2: Reductive amination reaction ofLacNac with 2-AA tag. 
Being the reaction rather sensitive to pH environment (see Table 4.2), the 
obtained high yield likely accounts for the inherent acid properties of the 2-AA tag. 
Besides, the tag molecule approaching the sugar reducing termini site might easily 
establish favourable polar, COO-NH2 mediated, interactions that, likely leading to the 
formation of a more stable intermediate favoured the final product synthesis. 
4.5 Conclusions 
Reductive amination reactions performed using 2-aminobenzoic acid provides 
a comparable derivatization yield for several of the major monosaccharides found in 
mammalian and plant glycoproteins. This dye offers high and comparable lN-vis 
sensitivity for ali saccharides tested here, including those that bearing an N-acetyl-
group are known to be scarcely reactive on their reducing termini. The 2-AA-labelling 
procedure and CZE analysis of the sugar derivati ves reported here seems to be optimal 
100 
for the study of complex saccharide mixtures as those obtained from glycoprotein 
processing (enzymatic or chemical hydrolysis). 
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Glycan structure analysis 
5.1 Introduction 
With current techniques, glycan portion of a given glycoprotein is generally 
performed after release of the oligosaccharides from the polypeptide backbone. A 
number of important considerations need to be taken into account regarding the release 
procedure and the following criteria may be set: (i) release should be nonselective with 
regard to the types of glycan; otherwise a representative profile will not be obtained; 
(ii) the release should cause no modification of the glycan; (iii) it should be suitably 
efficient to allow recovery of sufficient materia! for further studies; (iv) the peptide 
materia! should be easily separated from the released glycans. An additional 
consideration is that the yield of a free reducing terminai should be sufficient enough 
to simplifY subsequent derivatization of glycan, generally required by LC or CE 
analysis. Glycan release techniques can be either an enzymatic or chemical, the choice 
will depend from type of glycosylation, the nature and the available amount of sample. 
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A number of chemical techniques for the release 0- and N-linked 
oligosaccharides bave been described and used for severa! years, but the most 
commonly used is hydrazinolysis (1, 2). The use of anhydrous hydrazine for release of 
N-linked glycans has been applied to the analysis of a large number of glycoproteins 
and is thus a well established and validated technique (3-5). However, even though this 
chemical procedure yields reducing N- and 0-glycans; chemical modification of some 
sugars has been observed, as, for example, the loss of N-acetyl and 0-acyl groups in N-
acetylaminosugars and sialic acids, respectively (6, 7). Moreover the method causes 
also the cleavage of the polypeptidic backbone. More recently, improvements were 
sought through the use of 70% (w/v) aqueous ethylamine to release unreductively 0-
linked oligosaccharides from glycoproteins (8, 9). Regrettably, the overall reaction 
yields were low, as the oligosaccharides underwent significant peeling reaction or 
other forms of degradation. Also alkaline ,8-elimination has been successfully used for 
the chemical release of 0-glycans (10, 11). The presence of a strong reducing agent, 
such as NaBH4, in basic conditions, favours the release of 0-linked glycans; but 
concomitantly, converts the innermost sugar residue in its respective alditol, thus 
hindering a further chemical derivatization of the oligosaccharide for analytical 
purposes. Alkaline ,B-elimination is also difficult to practice at microscale, as the 
minute quantities of released glycans are overwhelmed by excessive amount of salts. 
In literature a new procedure, called ammonia-based ,B-elimination, has been 
developed, where ,B-elimination ts conducted in the presence of ammonium 
bicarbonate, yielding initially N- and 0-glycans as glycosylamines. These 
glycosylamines, reacting with borie acid, should produce the reducing N- and 0-
glycans. Even though this advancement seems to be very attractive, up to now only 
one paper reporting this procedure appeared (12). 
A lot of other chemical reagents were proofed in order to accomplish the 
release of carbohydrates from glycoprotein moieties, mainly inorganic acids. 
Generally, deglycosylation protocols using acids as cleaving reagents are relatively 
simple to apply: incubation of glycoproteins with acid at a given temperature for a 
certain time period. An eventual subsequent neutralization with a base is then 
sufficient to completely hydrolyze the oligosaccharides into their monomeric 
constituents. Although the oligosaccharide sequencing become no longer feasible, type 
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of constitutents and their abundance can be carried out with reasonable accuracy. This 
information helps to predict the type of oligosaccharide present and to determine the 
approach to a more detailed structural characterization. In some cases, it can also 
provide the first clues to the presence of a new type of sugar chain. Exhaustive 
chemical hydrolysis is usually performed using concentrated trifluoroacetic aci d (TF A) 
(13); a mild hydrolysis (at 80 oc for lh with TFA 0.2 M) produces the release ofthe 
most labile monosaccharides, such as sialic acid or terminai fucose, whereas more 
severe conditions (TF A 2 M for 4h at l 00 °C) result in the hydrolysis of all neutra! 
monosaccharides, including N-acetylhexosamines directly bound to the polypeptidic 
backbone. A final optional treatment with HCI 6 M at l 00 o c for 24 h, may completely 
cleave also the underlying protein chain. A bottleneck of this method is that N-
acetylsugars may be partially deacetylated and that it is impossible to recover the intact 
protein core. 
Trifluoromethanesulphonic acid (TFMS) has been widely used for 
carbohydrate release (14). The method is based on the finding that, upon treatment 
with anhydrous superacids (acids stronger than sulphuric), glycosidic bonds can easily 
be cleaved, whereas the peptide bonds remain intact. This procedure has been mainly 
developed to yield peptide intact backbone for amino acid sequence characterization, 
molecular mass determination or X-ray crystallographic studies. TFMS based strategy 
has as well been applied for glycan analysis (15). TFMS-mediated deglycosylation has 
the advantage that it removes carbohydrate chains from glycoproteins regardless of 
linkage and composition, leading to a single step hydrolyzing procedure ofboth N- and 
0-linked oligosaccharides. However, treatment ofbovine fetuin with TFMS at O °C or 
25 oc resulted in a rapid cleavage of peripheral sugars, slow loss of Ser- and Thr-
linked GalNAc and retention of N-glycosidically linked GlcNAc (15). Hence, the 
innermost Asn-linked GlcNAc of N-linkes sugar chains attached to the protein by an 
amide bond is stable to TFMS-based cleavage, whilst the rate of GalNAc loss is rather 
low, even after increasing temperature and time of incubation from, respectively, O °C 
and l h to 25 o c and 3h. The susceptibility of glycosidic bonds to TFMS vari es with 
the nature of the sugar and its substituents. 
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Chemical deglycosylation does not work well on proteins retained in 
polyacrylamide gels, because of the possible contaminations or side-reactions arising 
from the hydrolysis ofthe gel matrix itself. 
Due to the many difficulties regarding chemical deglycosylation, 
glycobiologist were always longing for a less harsh and non-destructive method for 
removing carbohydrates from glycoproteins. Enzymatic deglycosylation provides such 
a method. In the last two decades, a growing repertoire of enzymes, including 
endoglycosidases and glycosaminidases, able to catalyze the release of glycoprotein 
oligosaccharides under mild conditions, has been available. The use of some of these 
enzymes leads to convenient and non-selective release of N-linked oligosaccharides. 
Others having a high degree of specificity have been well characterized and some of 
them have been cloned (1). However the enzyme specificity may limit the use: for 
example, endoglycosidases able to release 0-linked sugars exhibit very restricted 
substrate specificity. The only available generally termed 0-glycanases cleave only the 
Gal,B(l-3)GalNAc 0-linked disaccharidic epitope, which must categorically be 
unmodified. Therefore, sialilated derivatives, commonly found in 0-glycans, cannot be 
hydrolyzed. 
Four oligosaccharide chain-cleaving enzymes have been identified and purified 
to homogeneity from cultura! filtrates of Flavobacterium meningosepticum: 
endoglycosidase Fr, F2 and F3 and the peptide-.i'0,N-acetyl-J3-D-glycosaminyl-
asparagme amidase (PNGase F) (16). Preliminary evaluation of the substrate 
specificity of these enzymes indicates that F2 cleaved biantennary N-linked 
oligosaccharides, whereas endo F3 cleaved both bi- and tri-antennary N-glycans. These 
enzymes are generally been sol d as endoglycosidase F. The highly stable 
endoglycosidase H, instead, is able to release ali high-mannose type as well as most 
hybrid types N-linked oligosaccharides (17, 18). The endoglycosidases Ft, F2, F3 and 
H, cannot, however, cleave tetraantennary N-glycans. To hydrolyze this class of N-
linked oligosaccharides, a different type of glycan releasing enzyme, the 
glycosaminidases, may be applied (19). These enzymes cleave N-linked 
oligosaccharides directly between the asparaginyl residue and the reducing end 
GlcNAc residue of the glycan by cleavage of the amide linkage. In this reaction, the 
asparaginyl residue is converted to an aspartyl residue with consequent oligosaccharide 
105 
releasing in the form of glycosylamine. These enzymes are known as glycopeptidases, 
peptide N-glycosidases, PNGases, N-glycohydrolases and N-glycanases and are in 
widespread use in glycoprotein research. PNGase F and PNGase A show very similar 
substrate specificity, as they cleave ali types of N-linked glycoprotein 
oligosaccharides, high-mannose, hybrid and complex. N-glycanase cannot remove 
oligosaccharides containing a fucose linked a(l-3) to Asn-linked GlcNAc, but 
endoglycosidase A from almond meal can be chosen in this case. Enzymatic release of 
oligosaccharides with PNGases also provides the possibility to recover the protein part 
and use it for physicochemical characterization or biologie activity assay. Moreover, 
when only a little amount of glycoprotein to be analyzed is available, N-glycans may 
be released from an excised band on a SDS-P AGE gel or on a spot on two-dimensional 
gel electrophoresis. However, given the PNGase steric bulkiness, glycoproteins 
generally need to be somehow denatured in order to expose their glycan moiety and 
avoid selective release of more accessible glycans. In addition, its use is not 
recommended on PVDF transferred glycoproteins: their possible partial would render 
PNGase treatment less effective (20). Furthermore, some glycoproteins, such as 
horseradish peroxidase, are particularly resistant to enzymatic hydrolysis by PNGase 
F, endo H andali endo F (21). In this case the treatment with anhydrous TFMS tumed 
out to be successful. 
5.2 Monosaccharide compositional analysis of ,8-glucosidase glycans 
Acid P,.glucosidase (GCase) is a lysosomal enzyme that degrades complex 
lipids found in all cellular membranes (22). The native enzyme has been purified to 
homogeneity from human placenta and extensively studied (23~ 24): mature GCase is a 
homomeric glycoprotein of 497 aminoacids, whose molecular mass ranges from 60 to 
68 kDa due to uneven glycosylation (25, 26). There are five potential N-glycosylation 
sites (27), but only the frrst four are normally occupied with typical bi- and tri-
antennary complexes (28). Glycosylation at the first site has been found to be essential 
for the development of the catalytically active form (29). GCase catalyzes the 
hydrolysis of glucosylceramide into ceramide and glucose (22). The enzymatic 
deficiency causes a process of sphingoglycolipids storage, essentially 
glucocerebrosides, in tissue macrophages, typically found in the liver, spleen, lungs, 
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bone marrow and, in rare cases, in the brain (30). Severa! mutations of the gene 
encoding the glycoprotein have been identified and all result in the deficiency of 
enzymatic activity, responsible for a variety of clinica! outcomes (phenotypes) 
collectively known as Gaucher's disease (GD) (31). This inherited metabolic disorder 
can be treated symptomatically by administrating the missing or inactive GCase by 
enzyme replacement therapy (ERT): the regular infusion of the enzyme is highly 
effective in reducing clinica! manifestations of the disease and improving patient 
quality of life (32). Human cells produce low amounts of GCase: 10-12 tonslyear of 
placentas are required to produce enough protein to satisfy the demand of the average 
GD patient; recombinant GCase obtained from cultured CHO cells is at present the 
only way to yield high amounts of the protein. The success of ERT is undeniable but 
the treatment is very expensive, thus accessible basically to patients of industrialized 
countries, and requires high drug dosage in order to give satisfactory clinica! response 
(33). 
Recently transgenic plants have been used as bioreactors for the large-scale 
production of vaccines, antibodies but also proteins of therapeutic relevance. 
Genetically engineered plants have severa! advantages as sources of recombinant 
proteins compared with mammalian, but also with bacterial, yeast and fungal systems: 
(i) animai cells cannot be conveniently stored for future use as source of recombinant 
products, they must be processed soon a:fter harvest to prevent significant product 
losses; accumulation of recombinant proteins in seeds warrants a better availability of 
the product, allowing long-tenn storage of the biomass necessary for industriai 
processing; moreover, directing protein synthesis to seed endospenn, easier extraction 
procedures may result; (ii) plant-derived products are less likely to be contaminated 
with human pathogenic microorganisms than those derived from animai cells because 
plants do not act as hosts for human infectious agents; (iii) economica! benefits are 
enonnous, as fennentation costs are cut down and the production of raw material on 
agricultural scale are relatively cheap; (iv) although some differences exist in post-
translational processing and in codon usage between plants and mammals, these are 
few compared with differences between mammals and microorganisms. A major 
limitation shared among heterologous expression systems like bacteria, yeast and 
insect cells, is their different glycosylation profile compared with mammals. In 
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contrast to bacteria, lacking N-glycans, and yeast, having polymannose glycans, plants 
are able to produce proteins with complex N-glycan structures. 
N-linked glycans are commonly found on secreted and vacuolar proteins and 
on proteins of the endomembrane system. All plant N-glycan structures share a 
common minima! trimannosyl N,N'-diacetyl-chitobiose unit (ManJGlcNAc2) and, 
according to the substitutions of this core, plant N-glycans have so far been classified 
into the four following categories: high-mannose-, complex-, paucimannosidic- and 
hybrid-type. 
High-mannose-type N-glycans, with Man5•9GlcNAc2 composition, arise from 
the limited trimming of Glc and Man residues from the precursor oligosaccharide 
Glc3MangGlcNAc2. The removal of Glc from this pre-fonned building block occurs 
through concerted action of glucosidase I and II in the lumen of the ER. After the 
transport of the Glc-free oligosaccharide into the Golgi apparatus, further eventual 
trimming of Man residues is then accomplished thanks to mannosidase I activity. As in 
other eukaryotic cells, plant complex-type N-glycans result from the processing in the 
Golgi plasmalemma of high-mannose-type N-glycans by action of specific 
glycosidases and glycosyltransferases. These glycans are characterized by the presence 
of a(l-3)Fuc or P(l-2)Xyl residues respectively linked to the proximal GlcNAc and to 
the ,BMan residues ofthe core and by the presence of ,8{1-2)GlcNAc residues linked to 
aMan branching units. After the transfers of Xyl and Fuc units on the core, complex-
type N-glycans can be further modified by addition of terminai Fuc and Gal residues to 
yield one or two antennae constituted of Ga1,8(1-3)(Fuca(l-4)]GlcNAc sequences. 
Paucimannosidic-f)lpe N-glycans are Golgi-processed plant oligosaccharides having 
only an a(l-3)Fuc and/or a P(l-2)Xyl residue linked, as above reported, to the 
Man3GlcNAc2 core. These glycans result from the elimination of terminai residues 
from complex-type N-glycans. Hybrid-type N-glycans result from the trimming of only 
the a(l-3)Man branch of the intennediate Man5GlcNAc2 leading to oligosaccharides 
having a(l-3)Fuc and/or ,8(1-2)Xyl residues linked to GlcNAcMan5GlcNAc2. The 
oligosaccharidic sequences corresponding to the four types of plant N-glycans are 
highlighted in Figure 5.1. 
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Figure 5.1: Main N-glycan structures isolated from plant glycoproteins. 
Hence, like other eukaryotic systems, plants synthesize glycoproteins having 
complex N-glycosylation pattems. There is an increasing interest in using plants as 
"bioreactors" for the production of recombinant pharmaceuticals, such as human 
lysosomal enzymes, which are needed in high quantities (molecular farming). In an 
attempt to provide a cost-effective and contamination-safe production system, human 
placenta! recombinant GCase was produced and purified in tobacco seeds. The final 
step of the biosynthetic procedure was devoted to the assessment of the stability and 
activity of the protein, essential features of pharmaceutical preparations before their 
release on the market for clinica! use. However GCase in vitro activity and uptake in 
human fibroblasts is guaranteed not only by a correct amino acidic sequence, but 
especially by a post-translational human-like glycosylation pattern. Here a method 
based on chemical exhaustive hydrolysis of the GCase saccharidic component was 
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developed in order to establish the type and amount of sugar residues involved in the 
formation ofthe glycan moiety. 
5.2.1 Materials and metbods 
T otal protein was extracted from tobacco seeds and concentrated by 
precipitation (34). The peli et was resuspended in l 00 !J.L 40 mM Tris buffer containing 
5 M urea, 2 M thiourea, 2% CHAPS and 2 mM tributylphosphine (35). A 12% 
polyacrylamide gel with l O wells was prepared and 6 !J.g of total protein were loaded 
in each well. Proteins were separated by SDS-PAGE and electroblotted at 4 mA/cm2 
for 25 min on a PVDF membrane. A Western blot analysis was carried out on two 
lanes using rabbit anti-GCase (l: l 00) as primary antibody and anti-rabbit conjugated 
to horseradish peroxidase (1:10,000) as secondary antibody. The rest of the PVDF 
membrane was coloured with Coomassie Brilliant Blue R-250 as previously described 
(36). The bands corresponding to the recombinant GCase, identified through 
superimposition of the gel with the photographic panel obtained by Western blot 
analysis, were recovered, excised and placed into a screw-capped Eppendorf tube. 
After addition of l 00 !J.L 0.1 M TF A, the membrane pieces were incubated at 80 o c for 
40 min in a dry-bath heating block. Then they were transferred in an Eppendorf tube 
containing l 00 !J.L 2 M TF A and further heated at l 00 oc for 4h. Solutions were 
freeze-dried and each lyophilized powder was resuspended in 50 !J.L double-distilled 
water. 25 !J.L of solution were derivatized with 4-aminobenzonitrile ( 4-ABN) as 
previously reported (37). Derivatized samples were analyzed by CE using the MEKC 
or CZE mode. The apparatus was a HP3°CE system equipped with a DAD UV 
detector and an uncoated fused silica column (72 cm effective length, 80.5 cm total 
length, 50 !J.m internai diameter). Ali runs were done at 30 oc applying a voltage of20 
kV. Samples were loaded under vacuum at a pressure of 16.9 kPa for 1.5 s. Between 
each analysis the capillary was rinsed for 2 min with 0.1 N NaOH and then 
conditioned with the running buffer for 4 min at a vacuum pressure of 67.6 kPa 
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Scheme 5.1: Procedure for compositional monosaccharide analysis of GCase. N-linked glycans 
are released through exhaustive chemical hydrolysis and characterized by means of capillary 
electrophoresis. 
A running buffer of 20 mM NH4HC03 and 100 mM SDS (pH 7.5) was used for 
MEKC analysis. The detection wavelength was set at 285 nm. Mixtures of standard 
monosaccharides were treated in similar manner and analyzed. The derivatized 
samples either alone were analysed by CZE using 50 mM borax as running buffer. In 
this case runs were recorded at 195 nm and setting ali other experimental parameters as. 
specified above. The whole procedure is summarized in Scheme 5.1. 
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5.2.2 Results and discussion 
Different lots of recombinant GCase were analyzed through MEKC with 
identica! results, shown on electropherograms A and B reported in Figure 5.2. 
Through co-injection of the derivatized sample and a series of 4-ABN-labelled 
standard monosaccharides, the presence of mannose, glucose, galactose and N-
acetylglucosamine could be ascertained in the 2 M TF A hydrolyzate. 
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Figure 5.2: CE analysis of 4-aminobenzonitrile neutra! sugar derivatives; (A) monosaccharide 
standard mixture; (B) neutral sugars mixture resulting from 2.0 M TF A hydrolysis of purified 
recombinant GCase. Running conditions: fused silica capillary (72 cm x 50 ~-tm ID), detection 
wavelength 285 nm, electrolyte solution 20 mM NHJIC03 and 100 mM SDS (pH 7.5), applied voltage 
20 kV, injection time 1.5 s. 
Other peaks of the electropherogram could not be identified but, more 
important, the absence of either xylose or fucose was ascertained. Indeed, ,B(l-2)Xyl 
and a( l-3)Fuc epitopes are known to be highly immunogenic for humans (38, 39). 
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From the analysis of the O.IM TF A hydrolyzate, the absence of sialic acid, 
tipically absent in plants N-glycans, was ascertained, remaining the only detectable 
signal at 195 nm unidentified (see Figure 5.3). 
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Figure 5.3: CZE analysis of the 4-aminobenzonitrile-derivatized 0.1 M TF A hydrolyzate 
before (E) and after (F) co-injection with underivatized sialic acid standard (ca. 3 mglmL). 
Electrophoretic conditions: fused silica capillary (72 cm x 50 IJ.ID ID), detection wavelength 195 nm, 
electrolyte solution 50 mM borax, applied voltage 20 kV, injection time 1.5 s. 
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By analyzing the sample mixture at 285 nm by coinjection with neutral 4-
ABN-sugar standards mixture the peak could be assigned to mannose, as reported in 
Figure 5.4. 
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Figure 5.4: Electropherograms of the 4-aminobenzonitrile~derivatized 0.1 M TFA hydrolyzate before 
(C) and after (D) co-injection with 4-ABN-mannose standard (0.105 mg/mL). Run ccmditions: fused 
silica capillary {72 cm x 50 JLffi ID), detection wavelength 285 nm, electrolyte solution 20 mM 
N~HC03 and 100 mM SDS (pH 7.5), applied voltage 20 kV, injection time 1.5 s. 
Partial acid hydrolysis with 0.1 M TF A is expected to release more outstanding 
sugar residues present on the non-reducing end of an oligosaccharide. The observation 
that Man residues are released through hydrolysis with 0.1 M TF A suggests that the 
GCase N-glycan pool contains mannose-ending glycans, such as high-mannose- or 
paucimannosidic-type N-linked oligosaccharides. The presence of Gal in the 2 M TF A 
hydrolyzate, however, suggested that complex-type N-glycan as well may populate the 
released glycan mixture. Considering that, likely, the four glycosylation sites on GCase 
are occupied by different types of (likely heterogeneous) glycans both complex and 
high-mannose- or paucimannosidic-type N-linked glycans might then be found upon 
chemical release, although the presence of hybrid-type N-glycans cannot be a priori 
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excluded. By integrating the peak areas, the monosaccharide composition of the GCase 
2 M TF A hydrolyzate was obtained in terms of sugar molar ratios: 
Man : Glc : Gal : GlcN Ac = l : 3 : 6 : 2 
Since GCase, likely, bears four glycan chains each contributing with a certain 
number of glycoforms, the above reported molar ratio composition cannot be taken as 
representive of any real saccharide chain sequence actually belonging to the 
glycoprotein but, rather, only as indicative for the composition of a "generic" mean 
oligosaccharide structure. However, the mannose abundance found in GCase 
hydrolyzate is not as significant as to justify the presence of high-mannose-type or 
even hybrid-type N-glycans and these two types of oligosaccharide, then, may be 
safely discarded as belonging to the protein. 
Moreover, the scarce detection ability of 4-ABN-labelled N-acetylamino 
sugars, already addressed in section 5.2.1, let the determined abundance of GlcNAc 
component be likely underestimated. Previous studies on the clearance and uptake of 
human placenta! GCase in rats suggested that some of the infused enzyme was taken 
up by liver non-parenchymal cells via GlcNAc/Man receptors (40, 41). This 
observation stimulated binding and intemalization studies of recombinant plant GCase 
by cultured fibroblasts of Type II Gaucher patient, with no endogenous GCase activity, 
in presence/absence ofmannose (42). Interestingly, in the presence ofmannose, GCase 
intemalization was greatly reduced (27% on average ), indicating a competition for 
mannose receptors. 
Likely then, paucimannosidic-type N-glycans, which expose two mannose 
residues on the outer end of the oligosaccharide chain, contribute to the total GCase 
glycan moiety. However, also multi-branched complex-type asparagine-linked 
glycans, bering {3(1-2)GlcNAc and {Xl-3)Gal residues present on the antennae might 
be part of GCase N-glycosylation according to the above reported (underestimated) 
GlcNAc molar ratio. 
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5.2.3 Conclusions 
In th~ biotechnology field, transgenic plants are rapidly emerging as factories 
for a low cost production of recombinant glycoproteins intended for therapeutic 
purposes. Here we showed the importance of identi:fying the plant-synthesized GCase 
glycosylation pattem that gives optimal clinical benefit and allows the release of the 
glycoprotein for therapeutic use. Here tobacco plants were engineered by solely 
introducing a DNA-construct carrying the GCase coding sequence. No crossing 
experiments of the tobacco plant expressing the active and mature GCase with other 
engineered plants, carrying DNA sequences related to silenced a{l-3)FucT and fX...l-
2)XylT, or enriched with the missing {X..,l-4)GalT, were performed. The plant post-
translational glycosylation machinery was not engineered in this case, therefore a 
GCase glycan expression analysis was of paramount importance. Through chemical 
exhaustive hydrolysis with TFA of the GCase glycan moiety, some very useful 
structure information for further detailed examination were obtained: as no signal for 
GalNAc was observed, the absence of 0-glycans could be postulated. The complete 
lack of immunogenic Fuc and Xyl residues in the sample mixture was also checked. 
The qualitative and quantitative analysis of the sugar residues recovered after acid 
hydrolysis suggested that mannose-terminating paucimannosidic structures, and likely 
also GlcNAc-rich multi-antennary complex-type oligosaccharides, eventually modified 
by addition of Gal and Glc residues, may be the more abundant N-glycans present on 
recombinant plant GCase. The structure hypotheses highlight the diversity that lies 
between mammalian and plant glycoprotein asparagine-N-linked glycans, regarding, 
respectively, the presence or absence of sialic acid. Anyway, protein stability and 
functionality can be guaranteed even if slight sequence variations occur between the 
human placenta! or recombinant plant GCase glycosylation pattems. The glycoprotein 
isolated from tobacco seeds, in fact, seems to be stable, active and taken up by human 
fibroblasts. However galactose, probably in the typical plant {X..,l-3)-linkage form, and 
glucose appendices present on complex-type N-glycan structures might be elements to 
be considered in allergenicity issues during in vivo studies. 
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5.2.4 Further studies 
Maybe the main bottleneck of the whole monosaccharide compositional 
analysis of GCase glycans is the 4-ABN sugar labelling procedure, which has been 
demonstrated to give low derivatization yields for N-acetylaminosugars and produce 
not easily comparable CE signals between sugar monomer derivatives. Therefore, as 
largely discussed in chapter 4, the best way to solve the problem is to try the 
derivatization of the TF A hydrolyzates with 2-aminobenzoic aci d, as the labelling dye 
chemically transforms ali monosaccharides with approximately the same yield and 
with very low detection limits (l 0-6 M order of magnitude ). 
Furthermore, it has been indicated in Iiterature (20) that protein transfer 
through PVDF blots yields a variable amount of glucose and to some extent galactose 
contamination in ali the analyses. We hope not to be run into such complication, 
because otherwise the analysis and discussion of the results need to be revised. 
However, in order to discard any doubt, the protein blotting should be performed, as 
contro!, also in a nitrocellulose membrane and check if the resulting CE 
electropherograms are reproducible changing the membrane matrix. 
In this study we were mainly interested in the monosaccharide compositional 
analysis of the recombinant GCase glycan moiety. It would be very interesting to 
continue the oligosaccharide structure mapping through alternative and more specific 
methods, such as the enzymatic release and sequencing of the intact N-glycans as 
described in the next section. 
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5.3 Bovine fetuin N-glycan heterogeneity determination 
Altered oligosaccharide profiles of glycoproteins are frequent in celi cultures, 
tissues and sera that undergo cancer development (43). In particular we were interested 
in the study of differential glycan expression of cell-surface liver glycoproteins in a 
healthy (Chang) and hepatocarcinoma (HepG2) cellline. 
Hepatocellular carcinoma (HCC) is one of the most common and aggressive 
malignant tumours, leading to one million deaths worldwide per annum (44), with a 
wide geographical variati o n in the incidence ( 45). The feature of HCC underscores the 
need to develop novel approaches that address the search of new HCC molecular 
marker for early diagnosis and improve the identification of therapeutic targets for the 
treatment of HCC patients with metastases. 
Nowadays population at risk of developing HCC are screened by ultrasound 
scanning and serum levels of a-fetoprotein (AFP). Unfortunately AFP levels do not 
distinguish between HCC and other diseases of the liver, as, for example, cirrhosis. 
However, studies performed on the type and amount of AFP glycoforms, suggested 
that these values may distinguish between patients with liver cancer and those with 
cirrhosis of the liver (46). Although proteome analysis is very informative, post-
translational modifications, such as glycosylation and phosphorylation, stili remain to 
be elucidated. To date the identification of proteins, in the term of proteomics, is 
routinely performed in many laboratories. On the other hand a routine glycoproteomics 
approach, glycosylation analysis in proteomics context, is stili in the stage of early 
development (47). The determination of protein glycosylation pattern is a key task in 
tumour investigation: an abundant a{l-6)-fucosylated variant of the AFP oncofetal 
glycoprotein has been found in sera ofpatients with HCC even at an early stage (48). 
As another example, increased a(2-6)-sialylation of N-glycans in a transgenic mouse 
model of hepatocellular carcinoma has been observed (49). The process of a(2-6)-
sialylation in liver glycoproteins has been reported to be altered in human HCC tissue 
homogenates and histological sections too (50). Enhanced branching events on N-
glycans (51) and increased a(l-6)-fucosylation degrees (52) in human 
hepatocarcinoma cells are frequently monitored. 
Being an altered glycosylation pattern of celi-membrane proteins restricted to 
specific cancer(s) they could be utilized as tumour markers but also be targeted for 
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drug-based therapy. Thus, profiling the cell-surface glycoproteome in diseases, such as 
liver cancer, can provide an effective approach for the identification of novel protein-
bound glycan targets for diagnostics and therapeutics. 
The comprehensive profiling and identification of cell-surface proteins 
generally involves the selective biotinylation of membrane proteins, easily recovered 
by affinity chromatography (53). Biotinylation is usually performed by using water-
soluble, membrane impermeable biotin-based reagents to prevent celi entry as well as 
to !abel extracellular oriented residues (Lys). The recovered proteins after separation 
by 2D-PAGE can be identified through MS analysis or Western blot. Once the 
proteome of the healthy and cancerous cellline is mapped, a glycomic approach would 
imply a further deglycosylation step of the in-gel biotinylated proteins identified as 
potential markers of the pathology and a detailed analysis of the component glycan 
moieties would be necessary to complete the scenario. 
In order to establish a reliable glycoproteomic analysis of membrane-bound 
proteins differently expressed in healthy (Chang) and hepatoma (HepG2) celi Iines, we 
were asked to optimize the avail~.ble methodologies for the isolation, purification, 
identification and, finally, for the characterization of the post-translational N-
glycosylation pattem. In this section we focused essentially our attention on the last 
step of this procedure: since protein separation techniques employ mainly l D or 2D 
gel electrophoresis, the in-gel digestion with PNGase F of the examined protein spot, 
the subsequent recovery of the N-glycan mixture and the oligosaccharide mapping 
through LC-ESIIMS were performed. Bovine serum fetuin was used as model protein 
in this methodological study. Bovine serum fetuin (Fet) (54) together with bovine 
pancreatic ribonuclease B (RNase B) (55), chicken ovalbumin (Ova) (56) and human 
immunoglobulin G (lgG) (57) is a glycoproteins commonly used as standard for N-
glycan characterization because commercially available in a relative highly pure form 
and because major glycoforms have been already characterized in literature. Many 
different enzymatic deglycosylation protocols yielding intact glycan chains, followed 
by derivatization with chromo- or fluoro-phores for their HPLC or CE separation or 
direct MALDI/MS or ESI/MS analysis, have been applied (58). The goodness of the 
different experimental procedures has been validated merging the extrapolated N-
glycan structures obtained from analytical results and the predicted glycoprotein 
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oligosaccbaride sequences. The most robust and reproducible methodological 
approacbes bave then been widely used for the N-glycan composition study of poorly 
cbaracterized and/or disease-related glycoproteins, usually recovered from ID or 2D-
PAGE separations. 
Bovine serum fetuin, in its native and active form, bas a molecular weight of 
ca. 68 kDa, and is known to bave 3 potential N-glycosylation sites and on average 2.4 
of them are glycosylated (59). In literature, bowever, even more than 23 distinct 
oligosaccbaride structures bave been assigned to the glycoprotein (60). 
Two parallel methodological strategies were tested: briefly, microgram 
amounts of denatured Fet were subjected to PNGase F treatment first in aqueous 
solution and then on a polyacrylamide gel spot. Both enzyme digests containing the 
released N-glycans were recovered and used for the N-link:ed oligosaccbaride 
sequencing througb HPLC-MS. The N-glycan structures were deduced from the 
possible monosaccbaride building block composition corresponding to the m/z values 
of the detected ions and according to the known Fet glycan sequences reported 
elsewbere (55, 61). As the deglycosylation in solution is performed in the best 
operational conditions, i. e., in bomogeneous pbase, the analytical results obtained from 
this procedure were compared with those extrapolated from the in-gel digestion, whicb 
is notoriously more difficult to perform, essentially due to the presence of the 
acrylamide gel matrix, whicb bampers the free PNGase F approacb to the protein to be 
deglycosylated. This double strategy was necessary in order to validate the in-gel 
digestion procedure, wbose principal steps are reported in Scheme 5.2. 
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Scheme 5.2: Flowchart representing the strategy employed for the N-glycan analysis of gel-
sepai:ated glycoproteins. 
5.3.1 Materials and methods 
In-solution PNGase F digest. 20 fA.g of Fet were dissolved in 50 fA.L NRtHC03 
50 mM (pH 8.6) and 0.4% w/v SDS or in 48 fA.L NRtHC03 50 mM (pH 8.6) and 0.4% 
SDS and 2 fA.L ~mercaptoethanol (62). The solutions were put in a screw-capped 
Eppendorf tub~ and heated for 3 min at l 00°C in a dry-bath heating block. The 
solutions were cooled at room temperature (RT), then 50 fA.L of the ionic detergent 
CHAPS l% in NRtHC03 50 mM (pH 8.6) and 5 U of PNGase F were added to each 
vial. The in cubati o n was performed under genti e horizontal stirring at 3 7°C for 24 h. 2 
fA.g F et aliquots were taken at the beginning and at the end of the procedure in order to 
test the hydrolyzing efficiency of the enzymatic treatment. Deglycosylated proteins 
were precipitated with 4 volumes cold EtOH 75% and the Eppendorf tubes transferred 
in an ice-bath for lh. After centrifugation at 13,000 rpm for 30 min, glycans were 
recovered in the supematant and dried in a Speed-Vac concentrator. 
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In-gel PNGase F digest. The Fet sample was treated exactly in the same 
manner as the protein extracts from Chang and HepG2 celi line samples, therefore a 
two-dimensional polyacrylamide gel was frrst of ali performed. 
Gel electrophoresis. Loading the first dimension, 20 11g Fet were solubilized in 
125 ~-tL rehydration buffer containing 7 M urea, 2M thiourea, 4% w/v CHAPS, 60 
mM DTT, 2% ampholines pH 3-10 and 0.002% bromophenol blue. The solution was 
incubated at RT for 1h then used to rehydrate a 7-cm pH 3-1 O linear IPG dry strip, 
overnight at 20 °C, with a constant 50 V potential applied across the gel strip, placed 
in the sample holder of an IPGphor. The rehydrated gel-strip was then electrophoresed 
at 500 V for l h, 2000 V for 30 min, and then at 8000 V fora total of 15,000 V-h. 
After isoelctrofocusing, the strip was placed in an equilibration solution, containing 
2% v/v SDS, 50 mM Tris-HCl pH 8.8, 6 M urea, 30% v/v glycerol, 0.002% 
bromophenol blue and 65 mM DIT for the reduction ofthe Fet disulfide bridges. This 
frrst equilibration step was performed under gentle shaking for at least 15 min. In a 
second 15-min equilibration phase, alkylation of free cysteines was carried out in the 
same equilibration buffer, but using 135 mM iodoacetamide instead of DTT. The 
second dimension, which is a classical SDS-PAGE, was performed on a Hoefer SE 
600 Ruby apparatus. After equilibration in the running buffer (25 mM Tris, 192 mM 
glycine and 0.1% v/v SDS), the strip was set on the top ( cathodic end) of a 8% slab-
polyacrylamide running gel (10 x 8 cm x 2 mm) and sealed in piace with a 0.5% w/v 
agarose containing bromophenol blue solution. The second dimension was developed 
at 100 V for 30 min and then at 200 V until the blue marker dye reached the bottom of 
the gel. After electrophoresis, the gel was stained with a solution made of 7.5% v/v 
acetic acid, 25% v/v isopropanol and 0.05% Coomassie Brilliant Blue G-250. The 
protein spots were visualized after destaining the gel with 7.5% v/v acetic acid. 
Protein reduction and alkylation. Three spots corresponding to Fet were 
excised with a disposable scalpel in order to avoid contaminations. The gel slices were 
placed in a sterile l ,5 mL Eppendorf vi al and washed with 300 ~-tL of sterile bidistilled 
H20 for 30 min, trying to remove residua! acetic acid. Water was discarded and the gel 
pieces were dehydrated with acetonitrile for l O min. The liquid phase was remo v ed 
and the gel slices dried in a vacuun1 centrifuge. The dried gel pieces were slowly re-
swelled by two-fold incubation (almost 30 min each) with 300 ~-tL 20 mM NaHC03 
122 
(pH 7.0). To this solution 20 !J.L 45 mM DTT were added to allow the reduction of 
disulfide bonds, heating the vial at 56 °C for l h. The reducing solution was cooled to 
RT and replaced with 300 ~J.L fresh 20 mM NaHC03 (pH 7.0), containing 20 !J.L of 
100 mM iodoacetammide. The alkylation reaction was conducted at RT for 30 min in 
the dark. The supematant was then removed and the gel pieces washed flrst with 300 
!J.L 20 mM NaHC03 (pH 7.0) for 30 min and then with an acetonitrile: 20 mM 
NaHC03 (pH 7.0) 1:1 solution. At this point the washing solution was removed and 
the gel slices were cut into smaller pieces (•l mm2 square) in order to ease the 
subsequent PNGase F penetration through the acrylamide matrix. The gel pieces were 
incubated for 5 min with 300 !J.L acetonitrile and completely dehydrated in a Speed-
Vac centrifuge. 
Enzymatic release ofN-glycans. To the reduced and alkylated gel slices, 15 U 
PNGase Fin 30 !J.L 20 mM NaHC03 (pH 7.0) were added. After re-swelling ofthe gel 
pieces, a volume of 20 mM NaHC03 (pH 7.0) solution, sufficient to leave the pieces 
constantly immersed in the liquid phase, was added. The enzymatic digestion was 
allowed to stand 20-24 h ( overnight for convenience) at 3 7 o c in horizontal agitation. 
Glycans were extracted from the gel medium by removing the incubation buffer 
followed by two extractions with approximately 200 !J.L pure bidistilled water and two 
extractions with · 50% v/v acetonitrile, with sonication for 30 min each. Ali extracts 
were combined and dried in vacuo. 
LC-ESI/MS N-glycan analysis. The lyophilized glycans were resuspended in 
l 00 !J.L bidistilled water and separated on an amine-bonded polymeric column (Luna 
5!J.rn NH2 Phenomenex, 250 x 3.0 mm) of an HPLC Surveyor system (Thermo 
Finnigan), supplied with an autosampler, a PDA UV -visible detector, MS pump and 
coupled to an electrospray ionization-ion trap (ESI-IT) LCQ Deca XP mass 
spectrometer (Thermo Finnigan). Experimental parameter setup and data handling 
were controlled by an Xcalibur 1.3 software. 
The normal phase liquid chromatographic separations were carried out at 27 °C 
using a flow rate of 0.4 mL/min. The mobile phases were 50 mM ammonium formate 
(pH 4.4) (solvent A) and pure acetonitrile (solvent B). The elution gradient reported in 
Table 5.1 was used for optimum resolution of bovine fetuin oligosaccharides. The 
column was washed with l 00% A for l O min at 0.05 mL/min flow rate before 
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conditioning with the initial solvent composition system. The UV -visible lamp at the 
column outlet was set at 195 nm. Sample injection volume was 20 ~-tL. 
Ali MS measurements were performed in the positive ion mode. For the 
ionization process of the Fet-released glycans, the accelerating voltage was set at 4.5 
kV and the electrospray source was constantly held at 240 °C; the capillary voltage 
was set at 24 V and the sheath gas flow (N2} was 0.3 L/min. The explored mass-to-
charge (m/z) values ranged from 200 to 2000. The scan type option was set at full 
mass. The N-glycan fractions were detected as mono- or multi-charged adducts with 
W or NfLJ + ions. 
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Table 5.1: Elution gradient ofthe LC analysis ofFet-released N-glycans. 
5.3.2 Results and discussion 
In-solution PNGase F digest. The most widely applied chemical and enzymatic 
deglycosylation procedures want the standard glycoprotein to be available in solid 
form and easily soluble. Since the amounts of protein needed to perform glycosylation 
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analysis exceed those needed for amino acid sequencing, almost 20 !J.g Fet powdery 
sample, dissolved in ammonium bicarbonate buffer with or without added ~ 
mercaptoethanol as denaturing agent, were necessary to perform the digestion with 
PNGase F. A small amount of sample prior and after enzymatic hydrolysis was 
collected and run on a 12% SDS-PAGE in order to check the efficiency of the 
deglycosylation time course. Results are reported on Figure 5.5. 
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Figure 5.5: Deglycosylation efficiency of the solution phase PNGase F digestion. The 
electrophoretic mobilities ofnative Fet (lane 2) and deglycosylated Fet under non-denaturing (lane 3) or 
denaturing conditions (lane 4) are compared. 2 f.lg ofFet were Ioaded on each well. On lane l molecular 
weight protein standards were loaded. 
It is known that some glycoproteins are difficult to deglycosylate in their native 
form because of steric hindrance due to attached oligosaccharides (63), which restrict 
the accessibility of the glycoprotein for the PNGase F. However, in the case of Fet, 
denaturation conducted with ~mercaptoethanol was unnecessary for successful 
deglycosylation. As can be observed from the positions and intensities of the protein 
bands in Figure 5.5, the enzymatic treatment in the absence of denaturing agent turned 
out to be more efficient. The PNGase F digest is responsible for a visible decrease in 
molecular weight from ca. 68 kDa to ca. 50 kDa between the Fet bands appearing on 
lane 2 and 3. In fact, it has been reported that the pure amino acidic Fet chain has a 
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mass of about 48 kDa. It can be postulated that the failure in deglycosylating Fet under 
reducing conditions with ,8-mercaptoethanol is due to the likely denaturation of 
PNGase F itself, whose three-dimensional structure loss heavily compromises its 
hydrolyzing activity. Initially, the Fet band (see lane 2) appeared broad owing to the 
heterogeneity of the glycan moiety. Also after PNGase F-based deglycosylation, the 
results did not show a single band (see lane 3), suggesting that the hydrolyzing 
treatment left some glycosylated protein over, due to insufficient amount of digesting 
enzyme or too short incubation times. However, some authors (62) reported that, even 
with an excess amount of PNGase F, it was impossible to improve in-solution 
deglycosylation efficiencies of Fet and reduce band broadening on SDS-PAGE. 
Therefore, although Fet was not deglycosylated to completion, the result was 
considered as satisfactory and the N-glycans recovered on the liquid phase after protein 
precipitation were freeze-dried and conserved at -20 oc for oligosaccharide sequence 
analysis. 
In-gel PNGase F digest. In principle ID or 2D SDS-PAGE enables proteins 
diluted in a biologica! sample to be concentrated into small areas of the gel matrix. 
Protein mixtures or protein variants ( such as glycoforms) become separated during gel 
electrophoresis. Standard 8% polyacrylamide gel of 2 mm thickness usually allowed a 
good separation of glycoproteins from HepG2 and Chang cell culture extracts. 
Therefore, in this study, the same recipe was used when Fet and other standard 
glycoproteins underwent P AGE, even though gels containing about l O times less 
bisacrylamide are used to run glycoproteins (55). In Figure 5.6 the two-dimensional 
polyacrylamide gel illustrates the rnain resolved glycoforms of Fet, which are visible 
as a series of spots (1, 2, 3) at relatively high molecular weight and located in the 
acidic region (3.5<pH<5) ofthe separating gel. 
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Figure 5.6: 20 preparative PAGE of a 20 J.lg sample of bovine serum fetuin (spots l, 2, 3) and 
chicken ovalbumin (spot 4) for in-gel enzymatic digestion trials. 
Protein visualization was here accomplished using the Coomassie blue staining 
technique, which is known to be fully compatible with subsequent manipulations for 
glycan isolation. 1t should however be noted that the staining and destaining solutions 
should not contain more than 7.5% acetic acid in order to preserve sialic acid-
containing glycans. Usually, in most proteomic studies, dealing with protein amount of 
the order of nanograms, gels are stained with the more sensitive silver-staining 
protocol. Differently, amounts of the order of micrograms are required to perfonn a 
reliable oligosaccharide mapping. Therefore, only proteins that are visualized with 
Coomassie stain are amenable to glycan analysis. 
Prior to PNGase F digestion, protein bands corresponding to Fet (spots l, 2, 3) 
were cut from the gel, joint in an Eppendorf vial and destained by washing with water. 
Although destaining was not always complete, this had no adverse effect on the 
subsequent enzyme treatment. To maintain their denatured state during 
deglycosylation, proteins were reduced and carboimidomethylated in the gel. 
Remaining Coomassie stain was also destroyed during this step, as generally noticed 
by the sudden disappearance of the blue colour. SDS had to be thoroughly removed 
from the gel plugs to prevent denaturation of the deglycosylation enzyme and to avoid 
interference with LC-MS analysis. Even though PNGase F removed glycans from Fet 
in its native confonnation in-solution treatment, this cannot be guaranteed in gel-
mediated hydrolysis. Hence, denaturation is always required to ensure complete 
deglycosylation of glycoproteins that are/are not resistant to PNGase F hydrolysis. 
Besides the pH optimum for PNGase F activity (i.e. pH 7.0) the buffer system 
used for in-gel digestions (20 mM NaHC03,) was chosen to meet several criteria. 
Phosphate, borate and citrate buffers are difficult to remove from carbohydrate 
samples containing anionic sugars while bicarbonate-based buffer, in equilibrium with 
carbonic acid in solution, can be removed as C02 by drying. A fully volatile buffer, 
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such as ammonium bicarbonate, however, could not be used because ammonium ions 
convert a certain percentage of the sugars in their respective glycosylamines, which 
cannot be labelled by reductive amination for HPLC or CE analysis and are detected 
on MS with mass difference of l Da with respect to their reducing sugar analogues. 
PNGase F was used at a concentration (lOOU/mL) higher than the one (60 or 
Iess U/mL) reported (63) to fully deglycosyiate a number of giycoproteins in their 
denatured state in homogeneous phase. Accounting for a possibie partial enzyme 
activity Ioss during penetrati an of the gei, a slightly higher enzyme concentrati an was 
then used. 
Released glycans could be efficiently extracted from the gel pieces by 
sonication in distilled water. The need for sampie clean-up was minimal because most 
contaminants such as SDS and electrophoresis buffers had been removed prior to 
PNGase F digestion. Nevertheless, many protocols suggest to perform "glycoclean" on 
microcoiumns packed with ion-exchange or reversed-phase resins prior to MS analysis 
in arder to improve spectra quality. However, interfacing as in our case MS to a NP-
HPLC system, glycan desalting and/or purification was achieved in loco. 
LC-ESIIMS N-glycan analysis. Sequencing an intact glycan pooi can be 
performed in several ways, as already pointed out in section 1.5.2.2. These are mainly 
based on the application of separation techniques, such as GC, CE and HPLC, which 
generally cali for a derivatization step of the oiigosaccharide moiety, and analytical 
means like MS. To achieve exhaustive information on branching points and linkage 
types of glycans, these investigation methods are usua11y crossed with exogiycosidase 
array treatment. 
Several papers have appeared reporting oligosaccharide derivatization with 2-
aminobenzoic acid (64, 65). The 2-AA-labelled glycans are then separated through 
NP-HPLC and subjected to sequential exoglycosidase digestions. Oligosaccharides 
originated from these digests are profiied trough MALDI-MS. As the in-gel enzymatic 
deglycosylation leaves the polypeptide chain intact, also peptide mapping studies on 
deglycosylated proteins, through in-gel trypsin digests, were successfully undertaken 
(55). 
In our case, since we could neither guarantee the success of the in-gel 
deglycosylation a priori nor estimate the quantity of N-glycans recovered from this 
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treatment, we decided to reject any derivatization procedure, which inevitably lowers 
the availability of oligosaccharides due to incomplete labelling yields, aiming to 
preserve the glycan amount as high as possible. 
Lyophilized N-glycans released from in-solution and in-gel PNGase F 
deglycosylation, were resuspended in l 00 J,tL bidistilled water, which is the minimum 
volume required to allow the autosampler to operate. 20 J,tL-injections in the LC-MS 
apparatus were performed and the oligosaccharides present in the two sample mixtures 
were fust chromatographically separated owing to their different hydrophilicity and 
then detected by means of the mass spectrometer according to their mass-to-charge 
ratio, after elution from the HPLC column. Since Fet N-glycans are reported to be 
mainly sialilated, and acidic oligosaccharides are preferentially associated to positively 
charged ions, MS measurements were chiefly accomplished in the positive ion mode. 
10-fold lower sensitivities were recorded when the same oligosaccharide mixtures 
were analyzed in the negative ion mode (data not shown). With great surprise, the 
spectral pro fil es of the in-solution and in-gel digests were very similar indicating that 
the same hypothetic N-glycan structures could be assigned to Fet subjected either to in-
solution or in-gel deglycosylation procedure. 
In Figure 5. 7 the most significant mass spectra recorded during the 
chromatographic elution are reported. The proposed N-glycan structures for the 
detected m/z values are illustrated too. These can be hypothesized knowing the sugar 
composition and mass of the most representative Fet N-glycans and calculating ali 
possible charge states deriving from the association of the oligosaccharides to one type 
of cation or a combination of two (or more). We compared the calculated the m/z 
ratios with the experimental ones and found that there was a good agreement regarding 
the W or NRt + charged species, while no correspondences were detected when the 
N a+ or K+ adducts were considered. As the elution gradient was carri ed out in 
HCOONRt/HCOOH buffer, we expected that the molecules would preferentially be 
coupled to H+ or NRt + ions during volatilization in the ESI source. For clarity, the 
results are summarized in Table 5.2. 
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mass 
oligosaccharide structures 
(Da) 
(fh•,.\ \r)J(Ilo).;'H'U \r hidnl i'J_i_;,! 
retention time 
inNP-HPLC 
mi n 
charge state 
calculated 
m/z 
experimental 
m/z 
--(~~~~~~):(~~x)~~~~~~)~------~~~~--~-2:~~:~--~-~--- ----~:~;-~~-~-~·- -2~~lf+--- 748.13 759.47 747.15 758.14 
(HexNAc)5(Hex)6(NeuAc)2 triant 2589.8 2.24 3ft 
(HexNAc)s(Hex)6(NeuAc)4 triant 3172.4 
4.50 
4.50 
''jì-fj'Nf1+ 
H+2Nlit+ 
86427 862.13 
--- -··-··------------------·----------··----·---~------
538.23 
1069.80 
537.69 
1071.71 
Table 5.2: LC-ESIIMS N-glycan mapping of bovine serum fetuin: three of the five main 
oligosaccharide structures were assigned. 
From the LC-ESI/MS glycan mapping, three oligosaccharide structures 
pertaining to the N-glycosylation profile of Fet were assigned. This is in agreement 
with our expectations, as the gel spots excised and subjected to enzymatic 
deglycosylation were effectively three. However, the same observations were made for 
the in-solution digested sample, which has not been enriched with the three major 
oligosaccharide chains, thus suggesting that the N-glycans present in minor amount 
could not be detected with this method. The heaviest and most acidic Fet N-glycan, 
labelled with the generai formula (HexNAc)5(Hex)6(NeuAc)4, was assigned to. 
glycoform of spot l on the 2D gel, while the remaining two unravelled structures, 
having the same number of sialic acid residues and differing by one Hex and one 
HexNAc unit, were expected to belong to glycoforms showing the same pl but 
different electrophoretic migration properties on the gel. Therefore, the glycoform 
assignments of spot 2 and 3 are not easily established and it remains stili unclear 
weather the biantennary and triantennary bisialilated structures are separated in the two 
spots or if they are rather concentrated in only one spot ( either 2 or 3). Indeed, 
observing the 2D gel more accurately, these two spots are resolved in two adjacent 
bands, which are lying just one over another. These bands couples, either 2 or 3, might 
comprise both oligosaccharide structures. However, judging from the molecular 
weight difference between the tetrasialilated glycan structure and the two bisialilated 
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ones, which is only about l 000 Da, we believe spot 3 to come from the two lighter 
glycoforms. 
The PDA UV-visible detector was set at 195 nm. This wavelength is absorbed 
by N-acetyl groups bound to carbon 5 of sialic acids or to carbon 2 of GlcNAc 
residues. As mentioned above, the HPLC chromatograms resulting from the Fet-
released glycans were not very meaningful. However, after monitoring the glycan pool 
on the mass analyzer, it was possible to assign retention times to the examined 
oligosaccharides a posteriori. A t frrst glance, the retention times associated to the three 
detected N-glycans appeared to be too short (2.2-4.5 min), considering the enhanced 
hydrophilic properties of oligosaccharides bearing sialic acid sugar residues on their 
non-reducing termini and the likely affmity of these analytes towards the stationary 
amino-bonded phase. Furthermore, the same glycan building blocks, differing 
essentially in the number of NeuAc units, generally show longer retention times in 
normal phase LC increasing the number of these acidic residues. In our analysis, the 
two bisialilated structures practically co-elute, while the tetrasialilated one is 
effectively detected at higher retention times. W e thought to bave built a proper elution 
gradient aimed to resolve nearly ali Fet glycans in an optimum manner. W e started the 
elution gradient using a not completely hydrophobic mobile phase, namely 80% 
acetonitrile and 20% HCOONRJHCOOH, but this mixture of solutes was already 
hydrophilic enough to release the bisialilated oligosaccharides. A slightly more 
hydrophilic eluent composition allowed the removal of the tetrasialilated glycan also. 
However, in Iiterature it was reported that separation of 4-aminobenzoic acid 
derivatives of human IgG and RNaseB more abundant N-glycans through NP-HPLC 
was performed in the gradient zone included between 65 to 58% of acetonitrile, hence 
in an essentially hydrophobic mobile phase (65). Moreover it has been suggested that 
the elution time of the oligosaccharides is more strongly influenced by the presence of 
sialic acid than the number of constituent monosaccharides. This could explain why 
the two bisialilated Fet oligosaccharides, despite their different molecular masses, 
show ca. the same retention time. Furthermore, profiling the N-glycan pattem of 
recombinant human IgG, it was observed that 2-aminobenzoic-labelled sialylated 
oligosaccharides eluted much earlier than their desialylated counterparts in NP-HPLC 
(64). The authors justified this observation postulating the Iikely formation of sialic 
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acid salt bridges with ammonium ions rendering a more hydrophobic character to the 
sialic acid-carrying oligosaccharides. 
N-glycan mapping of hepatic membrane-bound proteins. The glycan mapping 
technique here developed for the characterization of the Fet-released oligosaccharides 
was applied to a hypothetic glycoprotein detected on a 2D gel map of a celi surface 
protein extract from the HepG2 cellline. This protein appeared as a "train" of spots on 
the gel, while in the Chang cellline the same protein was found to be under-expressed. 
After the in-gel digestion with PNGase F and analysis on LC-MS, performed as 
explained above, triantennary glycan structures, varying in sialylation degree, were 
assigned to the two heavier and more acidi c spots (data not shown). The remaining 
polypeptide chain in the gel matrix, was digested with trypsin and subjected to peptide 
mass fmgerprinting through MS/MS analyses. However, the identification of the 
protein failed because the fragmentation pattem did not produce reliable responses, as 
confirmed by the database Mascot Search (Matrix Science) of the Turbo Sequest 
Search system. 
5.3.3 Conclusions 
The N-glycan analysis method described here seems to be very attractive since 
intact oligosaccharides can be recovered and sequenced directly from SDS-PAGE-
separated proteins. Unlike solution-phase release procedures, samples do not need to 
be totally free of contaminating agents ( dyes, salts, detergents, etc.) because these can 
be easily removed during electrophoresis. However, some aspects of the entire 
protocol must be revised: for example the percentage of bisacrylamide of the 2D gel 
has to be lowered and the LC elution gradient should be shallower in the first l O 
minutes. Some methodological improvements regarding the derivatization of a 
released glycan pool with the well-established 2-aminobenzoic acid labelling 
procedure should be tried also. However, conducting N-glycan mapping on labelled 
and on unlabelled oligosaccharides requires the availability of a great amount of 
sample, which is always a criticai issue in glycoproteomic analysis. Producing huge 
quantities of a given glycoprotein is possible through stepwise accumulation of the 
same gel spot from severa! 2D SDS-PAGE analyses, which is a very time consuming 
work. Moreover, i t would be very nice to achieve an exoglycosidase sequencing of the 
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released glycans, but by means of an ESI-IT mass spectrometer this seems to be quite 
difficult because of the complexity of the tesulting spectra. Therefore, without a final 
proof of the sequence of the component monosaccharides and their linkage type, the 
current mapping technique can merely furnish hypothesized glycan structures. Here we 
saw how even achieve a structure proposal is not a straightforward task, considering 
that we dealt with a well-characterized glycoprotein standard. 
5.4 Further studies 
Here we showed that the in-gel enzymatic deglycosylation is actually optimal 
for a glicoproteomic investigation of 2D gel-separated membrane-bound proteins. 
However a glycomic approach can not be disjoint from a proteomic one: as happened 
in our study, we defined the N-glycan structure of a protein which has not been 
previously identified and the knowledge of the component oligosaccharide sequences 
was not useful in this case. Two main problems arose from the differential proteomic 
study of normal and cancerous hepatic cells: first of all the Chang celi line 
unfortunately behaved quite similarly to the transformed hepatoma celi line and few 
differences in protein expression were visible in their respective 20 images. Secondly, 
it has been recently found by our group (66) that HepG2 cells massively express 
proteins with chaperone function on the celi membrane, which are generally poorly 
glycosylated proteins. Therefore, at present it is not possible to say ifwe will continue 
the research activity in this direction, however the developed N-glycan profiling 
procedure remains available for a number of other applications. 
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Immobilized p-galactosidase-based synthesis of N-
acetyllactosamine 
6.1 Introduction 
N-acetyllactosamine is a widespread sequence of complex celi surface 
oligosaccharides of glycoconjugates (1). The recognition and the controlled adhesion 
between cells are probably the _most important biologica! processes in which those 
carbohydrates are involved in (2). To examine the biologica! activities of N-
acetyllactosamine, it is necessary to accurately check its presence and amount in crude 
celi extracts. That is why much effort has been spent in synthesizing this disaccharide, 
drawing from chemical (3, 4) or enzymatic (5, 6) methods. Nowadays the most 
promising approaches focus on glycosidases (7). In a suitable environment, these 
hydrolysing enzymes may also catalyse the formation of glycosidic linkages: in order 
to favour synthesis over competing hydrolysis, transglycosylation reactions are 
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generally performed in low-water media, or increasing the amount of either the 
glycosyl donor or acceptor, affecting that way the position ofthe equilibrium (8). For 
istance, the use of p-galactosidase from Bacillus circulans in the biosynthesis of N-
acetyllactosamine, in presence of p-nitrophenyl P-D-galactopyranoside (pNPGal) as 
glycosyl donor and N-acetylglucosamine (GlcNAc) as acceptor, did result in high 
regioselectivity and yield (9). 
Enzyme immobilisation on biocompatible resins allows easy recovery and 
repeated use of the biocatalyst, advisable features for industriai or biotechnological 
purposes. lt has also been reported that the stability of artchored enzymes through 
multipoint attachment on splid carriers is even highet in comparison with their soluble 
analogues (10, 11). The matrix is normally considered as the most important 
component able to influence the performance of a heterogeneous enzyme-catalysed 
reaction system. Several immobilisation strategies have been developed so far: for 
protein tethering, fibrous, mostly polymeric, matrices are normally preferred to 
particulate materials, but the main drawback is represented by the lack of active sites 
on these supports. In this study two different types of functionalized polymers are 
tested for the immobilisation of P-galactosidase from B. circulans: one, Eupergit®, 
carrying a reactive epoxy group whereas the other, Sepabeads, bears a glutaraldehyde-
activated amino functional group. 
The kinetics of N-acetyllactosamine transglycolytic synthesis was followed 
monitoring qualitatively and quantitatively in time the disaccharide production. In 
literature mainly indirect methods are reported to identify and quantify N-
acetyllactosamine, based on the release of p-nitrophenol-chromofore during the 
synthesis, or techniques exploiting the weak UV -absorption properties of the amide 
group of N-acetyllactosamine. Detection of carbohydrates is in fact hampered by t11eir 
inherent absence of chromophoric properties. This feature can be imported when the 
reducing end of a saccharide reacts with a primary amino-group of a UV- or 
fluorescent-active molecule in the presence of a reducing agent like cyanoborohydride. 
Here 2-aminobenzoic acid (2-AA) was used as labelling dye for N-acetyllactosamine 
direct detection via capillary electrophoresis, an analytical technique which has been 
shown to be very powerful in characterizing a great variety of chemical spec1es, 
including carbohydrates (12). 
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6.2 Materials and metbods 
Immobi lisation procedures. 
(a) Enzyme immobilisation on epoxy supports (i.e. Eupergit®C and Eupergit®C 
250 L). The commerciai resin Eupergit® is obtained by copolymerization of N,N'-
methyl-bis-metacrylamide, glycidyl metacrylate, allylglycidylether and metacrylamide. 
A solid phase syringe was filled with 2 g of wet polymer and 8 mL of a potassium 
phosphate buffer solution (1.25 M, pH 8.00) containing 600 U of the enzyme in its 
lyophilized form (benzylpenicjllin units) and was stirred at 40 rpm for 18 hours at 
25°C in a blood rotator. The immobilization was then allowed to proceed for other 20 
hours without stirring. The mixture was filtered in vacuo and the solid and liquid phase 
were recovered. 8 mL of a diluted phosphate buffer solution (0.02 M, pH 8.00) were 
then added to the collected solid phase, in order to remove adsorbed, not covalently 
bound enzyme from the support. After 45 minutes stirring, the suspension was filtered. 
Protein quantification assays were carried out on the two collected filtrates. The 
activity of the polymer-supported enzyme was finally tested. The immobilized ~-D­
galactosidase was stored at 4 °C. 
(b) Enzyme immobilisation on amino supports (i.e. Sepabeads® EC-HA3). 2 g of 
wet polymer were suspended in 8 mL of a glutaraldehyde solution (l% in phosphate 
buffer, 0.02 M, pH 8.00). The slurry was transferred in a solid phase syringe and 
stirred for l hour at 25°C. 8 mL of enzyme solution (l mg/mL or 2 mg/mL) were then 
added for the preparation of EC-HA3( l) an d EC-HA3(2) supports, respectively. After 
18 hours stirring, the slurries were left to stand for other 20 hours at 25°C and then 
filtered. Adsorbed proteins were removed by adding 8 mL phosphate buffer (0.02 M, 
pH 8.00) with NaCl 0.5 M to the solid phase. After 45 minutes stirring, the mixtures 
were filtered again. Protein quantification and enzyme activity assays were then 
performed. The final preparations were stored at 4 °C. 
Protein determination. The percentage of immobilized enzyme was determined 
from the difference between the amount of protein initially added to polymer 
suspensions and that present in the filtrates. The protein concentration was measured 
using Bicinchoninic Acid Kit for Protein Determination. A calibration curve based on 
PGA solutions of known concentration was frrst performed (19). 
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Water conteni determination of activated suppor/s. The water content of each 
preparation was determined from the difference between sample weight before and 
after drying at Il ooc for 6 h on alluminium dishes. 
Enzyme activity assay. jJ-D-galactosidase activity was determined as follows: in 
a solid phase syringe 50 mg of wet supported enzyme were suspended in 2 mL 
potassium phosphate buffer (0.05 M, pH 6.5) and were gently stirred for 30 minutes at 
37°C. l mL of a diluted phosphate buffer solution (0.015 M, pH 6.5) containing the 
substrate pNPGal was previously heated at 37°C and then added to the enzyme 
suspension. The reaction mixture was incubated at 37°C for 10 minutes under 
continuous stirring. The reaction was stopped by adding l mL NazC03 0.2 M. 
Absorbance of released p-nitrophenol was then measured at 430 nm, using, as a 
reference, a solution containing ali the reaction mixture components but lacking the 
substrate. One uni t (U) of enzyme activity is the amount of enzyme hydrolysing l !JIDOl 
of substrate per minute under the conditions stated above. The specific enzyme 
activity is expressed as units per mg ofprotein (U/mg). 
Kinetic study of enzymatic jJ-galactosylation. A solution was prepared by 
dissolving 5 mg of pNPGal (16.5 f.UllOl, 6.6 mM) and 50 mg of GlcNAc (226 !JIDOl, 
90.4 mM) in 2.5 mL of a potassium phosphate buffer solution (0.1 M, pH 7.00). Five 
aliquots of this solution ( each 0.5 mL) were added with a 0.5 mL solution of 
immobilised or free jJ-D-galactosidase (0.3 U, in the same phosphate buffer) and 
incubated at 37°C for 6 hours in a 3 mL column. During incubation 25 J1L of the 
reaction mixture were collected every 30 minutes. In the case of supported enzyme 
aliquots were collected after sedimentation of the solid phase whereas the aliquots 
containing the free biocatalyst were immediately boiled for l O minutes and ice-cooled 
to stop enzyme activity. Ali the fractions were diluted with 225 J!L of bidistilled water 
and then freeze-dried. 
Sugar labelling with 2-AA by reductive amination. The composition of the 
reaction mixtures was monitored by CE after suitable derivatization of ali reducing 
sugars. The freeze-dried samples were resuspended in 25 j.lL bidistilled water, added 
of methanol (50 J.LL) and of derivatizing solution (50 J.LL, 0.25 M 2-AA, 0.159 M 
NaCNBH3 in 99% methanol and l% acetic acid) and the mixtures allowed to stand at 
60°C for 5 hours (12). LacNAc or alloLacNAc used as standards were treated in the 
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same manner. Labelling reaction mixtures used for capillary electrophoresis were 
diluted five fold with running buffer before injection. 
Capillary electrophoresis. The system was an Applied Biosystems HPCE Model 
270A-HT with UV detection and Turbochrom Navigator ( 4.0) software. A bare fused 
silica column (72 cm totallength, 50 cm effective length, 50 J.lil1 ID, 375 J.lil1 OD) was 
used. Ali runs were done at 30°C with the detection wavelength set at 214 nm. 
Samples were loaded under vacuum at a pressure of 16.9 kPa for 1.5 s. Before sample 
injection, a 4-minute condition of capillary with the buffer followed a 2-minute 
washing with 0.1 N NaOH (vacuum pressure of 61.6 kPa). CE/UV on 2-AA-derivative 
solutions was performed using 150 mM borate in 50 mM phosphate (pH 7.50) as 
running buffer (20 kV). All analyses were carried out in normal polarity. 
6.3 Results and discussion 
Enzymatic synthesis conditions. Previous studies (13) indicate that the bacterial 
source of P-D-galactosidase heavily influences chemo-, regio- and stereo-selectivity of 
the biocatalyst. Several authors (14, 15) observed that transglycosylation reactions 
catalysed by P-D-galactosidase from Bacillus circulans produce N-acetyllactosamine 
with high yield and low contaminations by its isomer N-acetylallolactosamine. The N-
acetyllactosamine synthesis was performed usingp-nitrophenyl P-D-galactopyranoside 
as glycosyl donor and N-acetylglucosamine as glycosyl acceptor (see Scheme 6.1) 
(15). T o enhance yields of glycosidase-catalysed reactions a large excess of glycosyl 
acceptor in the reaction mixture was using setting the molar ratio donor/acceptor to 
1:14. 
?~~~ 
HO~O~ + 
OH~ 
N02 
H3C)=O 
-pNP ~H NH 
- o lE~ 
HO 
1 
~=? OH 
OH OH 
Scheme 6.1: Galactose transfer to position C-4 of N-acetylglucosamine mediated by fJ-D-
galactosidase to yield N-acetyllactosamine and free p-nitrophenol. 
Transglycosylation reactions, here reported, were performed in mild medium 
conditions (i.e.: phosphate buffer, pH 7.00, 37°C). In more severe conditions, lower 
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pH values and bigber temperatures apparently act favouring the catalysis, but in 
anticipation of the recovery and reuse of the enzyme, a pbysiological environment 
sbould be preferable. Furthermore, acid conditions do not favour biocatalyst thermal 
stability. Addition of an organic water-miscible co-solvent (devoid of -OH functional 
groups whicb migbt interfere in transglycosylation reaction) can be recommended to 
prevent bydrolytic activity of glycosidases (16). However, since organic solvents 
might induce conformational cbanges on the bydropbobic protein core (17) with the 
consequence of a partial or total loss of catalytic enzyme activity, the addition of 
organic co-solvents bas been bere avoided. 
Enzyme immobilisation: a comparison between two types of polymeric supports. 
Tbe highly reactive epoxy groups carried by The Eupergit® resin spberical particles, 
readly reacting with severa! functional groups like -SH, -COO, -NHz, are exploited to 
covalently ancbor enzymes onto tbe polymer matrix (see Scheme 6.2). Two types of 
Eupergit® resins, Eupergit®C and Eupergit®C 250 L, were bere considered for 
immobilization, their main difference laying on the epoxy content (see Table 6.1). 
Support A verage particle A verage pore Functional group Content offunctional groups 
diameter {l:!:m} diameter {nm} {J.UlloVg~~o:} 
Eupergit C 100-250 epoxydic 600 
Eupergit C 250L 100-250 epoxydic 250 
Sepabeads EC-HA3 150-300 500 amine 
Table 6.1: Physico-chemical properties of the polymers used in P-D-galactosidase 
immobilisation 
Tbe solid support known as Sepabeads®EC-HA3 is a highly porous materia! 
whicb exposes esamethylamino reactive groups cbemically modified by reaction with 
glutaraldebyde. This activating agent can fix tbe enzyme on tbe polymeric matrix 
binding a lysine 6-aminogroup to a free aldebydic function (see Scheme 6.2). 
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Scheme 6.2: Immobilisation mechanisms of P-D-galactosidase on Eupergit or Sepabeads 
polymers. 
In both cases, the higher the number of lysine residues available to react with the 
solid matrix, the more chemically stable is the synthesized biocatalyst. This multipoint 
attachment might increase the rigidity of the protein as well as reduce, if not suppress, 
its catalytic activity. Several parameters contro l the success of enzyme anchoring on 
polymers, such as pH and ionic strength of the buffer, enzyme/support ratio and 
duration of the immobilisation procedure. Therefore the percentage of enzyme bound 
to the matrix and its final catalytic activity are strongly dependent on the 
immobilisation protocol. In Table 6.2 several characteristics of the prepared activated 
supports are reported. 
Polymer Concentration of Dry substance (%t Bound protein Catalytic activity k ( .. j)d inact mm 
(%)b (U/gdryt 
:pabeads EC-HA3 (2) 30 25 1.6 0.0506 
pabeads EC-HA3 (l) 28 33 l. O 0.1165 
Eupergit C 250L 19 28 3.8 
Eu~ergit C 27 26 3.7 0.1051 
a Known aliquots of wet preparations are heated overnight at l 05°C and weighed the morning after. Mass 
differences are related to the amount ofwater present in the samples. 
b The percentage of immobilised enzyme is obtained using Bicinchoninic Acid Kit for Protein 
Determination. 
c Catalytic efficiencies are calculated through hydrolysis of p-nitrophenyl-P-D-galactopyranoside, i.e. 
monitoring released p-nitrophenol per minute per gram of dry preparation. 
d Inactivation constants are evaluated by thermal degradation of weighed amounts of immobilised pro te in 
after O, 3, 6, 9 and 12 minutes; hydrolytic efficiencies ofthe inactivated preparations were then tested; the 
slope of the line obtained by plotting inactivation periods against the natura} logarithm of residua} 
percentage activities represents kinact· 
Table 6.2: Results ofthe immobilisation of P-D-galactosidase from B. circulans on different 
supports. 
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The polymers tested seem to adsorb water in the same amount. Only Eupergit®C 
250 L shows slightly lower weights of dry substance, i. e. higher water content in the 
wet preparation. From the indicated higher swelling ability, the highest total pore 
volume should then belong to the Eupergit®C 250 L polymer matrix. As shown in 
Table 6.2, ali the matrices bear approximately a comparable amount of bound protein. 
However and contrarily to expectations, in the case of Sepabeads® resins, the EC-
HA3(1) sample protein content turns out to be higher than that of EC-HA3(2), 
although the latter was prepared by doubling the enzyme concentration used for the 
former. Not necessarily, then, immobilisation performed using protein-richer solution 
willlead to a protein-richer biocatalyst. Equally, an higher density of active sites for 
protein binding is not necessarily leading to a greater immobilization degree, as 
deduced from the data reported for the two Eupergit samples. Compared to Eupergit-
anchored enzymes, those bound to Sepabeads resins show four-fold lower activities 
indicating a rather scarce functioning availability ofthe protein. Moreover, among the 
sepabeads matrix types, the lowest activity is shown by the highest loaded protein 
EC-HA3(1). 
Monitoring the transglycosylation produci LacNAc: a kinetic study. After P-D-
galactosidase from B. circulans immobilization, the biosynthesis of N-
acetyllactosamine was performed, using p-nitrophenyl galactopyranoside and N-
acetylglucosamine as substrates. The time course of the biosynthetic transformation, 
was followed by sampling every 30 min negligible amounts of the reaction mixture 
minutes for product identification. Parallel incubations were performed also with free 
enzyme. After enzyme inactivation, the collected fractions were derivatized with 2-
aminobenzoic acid and the yield oflabelled N-acetyllactosamine (Galfil-4GlcNAc), as 
well as of its isomer N-acetylal/olactosamine (GalP1-6GlcNAc), was obtained by 
means of capillary electrophoresis. 
The identity of ali components present in the collected fractions was confirmed 
by their comigration with added standards. In Figure 6.1 the electropherogram 
obtained with a transglycosylation reaction mixture with immobilised P-D-
galactosidase is compared with that observed with the two LacNAc isomers mixture. 
Ali samples run showed a similar peak pattern and by coinjection of different 
standards, the presence of GalpNP, LacNAc(-2AA), free pNP and not consumed 
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GlcNAc(-2AA) could be ascertained. No trace of alloLacNAc was detected in any of 
the samples tested. Frorn this finding, clearly showing that the transfer of galactose 
occurred solely at the OH-4 position of GlcNAc, the rnaintenance of stereo-specificity 
and regio-selectivity of P-D-galactosidase also after irnrnobilisation could be safely 
deduced. 
GlcNAc-2AA 
LacNAc-2AA 
~ ~ 3,0 
2,5 
GalpNP 
pNP 
"' 9 
::: 2,0 
~ 
l 
B 
g 
a 
q 
!il 1,5 
Ef LacNAc-2AA a//oLacNAc-2AA 
1,0 ~ / 
15 20 25 30 
time (min) 
Figure 6.1: Capillary electrophoretic runs of(A) a standard mixture ofLacNAc and a//oLacNAc 
and (B) a crude extract from transglycosylation reaction. Analytic conditions: the run buffer was borate 
150 mM/phosphate 50 mM (pH 7 .5); for other experimental conditions see Materials and methods. 
The electropherograms reported in Figure 6.1 shows the tirne evolution (2 h) of 
transglycosylitic LacNAc production by irnrnobilised catalyst. The enzyrne behaves 
quite differently when anchored on Eupergit or on Sepabeads carriers: in the forrner 
case LacNAc production slowly increases on tirne, reaching relatively a high 
concentration value (0.09 rnM) after two hours of reaction (see Figure 6.1 A). In the 
latter case the transglycosylation kinetic is very fast as deduced from the intensity of 
the related signal observed at short reaction tirne. However a sharp decrease of the 
initially synthesised LacNAc then occurred, as indicated by the signal intensity drop 
recorded after l hour (see Figure 6.1 B). 
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Figure 6.1: CZE-UV analyses related to the production of LacNAc by P-D-galactosidase-
mediated transglycosylation: (A) Enzyme anchored on Eupergit®C 250 L (B) Enzyme anchored on 
Sepabeads~C-HA3(1). Experirnental contitions: phosphate buffer (pH 8.0) was used as electrolyte 
solution; for other informations see Materials anli Methods. 
In Figure 6.2 the time dependence of LacNAc yield observed by using resins 
supported-catalyst is reported and compared with that obtained by the enzyme in free 
solution. Data of Figure 6.2 clearly showed an improvement of catalytic efficiency for 
Eupergit immobilised P-D-galactosidase, with respect to the free-enzyme, with a 
maximum molar yield of 64% observed for Eupergit®C 250 L. 
The rapid inversion of activity of the Sepabeads-anchored enzymes occurred 
concomitantly to the increase o galactose production (data not shown). Although the 
reasons for this rapid transglycolytic-to-hydrolytic activity switch are stili to be 
investigated a different partitioning of the reagents, either GlcNAc or GalpNP, 
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between the solid and the aqueous phase forced somehow fJ-D-galactosydase to 
operate according to its hydrolytic properties, destroying freshly synthesized LacNAc. 
Further analyses are under investigation in order to assess whether this effect is 
caused by other factors, as for example by the different nature of the free epoxy and 
amino functionalities present on the inner and outer surface ofthe polymers. 
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Figure 6.2: T ime course ofthe fonnation of N-acetyllactosamine by transglycosylation catalysed by free or 
immobilised P-D-galactosidase on four solid supprts. Operational conditions are the same as in Figure 6.1. 
Storage and recycle of the immobilised enzyme. Stability studi es were performed 
through enzyme recycling. The wet enzyme-preparations were left in phosphate 
buffered solution at 4°C for 3 months. Only then immobilised fJ-D-galactosidases were 
subjected to a second catalytic cycle. They preserved identical regioselectivity but 
their catalytic efficiencies decreased in each case approximately by a 60% (data not 
shown). Undoubtedly suitable storage conditions should be further developed and re-
usage of the catalyst has to be tested in a shorter time range. 
6.4 Conclusions 
Here we reported on the synthesis of N-acetyllactosamine using free or 
immobilized fJ-D-galactosidase from B. circulans as biocatalyst. Commerciai products 
(Eupergit®C, Eupergit®C 250 L, Sepabeads®EC-HA3) were employed as solid 
supports for enzyme anchoring. The presence of N-acetyllactosamine and the complete 
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absence of N-acetylallolactosamine in crude reaction mixtures were assessed by means 
of capillary electrophoresis. An improvement in catalytic activity (maximum 64% 
LacNAc molar yield) was observed when P-D-galactosidase was chemically bound to 
Eupergit®C 250 L. Sepabeads-immobilized enzymes, on the contrary, seem not to be 
advisable biocatalysts for LacNAc production. 
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Large-scale biosynthesis of a Helicobacter pylori 
lysozyme 
7.1 Introduction 
Many bacteria have been shown to contain one or more celi walllytic enzymes, 
called autolysins, such as glucosaminidases, chitinases, carboxypeptidases, amidases, 
endopeptidases, transglycosylases and N-acetylmuramidases (lysozymes). Over 50 
families of these glycohydrolases have been classified based on their amino acid 
sequences (l) Autolysins are described as being involved in bacterial celi wall 
metabolism (2). Biological events like bacterial growth, celi wall turnover, celi 
separation, formation of flagella and sporulation require alteration of the external 
bacterial wall, which is coordinated by concerted action of two sets of enzymes, 
capable of either polymerize or hydrolyze murein, the main structural component of 
the celi wall (3,4). 
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Figure 7.1: Celi wall composition ofGram-positive (a) and Gram-negative (b) bacteria. 
The lysozyme family. Lysozymes are generally defined as {1(1,4)-N-
acetylmuramidases, because they perform their antibacteric activity cleaving the {1(1,4) 
glycosidic bond between N-acetylglucosamine (NAG) and N-acetylmuramic acid 
(NAM) residues of the celi wall peptidoglycan layer (5). The peptidoglycan is the 
major structural component of the bacterial celi wall. lt is made of a polysaccharide of 
high molecular weight, whose backbone is a regularly alternating co-polymer of N-
acetylglucosamine and 3-0 -lactyl-N-acetylglucosamine, i. e., a substituted chitin. These 
repeating disaccharide units form long linear chains that are reticulated by a 
tetrapeptide containing both L- and D-amino acid residues. The tetrapeptide is bonded 
to the lactic acid part of the NAM. The peptidoglycan is essentially made of six 
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different components, ali present in equimolar proportions: NAG, NAM, aminoacids 
(L-Ala, D-Ala, D-Glu) and meso-diaminopimelic acid (meso-DAPA). Some species 
show a variation of this composition, namely including residues of Gly, L-Ser, L-Thr, 
D-Asp and additional residues of L-Ala. The cross-linked peptidoglycan chains form a 
very robust matrix, which can resist to high intracellular osmotic pressure. Celi wall 
properties of rigidity and insolubility depend on the integrity of the peptidoglycan 
architecture. Upon lysozyme treatment, significant damage is inflicted to the 
peptidoglycan, leading to the formation of ho l es in the matrix and to the solubilization 
ofthe celi wall saccharidic components and, ultimately, to celi death (6). 
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Figure 7.2: Schematic view and chemical formula of the peptidoglycan. 
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A protein classified as lysozyme must be basic, small sized (about 15 kDa), 
monomenc, stable at acidic pH, unstable in basic environments, active against 
suspensions of Micrococcus lysodeiticus (7). According to evolutionary studies, 
lysozymes can be grouped into four main families: chicken- (type-C), goose- (type-G), 
phage/viral- (type-V) and bacterial-type. The amino acid sequences within a family are 
related, but there are no clear sequence homologies among different families (8). 
Despite the lack of sequence similarity, lysozymes share severa! major elements of 
secondary structure and a well-conserved catalytic amino acidic triad (Glu, Asp, Thr) 
confined within the N-terminus half of the protein (9). Lysozymes are composed of 
two domains, one that is predominantly a-helical and a smaller domain that is mainly 
~-sheet in nature. The active site is located at the interface between two domains 
connected by a long a-helix. However, even though the catalytic cleft appears to bind 
substrates in a similar manner, enzymatic kinetics can be quite different among the 
four families. The stereochemistry of the hydrolyzing reaction can occur according to a 
retaining or an inverting mechanism, depending on the anomeric configuration of the 
N-acetylglucosamine unit in the hydrolysis product (10). 
A modellysozyme. Bacteriophage T4lysozyme (phage e gene product, T4L), is 
produced upon infection of host cells at a later stage of its life cycle. As many other 
bacteriophages, this 18 kDa-protein can exert muramidase activity only after 
expression of a holin (phage 5 gene product), which creates a pore into the host celi 
membrane to channel the lysozyme into the periplasm (11). T4L is made up of an a-
helical domain and a smaller domain that contains a four-stranded ~-sheet (12). Today 
a number of3D structures representing the wild-type (13-15), several mutants (16) and 
complexes with oligosaccharides (17) of the T4L are available. From crystallographic 
studies performed on the protein, the effects of mutation on structure, stability and 
enzymatic activity have been well characterized (18). As a very interesting example, 
the substitution of one key catalytic residue, namely Thr-26~His, has been shown to 
convert T4L from an inverting to a retaining enzyme. Moreover, the T26H mutant 
showed transglycosidase activity, which was even more effective than the hydrolizing 
one. In contrast, the wild-type T4L has no detectable transglycosidase activity (19). 
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Figure 7.3: Crystal structure ofbacteriophage T4 lysozyme. 
A new lysozyme? This evidence encouraged members of our laboratory, 
engaged with the search of new glycosidases for their use in transglycosylation 
reactions in the syhthesis of biologically relevant oligosaccharides, to investigate the 
presence in recently sequenced genomes of a gene whose predicted product exhibits a 
high level ofhomology with T4L. The nucleotide sequence ofT4L gene e was used as 
templat~ for the screening of a lysozyme-like candidate in published genome libraries. 
The search underscored a very high degree ofhomology (more than 67%) between the 
T4L e gene and the HP0339 putative gene in the genome of Helicobacter pylori strain 
ATCC 26695. The multiple alignment ofthe two amino acidic sequences revealed the 
existence of the catalytic triad in HP0339 too, being the key residues identically 
positioned within the primary structure, only shifted by 7 amino acid units, compared 
to the T4L sequence. This finding reasonably suggests that H pylori might express a 
protein with lysozyme-like activity against bacterial cell walls. 
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Figure 7.4: Comparison between HP0339 and T4L amino acid sequences. The conserved 
catalytic triad (E, D, T) is highlighted; matching residues are indicated with stars, whereas conserved 
and semiconserved residues are marked with colons and dots, respectively. 
A complex organism. H pylori is a helix-shaped, Gram-negative and 
pathogenic bacterium. It specifically invades the gastric mucosa of primates causing 
chronic gastritis, peptic ulcers or even more severe diseases. Infection with H pylori is 
a risk factor for developing gastric lymphoma and carcinoma (20, 21). Although the 
glycoconjugate composition of human gastric epithelial cells is not known in detail, i t 
is proposed that terminating sialylated N-acetyllactosamine units may serve as 
bacterial attachment sites in the stomach (22). H pylori infection is ubiquitous, with 
approximately 50% of the world population estimated to be infected (23). Once 
colonized, the bacterium persists in the host chronically unless antibacterial eradication 
therapy is administrated (24). This bacterium requires the gastric type mucosa for in 
vivo proliferation. It lives in the human stomach exclusively and is the only known 
organism that can thrive in that highly acidic environment. Under conditions of 
environmental stress, e.g., in presence of a more alkaline medium, this bacterium 
converts from spirai to coccoidal form, which enables H pylori to minimize exposition 
of its surface to the surrounding environment (25). This shape has been found in water 
sources in Latin America and is thought to be involved in the epidemiology of the 
bacterium (26). This organism shows a high grade of genetic diversity and adaptation 
potential, as demonstrated, for example, by antibiotic resistant strains appearing in the 
UK population. Furthermore, physiological differences resulting from apparent 
genomic variation among strains have been suggested to be responsible for the 
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diversity of diseases associated with H pylori infection (27, 28). A number ofproteins 
are implicated in pathogenesis caused by different H pylori strains, but a few common 
genetic features encode potential virulence factors: (i) bacterial motility, conferred by 
the presence of multiple unipolar flagella, has been suggested to be required for 
colonization of the gastric mucosa, since H pylori mutants unable to synthesize either 
of the flagellar subunits (FlaA or FlaB) fail to colonize gnotobiotic piglets (29, 30); (ii) 
the cagA bacterial gene codes for one of the major H pylori virulence proteins and is a 
marker for the cag pathogenicity island, composed of ca. 20 genes. Most of them 
encode for a type IV secretion apparatus, which injects the CagA protein into the 
cytoplasm of a gastric epithelial celi (31). After phosphorilation on Thr residues by a 
host celi membrane-bound tyrosine kinase, the protein starts a series of reactions that 
culminates with the disruption of the norma! function of the cytoskeleton. 
Approximately 50% of H pylori strains are cagA+, but in gastric cancer risk 
population the percentage jumps to 90; (iii) on the contrary, the vacA gene is present in 
ali H pylori strains, but the secretion of the cytotoxin V acA protein takes piace only in 
some strains. This protein induces vacuole formation in epithelial cells and may be an 
important component in the induction of gastric celi lesions by H pylori (32); (iv) 
additionally, ali fresh isolates of H pylori express significant urease activity, which 
converts urea into· ammonia and bicarbonate neutralizing the lethal effects of gastric 
acid. This appears to be essential to survival and pathogenesis of the bacterium in the 
gastric lumen (33). 
Surprisingly, a variable but significant fraction of ureases, almost exclusively 
located within the cytopla.smic milieu in other bacteria, is found to permeate the 
extemal membrane of H pylori (34). The hypothesized mechanism whereby ureases 
become associated with the surface of H pylori, is termed altruistic autolysis (35). 
This process involves the massi ve release of urease and other cytoplasmatic antigens, 
by genetically programmed autolysis with subsequent adsorption of the released urease 
onto the surface of neighbouring intact bacteria. Furthermore, as a consequence of celi 
lysis, the release of celi wall fragments, especially peptidoglycan (murein) 
components, may trigger inflammatory and arthropatic processes (36). Programmed 
eliminati o n of a fraction of the bacterial population presumably benefits the remaining 
viable bacteria. Furthermore, autolysis may play an important role in immune evasion 
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by overwhelming the immune system with released cytoplasmatic proteins. 
Inactivation of the autolysin gene or inhibition of the lysozyme protein, which seems 
to initiate the inflammatory cascade, should decrease virulence of H pylori, as 
observed for other pathologenic bacteria exhibiting autolysis (37). This is an important 
issue to be considered for the pathogenesis comprehension and development of drugs 
or vaccines for H pylori. 
Figure 7.5: Optical microscopy of H. py/ori colonies. 
H pylori expresses an active lysozyme. Experimental evidence that the H 
pylori HP0339 gene expresses an autolytic enzyme and that the hypothetic lysozyme 
actively interacts with the peptidoglycan layer by hydrolyzing murein, would be of 
great help in explaining why this non-invasive bacterium can present virulence factors 
and immunogens to its host, inducing a significant inflammatory response (38). 
Up to now several investigations in this direction were performed by our work 
group: some molecular modelling studies revealed that the product of the H pylori 
gene HP0339 matched that ofthe typicallysozyme fold (with more than 95% level of 
confidence ). Two domains were detected: a smaller B domain comprising residues 3 to 
27 and a bigger a domain ranging from residue 38 to 111. The region that connects the 
two domains, made up of 11 amino acids, was modelled as a loop. Superimposition of 
the theoretical tertiary structure of HP0339 with the crystallographic structure of T4L 
showed that the distance in the space between the Ca of the catalytic triad was 
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preserved. A good 3D matching ofthe other residues that are known to be involved in 
ligand binding for the T4L occurred. The result of the modelling brought more 
evidence to support the hypothesis that HP0339 is a lysozyme. Once the model of the 
HP0339 3D structure was available, the likeliness of binding to the peptidoglycan 
oligosaccharidic substrate was checked through molecular docking simulations. The 
finding of the theoretical existence of the protein-carbohydrate complex provided 
further evidence that the lytic function of the HP0339 product can actually take piace 
(39). 
In order to validate the theoretical predictions, the expression and hydrolyzing 
activity of the HP0339 protein remained to be confirmed experimentally. Therefore, 
bacteria isolated by gastric endoscopy from 38 local patients with R pylori infections 
were examined. AH clinica! strains showed the CagA+ and VacA + phenotype. Genomic 
bacterial DNA was extracted from cells and screened for the lysozyme-like gene 
through PCR, i.e., amplifying the 348-bp fragment using specific primers for the 
HP0339 nucleotide sequence. PCR genomic screening identified 23 unrelated strains 
that were positive for the HP0339 gene, while the gene was not detected in the other 
15 strains. Six HP0339+ unrelated clinica! strains were then isolated and sequenced. A 
comparison between the DNA sequence of the gene from the bacterial isolates and that 
of the HP0339 gene showed 96% identity in the full sequence, except for a 24-
nucleotide region, corresponding to 8 amino acid residues, inserted between nucleotide 
positions 140 and 141 of the HP0339 coding sequence. The insertion was well 
conserved among clinica! strains. The mutation affected about 7% of the gene, which 
is considered enough to qualify the newly found gene as different from HP0339. The 
nucleotide sequence of the clinica! strain named HPTSJ42 has been deposited in the 
GenBank database under AY054410 accessionnumber asHPLZJ gene (39). 
The presence of a gene in an organism does not prove that the gene IS 
expressed. In order to assess whether the R pylori HPLZJ gene was really transcribed 
in vivo into an encoding mRNA, total RNA was extracted from bacterial cells and 
subjected to RT-PCR assay. Among the six analyzed strains, three (HPTS142, 
HPTS65 and HPTS36) were producing the protein. To demonstrate the presence of 
celi wall hydrolytic activity, crude protein extracts from HPTS142, HPTS65 and 
HPTS36 strains were spotted on agar plates containing M lysodeiticus as a substrate. 
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After ovemight incubation at 3 7 °C, clea.r lysis zones, appearing as transparent spots 
on an opaque background, were detectable. No hydrolytic activity was found in the 
extracts from HP LZT H pylori strains (39). 
Finally, the 3D structure for the protein product of the newly found HPLZJ 
gene, which has been shown to possess lytic activity, was modelled using once again 
the T4L as template. The existence ofthe 8-amino acid insertion in the HPLZl protein, 
allowed us to model a helix in the region connecting the a. to the J3 domain, thus 
increasing the overall structure similarity between the HPLZ l protein and the wild-
type T4L. Indeed, the same region was modelled as a loop in HP0339. The predicted 
folding pattem of the new HPLZ l protein, which will be cali ed Lys from no w on for 
simplicity, was highly compatible with the generai architecture ofthe lysozyme family 
(39). The crystal structure of phage T4L and the predicted theoretical 3D structures of 
the HP0339 and Lys proteins are compared in Figure 7.6. 
Figure 7.6: Tertiary structures. Left, crystallographic structure ofphage T4L; center, proposed 
structure of the product of the HP0339 gene; right, proposed structure of the lys gene. The green 
segrnent refers to the 8-amino acid-insert that is peculiar ofthe hypothetic Lys protein. 
Cloning and high-leve/ expression of the H py/ori lysozyme. The complete 
structure characterization of Lys and of the complex with its saccharidic substrate 
would provide the ultimate proof that the protein with lytic activity we deal with is a 
lysozyme. Detailed knowledge of these 3D structures is necessary in order to develop 
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inhibitor models and pian therapeutic intervention. However, supposing we are only 
interested in X-ray diffraction studies, 10-20 mg/mL concentrated protein samples are 
required (40). T o that end, Lys must be expressed as recombinant protein, possibly in a 
non pathogenic organism, i.e., E. coli, produced in huge amounts and as pure as 
possible. This was briefly the aim of the study reported here. 
As aiready stressed in section 1.5.3.1, it is usually recommended to prepare a 
recombinant protein by performing expression triais with more than one expression 
construct. Therefore, two biosynthetic strategies were developed: (i) the PCR-
amplified DNA fragment ((Vs) coding for the Lys protein, obtained from the H py/ori 
HPTS142 clinicai strain, was cloned into the pGEX-4T-1 vector, which is designed for 
inducible high-level intracellular expression of genes as fusion products with 
glutathione-S-transferase (GST) from Schistosoma japonicum; a thrombin cleavage 
sequence, located immediately upstream of the multiple cloning site on the plasmid, 
enables subsequent removai of the GST tail; (ii) a second triai was performed cloning 
the same DNA fragment into a pET-21a+ plasmid, which produces a C-terminai HiS6-
tagged Lys protein and takes advantage ofthe virai T7 promoter for driving high-level 
expression of the target protein. 
Figure 7.7: The selected expression systems for the production of recombinant Lys as either 
6xHis-tagged or GST-fused protein. 
thrombin cleavage site 
~ 
4900 bp 
GST- Iysozyme 
pET21a• 
5443 bp 
lysozyme - 6xHis 
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The target DNA fragment was frrst cloned into a pCR-Blunt vector and the 
construct was used for sequencing. This step was necessary in order to check if, after 
PCR, consensus mutations occurred. Once it was clear that the lys DNA sequence 
remained unchanged, we started the cloning of the lys gene into the two expression 
vectors described above. 
(i) Transfonned E.coli (strain BL21) host cells with the pGEX-lys DNA 
construct, predominantly expressed the 43 kDa-fusion protein. The recombinant 
protein was found both in the soluble than in the insoluble fraction of the celi lysate. 
However, scaling-up the celi culture from culture flasks to a fennenter, the major 
percentage of GST-Lys was harvested in inclusion bodies. The bacterial pellet was 
first solubilized in 6M guanidine hydrochloride (GdmCl) and then refolded by rapid 
dilution and, after a concentration step, purified by affinity chromatography, using a 
glutathione-Sepharose 4B resin that specifically binds GST. After thrombin cleavage, 
separation of the Lys from the GST affmity tag was achieved through size exclusion 
chromatography. Correct folding was checked performing lytic activity tests. On the 
GST-Lys cleaved protein mi:xture a preliminary protein-carbohydrate interaction study, 
through capillary affinophoresis, was attempted, using a set of disaccharide standards 
as substrates. 
(ii) E.coli bacteria (strain Rosetta 2 DE3) were transformed with the pET-lys 
DNA construct and expression trials carried out in shake flasks revealed the presence 
of a 14 kDa-sized protein mainly in the insoluble celllysate. The Hi%-Lys protein was 
recovered from inclusion bodies and purified through IMAC affinity chromatography. 
Briefly, the bacterial pellet was resuspended in 6M denaturing GdmCl and directly 
applied on a Ni-NTA agarose filled column. Histidine-rich proteins were selectively 
bound by nickel bivalent ions immobilized onto the matrix. Renaturation procedure 
was simply performed on-column in the presence of the "artificial chaperone-assisted" 
method, i.e., gradually adding a fi-cyclodextrin-based refolding buffer to the blocked 
His-tagged protein in order to promote correct protein folding. Also in this case, the 
protein of interest collected in the chromatographic eluates was tested for its lytic 
activity on plates filled with a suspension of Mlysodeiticus cells. 
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7.2 Materials and methods 
Cloning of recombinant GST-Lys. The coding sequençe of the Hpylori lys was 
obtained by PCR perfonned by using genomtc DNA from one clinica! strain 
(HPTS142) as template. The forward primer 5'-
AAGAATTCGATTCAGAGGGGTTTTCG-3' and the reverse primer 5'-
AACTCGAGAAA TTTCCATATTCCTTGACG-3' and the restriction enzymes EcoRI 
and Xhoi, whose sites are respectively underlined in the oligonucleotidic sequences 
reported above, were used for cloning the gene in the pGEX-4T-1 expression vector. 
The amplified lys DNA fragment was purified by applying the sample on agarose gel 
and eluting the correct band from the gel into a solution. The purified lys gene and the 
expression vector were both incubated with the two restriction enzymes listed above. 
The digested pl~smid was dephosphorylated on the 5' tenninus with alkaline 
phosphatase to avoid self-ligation. Then the lys gene and the plasmid were combined 
and treated with DNA ligase at RT for 30 min. Clones were tested on agarose gel for 
positivity and those harbouring the DNA construct were selected for protein 
express10n. 
Expression of soluble GST-Lys on shake jlasks. E.coli electrocompetent 
bacteria (strain BL21) were transfonned through electroporation with the pGEX-4T-1-
/ys construct. The transfonned cells were grown on ampicillin ( Amp )-rich LB-agar 
plates and the resulting colonies precultured in 20 mL Luria-Bertani (LB) medium (l% 
tryptone, 0.5% yeast extract, 1% NaCl, pH 7.5) containing Amp (100 f.!g/mL). The 
bacterial broth was diluted in 200 mL or, scaling up the protein production, in IL and 
4L shake flasks and allowed to grow at 37°C until the optical density at 600 nm 
(OD6oo) was approx. 0.8. For recombinant protein expression induction, isopropyl-,8-
D-thiogalactopyranoside (IPTG) was added to a 0.1 mM final concentration. The 
preparation was then incubated at 30°C to minimize inclusion bodies fonnation. 
Almost every hour, before and after induction, a 4 mL sample was collected to test 
protein expression level. After 4 h, cells were harvested by centrifugation ( 4000 rpm, 
15 min, 5°C) and the pelleted bacteria were resuspended and incubated in lO mL ofTE 
buffer (Tris-HCI 10 mM, EDTA l mM, pH 8.0) per g containing hen egg white 
lysozyme (100 f.A,g/mL) for l h at 37°C. Sodium deoxycholate 0.1% was then added 
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and the preparation subjected to repeated sonication at 220 W for total 2 min, cooling 
onice between cycles. The soluble protein fraction was recovered after centrifugation 
(13000 rpm, 30 min, 5°C). 
Purification of soluble GST-Lys. GST-Lys purification was performed by AC 
usmg glutathione Sepharose 4B matrix, designed for the rapid and single-step 
purificati o n of recombinant GST -tagged proteins produced in E. coli cells. Liquid 
chromatography was performed using a prepacked GSTrap HP column with 5 mL 
resin that was operated with a syringe or a peristaltic pump. The column was 
conditioned with 5 bed volumes of binding buffer (PBS, pH 7.3) at a 5 mL/min flow 
rate. The filtered protein sample was applied to the column keeping the flow rate low 
(max. l mL/min) for maximum binding capacity. Unbound proteins were washed with 
approx. 5 column volumes of binding buffer until no materia! appeared in the effluent. 
Protein detection was performed trough Bradford chromogenic method on the 
collected chromatographic fractions. GST-tagged proteins were eluted with 3-5 
column volumes of elution buffer (50 mM Tris-HCI, IO mM reduced giutathione, pH 
8.0). Flow through, wash and eluted material from the column was monitored for 
GST-Lys protein using SDS-PAGE. 
The fusion protein contains a thrombin recognition site which can be used to 
cleave the GST tag. Therefore, after elution, removal of the GST tail was performed in 
solution. 0.1 U ofthrombin dissolved in cieavage buffer (20 mM Tris-HCI, 150 mM 
NaCI, 2.5 mM CaCh) were used to digest a !J.g of eluted GST-Lys protein. Once the 
proteolytic step was complete, a successive SEC purification step for separating Lys 
from its GST fusion tag and to remove thrombin protease traces and low molecular 
weight reduced g1utathione was necessary. A Superdex 75 (16/60) preparative grade 
HiLoad column working in the 4000-40000 fractionation range was chosen. 
Preconditioning was performed with 5 bed volumes of PBS at l mL/min flow rate. A 2 
mL syringe was used to load the filtered protein sample in the coiumn. After injection, 
chromatographic development was carried out maintaining the eluent flow rate 
constant at l mL/min. A UV-visible spectrophotometer detector was positioned at the 
column outlet to monitor absorbance at 280 nm of the eluted material, collected as 
discrete fractions in 2 mL vials. These fractions were analyzed through SDS-PAGE to 
check the presence of pure L ys. 
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Altematively, on-colurnn cleavage of the GST-fused protein was performed. 
Tag removal was made after the colurnn wash step, by incubating the resin for min. 6 h 
at 16°C with 5 mL of cleavage buffer containing 0.5 U of thrombin per ~g of fusion 
protein. Elution of Lys was carried out loading the column with 3 bed volumes of 
binding buffer. Remaining GST stili bound to the column was washed out with the 
elution buffer. 
Expression of insoluble GST-Lys on fermentor. A single E. coli BL21 colony, 
harbouring the pGEX-4T-l-lys construct, was picked up from a LB-agar plate and 
used to set up 15 mL of a preculture in LB medium supplemented with Amp. The cells 
were diluted to 200 mL of a new preculture with the same medium and antibioticum. 
This broth was used to inoculate 8 L of main culture (50 g/L yeast extract, 0.5 g/L 
NH. CI and 5 giL glucose as carbon source) grown in a BioFlo C32 fermentor. The 
culture was constantly agitated with a mechanic stirrer set at 200 rpm. The starting 
OD6oo was 0.1. 7.5 was chosen as pH value of the fermentation system. Automated 
regulation of the pH-meter was performed by contro Il ed addictions of aci d (l 0% 
solution of H3P04 85%) or base (IO% NaOH). To assure optimal oxygenation of the 
culture, a p02-meter was used to adjust the airflow rate inside the fermentor. Initial 
temperature was set at 37°C. Every 10 OD600, 15 mL of a 1M MgS04 solution was 
added. After ca. 4 h, when OD60o reached 15 and the glucose concentration dropped to 
zero, feeding with glycerol (250 mL/L) and yeast extract (300 g/L) started. After l h 
the OD6oo jumped to 50 and induction with IPTG was carried out. Temperature and p H 
conditions were respectively lowered to 30°C and 6.5. 4 h after induction, cell growth 
reached a stationary phase, as the OD6oo became constant, oscillating around 75. Cells 
were finally harvested by centrifugation (6000 rpm, 30 min, 5°C). The bacterial pellet 
was resuspended in 420 mL TE buffer supplemented with 5 mL of sodium 
deoxycholate l 0%. Bacterial lysis was performed with a French press, applying 3 
cycles ofhigh pressure homogenization (1000-1200 bar) to disrupt the cells. The lysate 
was centrifuged (10000 rpm, 30 min, 5°C) and ca. 800 g of inclusion bodies were 
obtained. 
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Solubilization, refolding and purification of insoluble GST-Lys. l g solid 
inclusion bodies were resuspended in the solubilization buffer (6 M GdmCl or 8M 
urea, 100 mM DTT, 0.1 M Tris, l mM EDTA, pH 8.0) and incubated for 4 h at RT on 
a shaker to fully dissolve. The pH of the solution was decreased to 3-4 by dropwise 
addition of l M HCI. Cell debris were discarded after centrifugation at 4000 rpm for 
30 min. DTT was completely removed by exhaustive dialysis, first against IL 4 M 
GdmCI, IO mM HCI fot 2 h at RT, then overnight at 4°C against IL 4 M GdmCl. The 
protein concentration was roughly estimated through BCA assay. 
Refolding of the protein was performed by rapid dilution: the denatured protein 
solution was added dropwise into the precooled refold buffer ( approx. l 0°C) to less 
than 0.1 mg protein per mL. The folding process was developed for at least 24 h at 4 oc 
under slow stirring. The right concentration was obtained diluting the solubilized 
inclusion bodies into a ratio of approx. 1:100 (voVvol), i.e., adding ca. 20 mg of 
protein in 2 mL GdmCl to 200 mL refold buffer in a 500 mL conical flask. The refold 
buffer was made up of200 mM Tris, 10 mM EDTA, l M L-arginine, 0.1 mM PMSF, 
6.5 mM cysteamine, 3.7 mM cystamine, pH 8.0 or 9.0. Concentrated HCI was added to 
reach the right pH value. PMSF and the redox couple were put in the buffer just before 
use. The diluted solution was concentrated 10-fold (to ca. 20 mL) using an Amicon 
Stirred Celi operating under nitrogen pressure. The protein concentration was 
measured by means of the Bradford assay. Before starting the purification process, the 
protein sample was dialyzed twice against 200 mL PBS and l mM DTT at 4°C. In 
order to remove protein aggregates after dialysis, the sample was filtered through a 
0.45 J.tm waterproof (WP) nitrocellulose membrane. The solution was then further 
concentrated l O times before AC. 
Spot assay. 20 J.tg of total protein from a crude bacterial extract were spotted on 
a l% LB-agar plate containing a suspension of dried cells of Micrococcus lysodeticus 
(0.05% w/v) in 20 mM phosphate buffer (pH 7.0) and IO mM MgCh. After incubation 
ON at 3 7°C, the plate was check ed for areas of lysis. 
Affinophoresis. Affinity capillary electrophoresis was performed usmg an 
Applied Biosystems HPCE Model 270A-HT with an UV detection coupled with a 
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Turbochrom Navigator ( 4.0) software for instrument control, data acquisition and data 
handling. The detection wavelength was fixed at 195 and 214 nm. Analyses were 
performed with a fused silica capillary (totallength 60.5 cm, effective length 52 cm, 
50 ~m ID, 375 ~m OD) or with a PVA-coated capillary (totallength 64 cm, effective 
length 55.5 cm). In the former case different concentrations ofborax were used as run 
buffers, prepared by dilution from a stock solution made up of l 00 mM borie acid and 
250 mM NaOH (pH 10.5). The applied potential was 20 kV. In the latter case the 
electrolyte buffer was 50 mM potassium phosphate (pH 6.0) and the electrode voltage 
set at 25 kV. The phosphate run buffer was also supplemented with 40 mM cellobiose 
or 16.3 mM LacNAc. The protein samples analyzed were digested and undigested 
GST-Lys eluates with thrombin, having an average concentration of 0.5 mg/mL. 
Samples were Ioaded under vacuum at a pressure of 16.9 kPa for 1.5 s (hydrodynamic 
injection). Silica capillary was previously rinsed with 0.1 N NaOH for 2 min, then 
conditioned with the run buffer for 4 min, while PVA-coated capillary was simply 
washed with bidistilled water for 2 min and equilibrated with the electrolyte buffer for 
4 min. Ali washes were carried out at a vacuum pressure of 67.6 kPa. Detailed analysis 
conditions are Iisted in the figures. 
Cloning, expression and puri.fication of recombinant His6-Lys. Starting from 
the pGEX-4T-I-lys construct, the DNA sequence of interest was obtained by PCR 
usmg 5' -CGTGGATCCCCGCATATGGATTCAGAGGG-3' and 5'-
AACTCGAGAAATTTCCATATTCCTTGACG-3' respectively as forward and 
reverse primers. These oligonucleotides were designed so as to introduce the Ndei 
cloning site (CATATG) in the lys DNA fragment. The Xhoi restriction site 
(CTCGAG) was already present on the originai DNA construct. The reaction was 
performed using a Phusion DNA polymerase which produces blunt end DNA 
products. After purification of the PCR product on preparative agarose gel, the 
amplified DNA sequence was digested with Ndel and Xhol restriction enzymes. Also 
the pET2la+ expression vector was treated with the same restriction endonucleases and 
then with antarctic phosphatase in order to catalyze removal of 5' phosphate group and 
prevent self-Iigation of the plasmid. The PCR product and the expression vector were 
combined and incubated with T4 DNA ligase at 16°C overnight. The ligation products 
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were scr~ened on agarose gel and the positive clones chosen for protein expression 
trials. 
Rosetta 2 (DE3) chemocompetent E.coli strains were transformed through 
thermal shock with the p ET -21 a+ -lys construct and grown on agar plates enriched with 
Amp and chloroamphenicol (Cam) antibiotics. Single bacterial colonies were grown 
overnight on 20 mL vials containing LB medium supplemented with Amp (l 00 
f.A.g/mL) and Cam (25 f.A.g/mL ). The bacterial broth was diluted to l: IO in shake flasks 
using fresh LB medium and cultured at 3JCC until OD6oo reached 0.7-0.8. Then 0.1 
mM IPTG was added to induce expression of the recombinant protein and the culture 
broth was allowed to shake vigorously at 30°C for 4 h. Every hour, before and after 
induction, a 4 mL aliquot was taken to check protein expression. Cells were harvested 
by centrifugation ( 4000 rpm, 15 min, 4 °C) and the pelleted bacteria resuspended in 15 
mL PBS (lO mM Na2HP04, 1.8 mM KH2P04, 140 mM NaCl, 2.7 mM KCI) for l h at 
room temperature (R T). Bacteriallysis was performed through sonication cycles at 220 
W (6x20 s per pulse with a 2 min cooling interval between pulses). The lysate was 
centrifuged for 30 min at 13000 rpm and the insoluble pellet resuspended in 8 mL 
denaturing binding buffer (8 M urea, 20 mM sodium phosphate, 0.5 M N aCl, pH 7.8). 
Inclusion bodies were solubilized through gentle agitation for at least 4 h at RT. The 
suspension was centrifuged for 30 min at 4000 rpm and the insoluble residues were 
discarded. The clear supernatant containing the His-tagged Lys was used for 
purification. 
Immobilized metal ion affinity chromatography (IMAC) was performed as 
follows: the protein sample was loaded on a Ni-NT A agarose column, previously 
equilibrated with denaturing binding buffer. The washing step was first performed with 
denaturing wash buffer (8 M urea, 20 mM sodium phosphate, 0.5 M NaCl, pH 6), thèn 
with the same buffer but containing 20 mM imidazole to remove non-specifically 
bound contaminants. All renaturation steps were carried out in buffer A (20 mM Tris-
HCl, 0.1 M NaCl, pH 8.0). The column was conditioned with buffer A containing 
0.1% Triton X-1 00 as detergent in order to prevent protein aggregation by formation of 
a protein-detergent complex. Buffer A containing /)-cyclodextrin was then added to 
strip the protein of detergent, thereby inducing refolding. An additional wash with 20 
mM Tris-HCI, 0.5 M NaCI, pH 8.0 was applied to remove remaining impurities and p.. 
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cyclodextrin. Refolded protein was eluted with buffer A supplemented with 300 mM 
imidazole. 
4 mL aliquots with crude protein extracts and chromatographic eluates were 
run on SDS-PAGE to check respectively expression level and protein purity. The 
amount of HiS(;-Lys in the recovered chromatographic fractions was estimated by 
Bradford assay. Lysozyme activity was assessed by means ofthe spot assay described 
above. 
7.3 Results an d discussion 
Overexpression and purification of soluble GST-Lys. The GST fusion system is 
known to lead to high expression levels and allows a simple and efficient one-step 
purification of the fusion protein from bacteriallysates (41). GST fusion proteins are 
amenable to purification by virtue of the affinity of the GST domain for a glutathione 
ligand immobilized on a polymeric matrix. Fusion proteins are recovered from the 
matrix under mild elution conditions, which preserve antigenicity and functionality of 
the proteins. Furthermore, cleavage of the desired protein from the GST fusion tag is 
easily achieved using a site-specific protease (thrombin), whose recognition sequence 
is located immediately upstream from the multiple cloning site provided by the pGEX 
expression vector system. Therefore we decided to investigate the production of Lys as 
fusion product with GST in E. coli. The first expression trial was performed on reduced 
scale, starting with a 200 mL culture on shake flasks. The only precaution that was 
taken in order to maximize the yield of GST-Lys in the soluble fraction of the celi 
extract, was to lower the temperature of the culture from 37 to 30°C after induction 
with IPTG. lndeed it has been reported that formation of inso1uble protein aggregates 
can be reduced or even prevented by decreasing the rate of protein synthesis, which 
can be done by cultivation at low temperature or by limited induction (42). Results 
were quite satisfactory since in these conditions a recombinant fusion protein was 
efficiently expressed and appeared in SDS-PAGE as a predominant band 
corresponding to a molecular mass of ca. 43.5 kDa (see lane 2 in gel of Figure 7.8). 
The recombinant protein and endogenous GST were purified from bacterial proteins 
by AC, using a glutathione Sepharose 4B resin. The GST-tagged protein was 
recovered from the affinity column eluting with free glutathione in Tris buffer to 
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iisplace the fusion protein and the 30 k.Da sized GST (see lane 5 and 6 in Figure 7.8). 
fhe purification yielded the GST-fused protein in high amount, which was estimated 
to be around 0.75 mg/L of bacterial culture. Crude celllysates and chromatographic 
eluates were tested by SDS-PAGE respectively for expression and purity assessment 
(see Figure 7.8). 
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Figure 7.8: SDS-PAGE analysis of GST-Lys protein expression and purification. Lane l, 
molecular weight markers; lane 2, 20 J.tg of total protein extract from disrupted BL21 cells containing 
the pGEX-Iys recombinant plasmid before affmity chromatography; lane 3, the same crude protein 
lysate after loading on affinity resin; lane 4, tlow-through from wash step with binding buffer (PBS, pH 
7.3); lane 5 and 6, eluates collected by applying 10 mM reduced glutathione in 50 mM Tris-HCl, pH 8.0 
on the glutathione Sepharose 4B resin; bere two main bands at 43.5 and 30 kDa are visible, 
corresponding respectively to GST-Lys and endogenous GST; a minor band at ca. 28 kDa appeared as 
well, which is very likely due to the presence of a proteolytic product of one of the two purified 
proteins. 
On a purified GS_T-Lys sample, the cleavage ofthe GST-tail with thrombin was 
performed directly on-colurnn. SDS-PAGE analysis of the eluates, collected after 
digestion with the protease, revealed the presence of a predominant band at ca. 13.5 
k.Da, as expected by comparison with the theoretical molecular weight of the lys gene 
product (see lanes 4-7 of Figure 7.9). After elution of the thrombin-cleaved 
recombinant protein, remaining GST bound to the resin was also removed loading a 
Tris-buffered solution containing reduced glutathione (see lane 8 of gel in Figure 7.9). 
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Figure 7.9: SDS-PAGE of GST-Lys protein expression, purification and cleavage. Lane l, 
crude bacterial sonicate with the overexpressed GST-Lys fused protein; lane 2, molecular weight ladder; 
lane 3, standard hen egg white lysozyme; lane 4-7, eluates collected after on-column thrombin digestion 
containing the 13.5 kDa recombinant protein; lane 8, flow-through containing GST recovered after 
washing the column with a solution ofreduced glutathione. 
Choosing the same experimental culture conditions, bacterial cultures were 
scaled up to larger amounts, namely to l L and 4L total volume, always in shake flasks. 
However the result was not as encouraging as for the small-scale culture probe. As can 
be observed in Figure 7.10 (lane l 0-13) the relative abundance of the GST -Lys in the 
soluble portion of the bacterial sonicate is drastically diminished compared to the 
production of endogenous GST. On the contrary, after induction with IPTG, one can 
easily notice how huge is the amount of GST-Lys which compares in the insoluble 
fraction of the bacteriallysate (lane 4-7). 
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Figure 7.10: SDS-PAGE ofGST-Lys protein expression from a 4L bacterial culture. Lane l, 
marker proteins; lane 2 and 3, insoluble fraction ofthe celllysate before induction with IPTG; lane 4-7, 
insoluble fraction ofthe celllysate after induction with IPTG (l h, 2h, 3h and 4h samples); lane 8 and 9, 
soluble portion ofthe bacterial sonicate before induction; lane 10-13, soluble portion ofthe bacterial 
sonicate after induction {l h, 2h, 3h and 4h samples). 
Apparently, high-level expression of the GST-Lys protein in BL21 E. coli host 
cells beyond certain limits is sufficient to drive the recombinant protein into 
aggregation and inclusion body (IB) formation. This means that the desired protein is 
not synthesized in the correctly folded and native form, but that dense particles, mostly 
insoluble and biologically inactive, are formed. As evidenced in lane 4-7, this 
insoluble protein aggregates predominantly contain the overexpressed recombinant 
protein and only small amounts of host celi materia!. The exact mechanism by which 
IB formation is induced and the reason why the recombinant protein is deposited 
predominantly in the inclusion bodies are stili unclear, but it has been proposed that 
very likely essential components of the chaperone machinery, whose function is to 
assist proteins in achieving proper folding, may be simply oversaturated upon massive 
overproduction of recombinant proteins ( 43). It is however unknown exactly which 
chaperones are involved in this process. In some cases, IB formation can be suppressed 
by co-overexpression of some molecular chaperones (44, 45). Alternatively, the 
addition of EtOH 2-3% (v/v) in the celi culture just prior to induction with IPTG 
turned out to be very effective for the increase of intracellular concentrati o n of various 
molecular chaperones which are responsible for maintaining the overexpressed 
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recombinant protein in solution (46). However, ali our attempts to increase the 
proportion of soluble, active product by altering expression conditions for the IL and 
4L cultures (i. e. temperature, IPTG concentration, addition of EtOH, pH, cell-density 
aeration condition) were unsuccessful. We also transformed seven different E.co/i 
strains (C600, DHl, HBIOI, JM83, JM105, XLI blue, BL21) with the pGEX-4T-1-lys 
DNA construct in order to check if the E. coli source used had a bias towards the 
production of the recombinant protein as either soluble or insoluble. Ali strains tested 
showed the same behaviour, e.g., they expressed high quantities of the the GST-Lys 
protein in IBs (see gel in Figure 7.11). 
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Figure 7.11: SDS-PAGE analysis of insoluble GST-Lys expression indifferentE. coli strains 
(listed above in orange). M stands for molecular weight marker, U for uninduced and I for induced. 
On the basis of the obtained results, we ascertained that the majority of the 
GST-Lys, which was produced upon Iarge-scaie celi cuituring, was recovered from the 
bacterial broth as solid precipitate after celi Iysis. Therefore, the only way to obtain a 
large amount of recombinant GST -Lys was to find a viabie protocol for the treatment 
of IB. The development of the isolation, soiubilization and renaturation procedure for 
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this material seemed very attractive, not only because ofthe GST-Lys protein, but also 
because i t could significantly extend the use of the popular GST fusion system, which 
is known to fonn IBs in a number of cases. 
Large-scale production and isolation of insoluble GST-Lys. In a many cases 
and in several host systems, high-leve! expression of recombinant proteins leads to 
their misfolding and to intracellular accumulation in insoluble aggregates. The proteins 
in these so-called inclusion bodies (IBs) are mostly inactive and in denatured state. 
However, the expression of recombinant proteins in IBs can also be advantageous: (i) 
the recombinant protein deposited in IBs can be 50% or more of the total cellular 
protein; (ii) the IBs often contain almost exclusively the overexpressed protein; (iii) in 
IBs the protein is protected from proteolytic degradation; (iv) expression in IBs will 
protect the cell against the eventual toxicìty ofthe recombinant protein. Unfortunately, 
the recombinant protein obtained from the IBs must be properly refolded, which is not 
a trivial matter. 
The large-scale production of the recombinant protein was carri ed out on a 8L 
fennentor, since high density fennentation assures the production of gram amounts of 
the protein of interest per liter of fennentation broth. Cells were cultured at 3 7°C to 
late exponential phase, then induced with l mM IPTG and allowed to grow further at 
30°C. Two hours after induction, a slow arrest in cellular growth has been observed as 
deduced from the OD6oo values recorded in function of time (see diagram of Figure 
7.12). 
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Figure 7.12: E.coli BL21 cellular growth on ferrnentor. The red dot indicates the 00600 value 
of the culture at the moment of induction with IPTG. 
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Immediately before addition of IPTG and at specified times postinduction, 3 
mL samples were withdrawn and the absorbance at 600 nm recorded. Finally cells 
were harvested, centrifuged and disrupted with a French press. After celi lysis, IBs 
were harvested by solid-liquid separation. This isolation procedure simply based on 
centrifugation yielded relatively pure and homogeneous IB isolates. 
IBs were solubilized in high concentration of denaturing agent, i. e. 8 M urea or 
6 M guanidinium chloride (GdmCl). GdmCI, which is the stronger denaturant, allowed 
solubilization of IB isolates that were resistant to urea. T o guarantee the complete 
reduction of any accidentally formed disulfide bonds, the reducing agent dithiothreitol 
(DTT) was added during solubilization. lncubation temperature around 25°C was 
chosen to facilitate the solubilization process. After solubilization the suspension was 
centrifuged to remove remaining aggregates, which could act as nuclei to trigger 
aggregation during the successive refolding step. 
Refolding of the solubilized proteins was initiated by removal of the 
denaturant. Since the efficiency of refolding depends on the competition between 
correct folding and aggregation, the renaturation process was carried out at low protein 
concentration, according to the so-called rapid dilution method. The transfer of the 
unfolded proteins into refolding buffer was achieved by dropwise addition of the 
protein sample in the refolding vessel, taking no more than half an hour to complete 
the dilution process. If the refolding was made exposing the protein for an extended 
period of time to an intermediate or low concentration of solubilizing denaturant, 
where it is not yet folded but no longer denatured, it would be extremely prone to 
aggregation. Therefore, to avoid complication and prevent protein misfolding, 
renaturation was performed quite rapidly. 
The refolding buffer composition is not universal and depends upon the amino 
acid sequence of the protein to be refolded. If the target protein contains disulfide 
bonds, then the solubilized protein solution may be directly diluted into a refolding 
buffer containing a redox system. The addition of a mixture of reduced and oxidized 
forms of low molecular weight thiol reagent usually provides the appropriate redox 
potential to allow formation and reshuffling of S-S bonds. We used the 
cystamine/cysteamine couple for helping the correct pairing of the two intramolecular 
cystine bridges of the GS T. Furthermore, in order to facilitate the refolding of a pro te in 
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by limiting unspecific aggregation, usually refolding additives, such as amino acids, 
polyamines and mild detergents, are present in high concentration in the refolding 
buffer. L-arginine (L-Arg) was found to be the most effective amino acid in 
suppressing aggregation of hen egg white lysozyme after heat-induced denaturation 
(47). Therefore we chose L-Arg as an enhancer ofprotein renaturation. After refolding 
through rapid dilution, the protein preparations were concentrated to ca. l mg/mL 
upon ultrafiltration and centrifuged to remove insoluble aggregates. 
In Figure 7.13 SDS-PAGE analysis of the urea-solubilized, refolded and 
concentrated protein samples is shown. One can easily see how renaturation of the 
GST-Lys fused protein worked well for the BL21 (lanes 2, 3) but not for ali other 
E.coli strains. As an example, only the endogenous 30 kDa-sized GST produced by 
HB l O l cells remained left after the refolding process (lanes 4, 5). 
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Figure 7.13: Urea-solubilized and refolded GST-Lys protein samples loaded on a 12% 
polyacrylamide gel. Lane l, standard protein ladder; IBs from BL21 E.coli cells renaturated in refolding 
buffer at pH 8.0 (lane 2) or 9.0 (lane 3); IBs from HBlOl E.coli cells renaturated in refolding buffer at 
pH 8.0 (lane 4) or pH 9.0 (lane 5). 
Cellular debris of the BL21 crude protein extract, recovered via centrifugation 
after solubilization with 8 M urea, were resuspended in the stronger chaotropic agent 
which is 6 M GdmCl, following the same solubilization protocol as with urea. The 
greater efficacy in solubilizing IBs of GdmCI with respect to urea was suddenly 
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evident, since no protein precipitates were visible at the bottom of the vial after 
centrifugation. These protein samples were then refolded according to the usual 
procedure, dialyzed against PBS and loaded on a glutathione Sepharose 4B affinity 
column. The collected eluates were analyzed through SDS-PAGE (see lanes 3-5 of 
Figure 7.14) and surprisingly the GdmCl-solubilized samples showed relative pure 
bands at ca. 43.5 kDa. This means that nQt only the GST -Lys recombinant protein is 
refolded by this technique, but that the GST tail seems to be correctly refolded too, 
otherwise an affinity interaction with the glutathione-immobilized resin would be 
impossible. 
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Figure 7.14: SDS-PAGE ofBL21 E.coli IBs containing the recombinant GST-Lys protein not 
solubilized in urea, recovered, solubilized in GdmCI, renaturated and purified through affinity 
chromatography with a glutathione Sepharose 4B column. Lane l, molecular markers; lane 2, flow-
through recovered from wash step; lane 3-5, fractions collected eluting the column with a glutathione-
containing solution. 
Purification of another GST-Lys protein sample from BL21 E.coli IBs, 
solubilized with GdmCl, refolded according to the usual protocol and concentrated, 
was performed trying to cut the GST fusion tag directly on-column. Therefore, on the 
sample loaded on the affinity column, a solution containing thrombin protease was 
added and after a period of incubation, the flow-through harvested and analyzed by 
SDS-PAGE. Applying Tris buffer supplemented with reduced glutathione to the 
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chromatographic column, also the remaining proteolytic waste, GST, was recovered. 
From the gel ofFigure 7.15 (lanes 2 and 3) the total IB protein extract before and after 
loading it on the glutathione Sepharose 4B resin is reported. The band at 43.5 kDa, 
corresponding to the fusion protein, disappeared almost entirely on lane 3, meaning 
thàt the refolded GST-Lys binds strongly to the affinity matrix. The eluates collected 
after thrombin digestion (lanes 4 and 5) did not contain the GST-cleaved Lys, as would 
have been expected, but only excess of thrombirt (approx. molecular weight 37 kDa), 
GST and other impurities. Free Lys eluted only a:fter loading a glutathione solution to 
the column, together with GST and traces ofundigested GST-Lys (lane~ 6-8). 
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Figure 7.15: SDS-PAGE analysis of the eluted chromatographic fractions from affmity 
purification on a glutathione Sepharose 4B resin with on-column thrombin cleavage of GST-Lys from 
IB preparation. Lane l, molecular weight markers; total protein extract from refolded IBs before (lane 2) 
and after (lane 3) application to the affinity column; lane 4 and 5, flow-through following thrombin 
digestion of GST-Lys bound to the affmity matrix; lanes 6-8, chromatographic eluates recovered after 
elution with reduced glutathione. 
A successful refolding procedure leads to a correctly folded, renaturated and 
biologically active protein. Therefore, the lytic activity ofthe refolded GST-Lys fused 
protein and of the cleaved product was checked by spot assay. Activity test of the 
cleaved Lys protein, directly performed on thrombin digests of purified GST-Lys 
samples, was positive (see Figure 7.16), while the recombinant protein fused with 
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GST did not show any lysis area on LB-agar plates containing a suspenston of 
M lysode iticus. 
Figure 7.16: Spot assay for the hydrolytic activity of the recombinant Lys protein performed 
on crude thrombin digests collected from affinity chromatography. The clear zones represent Iysis areas. 
Probably the fusion protein expressed in E.coli BL21 and refolded from IB 
forms a correctly folded GST tail, since productive interaction with the glutathione-
immobilized substrate on the affinity resin exists. Proper refolding of Lys protein, 
instead, seems to be prevented by the presence of the GST affinity tail, because the 
whole GST-Lys is not active, as demonstrated by the spot assay. However, protease 
cleavage yields an active Lys: very likely the correct in vitro refolding ofthe protein is 
not so difficult since Lys lacks any cysteine residues, hence there is not the problem of 
correct pairing of cysteines to form disulfide bords. 
The aforementioned afftnity purification technique should yield pure Lys 
samples, eventually contaminated by a negligible amo un t of thrombin. However in our 
case, also changing elution conditions by varying pH or ionic strength of the mobile 
phase or adding a chaotropic agent, it was not possible to separate cleaved Lys from 
the GST tail. W e postulated that, after proteolytic cleavage, Lys and GST, even if no 
more covalently linked, were hold together by some particular type of interaction, 
forming a real protein-protein complex. This holds only for refolded GST-Lys 
recovered from IB preparation, because soluble GST-Lys, subjected to affinity 
purification and thrombin cleavage, produced relatively pure Lys (see Figure 7.9). 
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In the attempt to separate Lys from GST, gel filtration was used as further 
purification step. W e thought that hopefully the presence of a sieving matrix could be 
sufficient to disrupt the cohesive forces of the protein complex. Instead of preparing 
the protein samples by digesting them on-column with thrombin protease in presence 
of glutathione Sepharose 4B affinity resin, we carried out the cleavage in solution, 
because enzymatic treatments are always more efficient in homogeneous than in 
heterogeneous phase. Column chromatography was performed using a Superdex 75 
column and PBS as wash and elution buffer. Unfortunately the refolded and cleaved 
protein sample precipitated inside the column and on the UV detector, set at the outlet 
of the chromatographic system, only GST (as dimer), thrombin, reduced glutathione 
and Tris could be detected at 280 nm (data not shown). 
Remairùng purified and thrombin-cleaved protein samples were saved for 
affinity studies with saccharidic ligands which resemble the natural substrates of 
lysozymes. Lys obtained from IB formed a stabile complex with the GST tail after 
thrombin cleavage and could not be purified neither through AC nor by SEC. Only on 
denaturing SDS-PAGE the two proteins were visualized as separated. We therefore 
tried to verify if the presence of a disaccharide with a p(l,4) glycosidic linkage (the 
same as between N-acetylglucosamine and N-acetylmuramic acid) would break the 
interaction of Lys with the GST tail favouring the protein-carbohydrate complex 
formati o n. 
Binding studies ofGST-Lys through a.ffinophoresis. This technique, also called 
affinity capillary electrophoresis, can be exploited to measure interactions between 
carbohydrates and proteins by capillary zone elctrophoresis. Differences in 
electrophoretic mobilities between the free protein and the protein-sugar complex can 
be exploited to determine the parameters of the interaction ( 48, 49). The basic 
principle involves the measurement of an altered electrophoretic mobility of the sugar-
complexed species as compared with the free protein. 
H ere CZE was used to determine the effect of two disaccharide samples added 
in the separation buffer on the migration time of Lys protein and to investigate their 
molecular interaction in free solution. Briefly, a sample of the refolded, purified and 
thrombin-cleaved GST-Lys recombinant protein was first analyzed using a fused silica 
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capillary in order to test if, in a strong electric fieid, the GST -Lys compiex may be 
broken. Then, the same sampie was run on a PVA-coated capillary in an eiectrolyte 
buffer containing a disaccharide as ligand and the migration time deiay of the sample 
protein was recorded. 
Analysis with fused silica capillary. The thrombin digested GST -Lys sample 
was anaiyzed through CZE using a borate buffer (pH l 0.5). Runs were carried out in 
normal polarity recording the eiectropherograms at 195 and 214 nm. Coinjections of 
the protein sampie with standards, aliowed assign peaks reiated to acetone (EOF 
marker), reduced giutathione, pure GST and thrombin (see Figure 7.17). 
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Figure 7.17: Electropherogram of purified and thrombin-cleaved GST-lys sample. CZE 
analysis was performed in a fused silica capillary (52 cm effective length) and using 20 mM borate as 
run buffer. Applied potential was 20 kV and detection wavelength 195 and 214 nm. Peak l, acetone 
(EOF marker); peak 2, reduced glutathione; peak 3, impurities; peak 4, unresolved GST and GST-Lys. 
In these experimental conditions thrombin elutes at ca. 15 min and is therefore not visible in the above 
reported time frame. 
The eiution order of the components of the mixture was not easiiy predictabie, 
since the various analytes differed greatiy in charge-to-mass ratio. In the experimental 
conditions mentioned above, mostiy ali proteins (Lys, GST, GST-Lys) shouid carry a 
negative charge because they are analyzed at a pH which is greater than ali their pl 
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values. Lys is a relatively light and basic protein characterized by a 9.1 pl, while GST 
is a quite neutral (pl 6.8) and intermediate-sized protein of ca. 30 kDa. These different 
properties of the two proteins are counterbalanced in the present CE conditions, 
leading to poor separation efficiency. Therefore the ioni c strength of the bo rate buffer 
was gradually increased, with the purpose of enhancing the difference in charge-to-
mass ratio between the two proteins. Unfortunately Lys could not be separated from 
GST, neither running the samples in l 00 mM borate buffer. This statement was 
confrrmed analyzing the undigested GST-Lys protein, which showed essentially the 
same electropherogram of the thrombin-digested sample (see Figure 7.18). This 
missed separation, as already stressed before, is due to the formation of a stable 
complex between the two proteins, characterized by stili unknown interactions that 
persist also after successful digestion with thrombin. 
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Figure 7.18: A: Electropherogram of a GST-Lys sample digested with thrombin; 
Electrophoresis condition were the same as before, but the borate concentration was 40 mM; a, acetone 
(EOF marker); b, reduced glutathione; c, fused GST-Lys; d, GST. 8: Electropherogram of an undigested 
GST-Lys sample. Peak assignation is the same as before, but cis referred to the GST-Lys complex. 
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Analysis with PVA-coated capillary. Analyses with the coated capillary were 
performed at slightly acidic pHs. Under these analysis conditions, proteins were 
positively charged, but they did not adhere on the inner capillary wall because of the 
inert coating. The positive charge is greatly higher for Lys than for GST, therefore in 
normal polarity, given the reduced mass of Lys, this protein has far greater mobility 
than GST and should migrate faster through the capillary. Also exploiting these 
alternative CZE conditions it was impossible to separate the two proteins: digested and 
undigested GST-Lys showed one more time the same electropherogram, exhibiting 
only one large peak, while a pure GST protein standard eluted at slightly higher 
retention times (see Figure 7.19). However, without a negatively charged internai 
standard, we could not assign any numerica! mobility data to the eluted species. 
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Figure 7.19: Electropherograms of thrombin-digested GST-Lys (A) and standard GST (B). In 
diagram A, two peaks relative to GST-Lys complex and endogenous GST, eluting respectively at ca. 24 
and 25 min, are detectable. Undigested GST-Lys sample showed the same electrophoretic profile as A. 
CZE analysis was performed in a PV A-coated capillary (64 cm total length) and using 50 mM 
potassium phosphate (pH 6.0) as run buffer. Applied potential was 25 kV and detection wavelength set 
at 195 and 214 nm. 
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We tried to break the interaction existing between Lys and GST adding two 
disaccharides with similar structure to the natura! substrate of Lys, namely cellobiose 
(Glc,8(1,4)Glc) and N-acetyllactosamine (Gal,8(1,4)GlcNAc), to the run buffer. This 
affinity study could not be performed previously in borate buffer, because borate ions 
actually form stable complexes with polyols like saccharidic compounds and may 
"chelate" the structure hampering the interaction with the protein. 
No changes in mobility data were expected when the protein sample was 
injected in a steam of cellobiose-rich buffer, while analyzing the sample in buffer 
supplemented with N-acetyllactosamine a shift in retention times ofthe cleaved GST-
Lys sample was reasonable to be observed. In fact N-acetyllactosamine is a 
disaccharide having not only a ,8(1,4) glycosidic linkage between monomers but also a 
N-acetylglucosamine as glycosyl acceptor, similarly to the Lys substrate structure. 
However the resulting electropherograms could not be interpreted because during the 
analysis permanent modification of the inner capillary coating happened, as emerged 
from the appearance of a big negative peak at ca. 25 min (data not shown). 
Biosynthesis and purification of insolub/e His6-Lys. Despite the successful 
large-scale expression in IBs, refolding and purification of the fused GST-Lys, the 
recovery of only pure Lys turned out to be a difficult task. Therefore, as reported in 
this section, an alternative procedure was developed in order to obtain the protein of 
interest. 
The pET vector has been widely used to express many different types of 
heterologous proteins. Based on the virai T7 promoter-driven system, high expression 
levels of the cloned protein are guaranteed. The vector-encoded polyHis fusion tag, 
included in the pET2la+ sequence, can be exploited for simple purification of the 
recombinant protein, under native or denaturing conditions, using high affmity Ni-
NT A agarose chromatographic columns. Therefore we decided to choose this 
expression plasmid for cloning our lys DNA sequence and produce a C-terminai 
6xHis-tagged recombinant Lys in large amounts. The first expression trial was 
performed culturing transformed Rosetta 2 (DE3) E. coli bacteria in 200 mL Ii qui d 
medium. Also in this case, after induction with IPTG, temperature was lowered from 
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37 to 30°C, trying to decelerate protein synthesis and consequently reduce 
accumulation of recombinant protein in IBs. However, even though the bacterial strain 
efficiently produced the recombinant Hi%-Lys protein, it was almost totally expressed 
as IBs and collected as a pellet after centrifugation of the disrupted cells (see Figure 
7.20). 
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Figure 7.20: SDS-PAGE analysis of His6-Lys expressed in E.coli as IB. lnsoluble fractions 
from bacterial sonicates collected before (U) and after (l) induction (lh, 2h, 3h and 4h samples) are 
loaded on the gel. M stands for molecular weight protein marker. 
From the polyacrylamide gel in Figure 7.20 a band at ca. 14 kDa clearly 
appears after induction with IPTG with increasing intensity in function of 
postinduction time. Also basai expression of a ca. 45 kDa-sized protein could be 
observed. The soluble fraction of the bacterial lysate was also tested through SDS-
p AGE and did contain very small amounts of the fusion protein of interest (data not 
shown). The overexpressed recombinant 6xHis-tagged Lys, present in the form of 
inactive IBs, was first solubilized under denaturant conditions (8 M urea) then, after a 
capture step using immobilized metal affinity chromatography (IMAC), a graduai 
refolding of the protein was performed on-column, based upon an "artificial 
chaperone-assisted" method. The bound proteins on affinity column were exposed to a 
detergent wash to prevent misfolding then, a ,8-cyclodextrin solution loaded on the 
chromatographic system, removed the detergent and assisted correct folding (50). 
Similarly to L-Arg, low molecular weight additives such as surfactants and detergents 
bave proven to be efficient folding aids by reducing protein aggregation. One 
drawback in their use, however, is that they are difficult to remove, a direct result of 
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their ability to bind to proteins and to form micelles, but after exposing the protein to 
the detergent-containing solution, the stripping of the detergent with a buffer 
containing cyclodextrin, has been shown to promote refolding (50). Efficient stripping 
of the detergent is achieved by its intercalation into the cyclodextrin ring. This method 
has been claimed to mimic the GroEL-GroES chaperonin action in vivo and has been 
called "artificial chaperone-assisted refolding". The 6xHis-tagged Lys protein was 
finally eluted with ~ solution containing 300 mM imidazole and analyzed by SDS-
PAGE (see Figure 7.21) to check sample purity. Collected eluates were then tested by 
Bradford assay to calculate protein concentration. 
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Figure 7.21: SDS-PAGE analysis shows the purification of recombinant 6xHis-tagged Lys 
recovered from IB and refolded according to the artificial chaperone-assisted method. Lane l , molecular 
weight protein standards; lanes 2-4, flow-through from washing steps after loading the protein sample 
on the Ni-NTA agarose column; flow-through recovered after application ofrenaturation agents, such as 
Triton X-100 (lane 5), ,8-cyclodextrin (lane 6) and Tris-buffer (lane 7) to the column; lanes 8 and 9, 
fractions collected using 300 mM imidazole as eluent; lane 10, 20 ~J.g of affinity resin analyzed at the 
end ofthe chromatography. 
With great surprise, the HiS(;-Lys-containing protein samples recovered after 
affinity chromatography on Ni-NTA agarose resin, showed high degree of purity, as 
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could be observed from the SDS-PAGE analysis. Moreover, 0.8 mg of pure HiSt;-Lys 
were recovered from the 200 mL culture. Scaling up the biosynthesis, one could 
hypothesize to obtain a mean protein yield of ca. 4 mg/L culture, which is quite an 
achievement. Spot assay on the chromatographic eluates were then suddenly 
performed, but unfortunately no hydrolytic activity could be detected. 
The lack of lytic activity of the HiS6-Lys protein obtained from IBs can not be 
attributed to unsuccessful refolding because also the soluble fraction of crude celi 
sonicates contained inactive His6-Lys (data not shown). We suspect that the presence 
of the poly His tail at the polypeptidic C-terminus may alter the correct or native 
conformation of the Lys protein, hence influencing negatively also its biologica! 
activity. The pET2la+-/ys DNA construct we engineered did not contain any 
proteolytic cleavage sites between the polyHis and the lys DNA sequence, because we 
meant to synthesize and structurally characterize the whole HiSt;-Lys protein. However, 
it would be interesting to newly clone the lys fragment in a pET vector provided with a 
N-terminai hexa histidine-tag, followed (or not) by a suitable amino acid sequence that 
facilitates the removal ofthe ofthe polyHis tail using endoproteases. 
7.4 Conelusions 
Nowadays recombinant DNA techniques allow the large-scale and low-cost 
production of almost any imaginable protein. Proteins that are available only in minute 
amounts from natural sources can now be produced in huge quantities in host cells 
such as E. coli. Due to fast growth and easy handling, E. coli is the principal expression 
system of choice for most genomic projects. There is, however, one major problem 
associated with overexpression in E.coli: o:ften the desired polypeptide is synthesized 
in these host cells, but not in a soluble form. Instead of the active and correctly folded 
product, insoluble protein aggregates - inclusion bodies - are formed. There is 
therefore an increasingly pressing interest in the "protein refolding problem", because 
recombinant proteins for therapy, diagnosti es and basic research overproduced in 
genetically engineered cells in non-native forms require that the native conformation 
be achieved. There is no single in vitro refolding strategy, but some guidelines for the 
achievement of active and correctly folded materia! from high-density IBs were here 
addressed. Briefly, an overproduced protein is purified in IB form, the IBs are 
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solubilized with a chemical denaturant (typically guanidinium or urea), and refolding 
is attempted by removing the denaturant, via dilution or matrix-assisted refolding. 
H ere we compared two expression vectors, the pGEX and the pET -based 
system. Both release preferably the overexpressed recombinant Lys protein in IBs and 
protein renaturation seems to be always successful. The experimental procedures 
aimed at obtaining consistent amounts of pure Lys are scalable in both cases. The 
cleaved GST-Lys fusion protein yields an active product, while the HiS6-Lys adduct 
leads to high expression levels and optimal degree of purity of the target protein. 
However, neither of the two proteins was amenable to structural characterization 
studi es. 
7.5 Further studies 
Great effort was devoted to the large-scale expression and purification of the 
Lys protein, especially using the pGEX expression system. In fact, even if the GST-
Lys production in IB was satisfactory, the refolding protocol (based on rapid dilution) 
and the consequent concentration step, were really time-consuming. On the contrary, 
with the pET expession vector, taking advantage of the polyHis tag coupled to the 
recombinant Lys, refolding is assisted by an affinity matrix and the process of 
concentrating large volumes of protein samples is eliminated. Therefore, we would 
like to attempt a novel cloning of the lys sequence into a pET plasmid and express the 
Lys as N-terminai His6-tagged protein, because the purification and renaturation 
procedures on Ni-NTA agarose, can be simply performed on-column. 
The ultimate goal of the large-scale biosynthesis of the Hpylori lysozyme is to 
attempt various structural characterizations and to clarify its biochemical role in 
Hpylori pathogenesis. Knowledge of the three-dimensional structure of enzymes is 
necessary to develop eventual inhibitor models and pian therapeutic intervention, as, 
for example, the development of a non-invasive test for the diagnosis of Hpylori 
infection. Many methods are available today for the molecular structure 
characterization of proteins in solution, but very likely X-ray crystallography remains 
the chieftechnique for elucidating the structure ofbiopolymers and their complexes. 
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Concluding remarks 
The issues reported in these pages have been discussed from a glycobiological 
point ofview, i. e., investigating the role of carbohydrates not merely as energy source 
for sustaining life but chiefly as modulators of celi communication. Saccharides 
mediate severa! important cellular recognition events that basically start when an 
interaction between a sugar receptor and another molecule, usually a protein, takes 
piace. Therefore, the comprehension of the unique role of carbohydrates in biology 
calls for a structural study of saccharides, glycan interaction partners and their 
complexes. Efforts were here devoted to the development of suitable technical and 
methodological procedures for the detection, synthesis, and characterization of some 
oligosaccharide sequences, glycoproteins or sugar-binding proteins. 
The first problem we tried to sol ve concerned the UV -visible detection of 
monosaccharides for capillary electrophoresis analyses. The compositional 
monosaccharide determination of a hydrolized glycan sample is generally the first step 
in oligosaccharide mapping but is not always a straightforward task. Saccharides 
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indeed inherently lack chromophores and must be suitably derivatized prior to 
detection. Our study focused on the search of a labelling agent for monosaccharides 
commonly found in plant and mammalian glycoproteins, especially for N-acetylamino 
sugars, which are known to give poor derivatization yields. The results showed that, 
among frequently used tagging dyes, 2-aminobenzoic acid turned out to be the most 
efficient, offering high and comparable sensitivity at the CE UV -visible detector for ali 
saccharides tested. Choosing optimal CE running conditions, it was also possible to 
achieve proper separation of eleven 2-AA-labelled monosaccharides in a very short 
time frame. 
The derivatization procedure here developed, was very useful to monitor the 
presence of N-acetyllactosamine in various reaction mixtures through CE. This 
disaccharide, very commonly located at the outermost portion of celi surface 
oligosaccharides of glycoconjugates, was here obtained fr<;>m ,8-galactosidase-based 
synthesis, starting from p-nitrophenyl ,8-D-galactopyranoside as the glycosyl donor 
and N-acetylglucosamine as the acceptor. The study was aimed at improving 
transglycosylation yields and allow the recovery and reuse of the enzyme through 
immobilization of ,8-galactosidase on soli d polymers bearing epoxy (Eupergit®) or 
amino (Sepabeads) functionalities. Kinetic analysis revealed that the immobilization 
procedure did not suppress enzyme activity and that the production of LacNAc 
strongly depends on the type of supporting matrix chosen for enzyme anchoring. 
Maximum LacNAc molar yield (64%) was obtained using Eupergit® as solid carrier. 
An interesting glycan analysis was performed on the saccharidic portion of 
recombinant beta-glucocerebrosidase, produced from transgenic tobacco seeds. Prior 
to the delivery to humans, the structure of this therapeutic glycoprotein must be first 
thoroughly characterized. The glycosylation pattern of the protein expressed in plant 
should reflect that of the human placenta! glucocerebrosidase, so that correct folding 
and proper biologica} activity are guaranteed. Treatment with trifluoroacetic acid led to 
exhaustive hydrolysis of the glycan moiety. From CE analysis of the released 
monosaccharides, no GalNAc could be detected, suggesting the complete absence of 
0-glycans. No signal for immunogenic Fuc or Xyl, frequent sugar residues found in 
plant glycoproteins, was observed. From the quantitative analysis of the remaining 
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saccharidic spec1es, the Iikeiy mannose-terminating paucimannosidic as well as 
GicNAc-rich muitiantennary compiex type N-glycan structures could be predicted. 
An alternative procedure for giycan mapping was appiied to bovine fetuin, 
chosen as modei of a heavily glycosylated protein. This study was indirectiy addressed 
to the glycoproteomic analysis of membrane-bound proteins differently expressed in a 
healthy and hepatoma celi line, trying to determine alterations of glycan expression. 
Fetuin was first enzimatically deglycosyiated (using PNGase F) according to a in-
solution or in-gel method and the resulting hydrolizate was analyzed through LC-MS. 
A biantennary and two triantennary oligosaccharide structures, pertaining to the N-
glycosyiation pro file of the protein, couid be finaliy assigned. 
The Iarge-scale biosynthesis and purification of a sugar-binding protein, the 
Helicobacter pylori Iysozyme (Lys), was deveioped expioiting two alternative 
expression systems, the pGEX and pET vectors, in order to attempt its structural 
charactf 1zation and clarify the role of the protein in Hpylori autoiysis, which seems 
to be ~. fundamental process in gastric coionization of the bacterium. The former pGEX 
piasmid yieided Lys as fusion protein with giutathione S-transferase (GST) which was 
pr ..>duced preferentialiy as inclusion body in E. coli host cells, especialiy when scaling-
up the culture voiumes. The protein was isoiated from insoiubie celi pellet, soiubilized 
and successfuliy refolded according to the rapid dilution method. Protein renaturation 
was confirmed also from positive Iytic activity test performed on thrombin-cleaved 
GST-Lys sampies. However, after purification and digestion with protease to remove 
the GST fusion tag from the Lys protein, separation could not be achieved. Binding 
studies performed through affinophoresis on these sampies dìd not provide any 
evidence on the affinity ofthe Lys fora disaccharide (LacNAc) mimicking the natura! 
sugar substrate, i.e., a portion of the peptidoglycan layer of bacterial celi walls. 
Therefore, the latter p ET vector was chosen for an alternative cloning strategy. The 
system expressed the Lys with a C-terminai 6xHis-tag. Also in this case the protein 
was almost totally expressed in the insoluble fraction of the celi lysate, but refolding 
through matrix-assisted technique, directly on Ni-NT A agarose affinity coiumn, 
yieided highly pure protein samples. Unfortunately they were inactive against 
M lysodeiticus suspensions. 
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